{"id":746,"date":"2026-07-27T17:21:19","date_gmt":"2026-07-27T15:21:19","guid":{"rendered":"https:\/\/coati-x.com\/?page_id=746"},"modified":"2026-07-28T14:10:42","modified_gmt":"2026-07-28T12:10:42","slug":"market-intelligence-dashboard","status":"publish","type":"page","link":"https:\/\/coati-x.com\/index.php\/market-intelligence-dashboard\/","title":{"rendered":"Market Intelligence Dashboard"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"746\" class=\"elementor elementor-746\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4d5d91b e-con-full e-flex e-con e-parent\" data-id=\"4d5d91b\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a3eba4a elementor-widget__width-inherit elementor-widget elementor-widget-html\" data-id=\"a3eba4a\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<meta name=\"robots\" content=\"noindex, nofollow\">\n<link rel=\"preconnect\" href=\"https:\/\/fonts.googleapis.com\">\n<link rel=\"preconnect\" href=\"https:\/\/fonts.gstatic.com\" crossorigin>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Poppins:wght@300;400;500;600;700;800&display=swap\" rel=\"stylesheet\">\n<style>\n\n:root{\n  --brand-red:#B51826;\n  --brand-burgundy:#65121F;\n  --brand-black:#161617;\n  --brand-white:#FFFFFF;\n  --text:#161617;\n  --muted:rgba(22,22,23,.66);\n  --line:rgba(22,22,23,.13);\n  --line-red:rgba(181,24,38,.24);\n  --surface:#FFFFFF;\n  --shadow:0 18px 44px rgba(22,22,23,.10);\n  --shadow-strong:0 24px 64px rgba(22,22,23,.16);\n  --radius:12px;\n}\n*{box-sizing:border-box}\nhtml{scroll-behavior:smooth;scroll-padding-top:148px}\nbody{\n  margin:0;min-height:100vh;color:var(--text);background:var(--brand-white);\n  font-family:'Poppins',sans-serif;font-size:16px;line-height:1.55;\n  -webkit-font-smoothing:antialiased;text-rendering:optimizeLegibility;\n}\nbutton,input,select,textarea,table{font-family:'Poppins',sans-serif}\na{color:inherit}\n::selection{background:var(--brand-red);color:var(--brand-white)}\n::-webkit-scrollbar{width:10px;height:10px}\n::-webkit-scrollbar-track{background:rgba(22,22,23,.06)}\n::-webkit-scrollbar-thumb{background:var(--brand-burgundy);border:2px solid var(--brand-white);border-radius:999px}\n.coati-navbar{position:sticky;top:0;z-index:60;background:var(--brand-red);box-shadow:0 8px 26px rgba(22,22,23,.18);width:100%;display:block}\n.nav-inner{max-width:1540px;height:82px;margin:auto;padding:0 30px;display:flex;align-items:center;gap:24px}\n.brand-lockup{display:flex;align-items:center;text-decoration:none;flex:0 0 auto}\n.coati-logo{display:block;height:auto;overflow:visible}\n.logo-white{width:178px;color:var(--brand-white)}\n.logo-color{width:160px}\n.product-label{padding-left:24px;border-left:1px solid rgba(255,255,255,.55);color:var(--brand-white);font-size:12px;font-weight:500;letter-spacing:.08em;text-transform:uppercase;white-space:nowrap}\n.navlinks{display:flex;align-items:center;gap:24px;margin-left:auto}\n.navlinks a{position:relative;color:var(--brand-white);text-decoration:none;font-size:13px;font-weight:500;padding:10px 0}\n.navlinks a:after{content:\"\";position:absolute;left:0;right:100%;bottom:4px;height:2px;background:var(--brand-white);transition:right .2s ease}\n.navlinks a:hover:after,.navlinks a:focus-visible:after{right:0}\n.hero{position:relative;overflow:hidden;background:linear-gradient(112deg,var(--brand-burgundy) 0%,var(--brand-black) 76%);color:var(--brand-white)}\n.hero:before,.hero:after{content:\"\";position:absolute;border:1px solid rgba(255,255,255,.13);border-radius:50%;pointer-events:none}\n.hero:before{width:680px;height:680px;right:-250px;top:-300px}\n.hero:after{width:410px;height:410px;left:-185px;bottom:-230px;border-color:rgba(181,24,38,.60)}\n.hero-inner{position:relative;z-index:1;max-width:1540px;min-height:570px;margin:auto;padding:76px 30px 68px;display:grid;grid-template-columns:minmax(0,1.16fr) minmax(390px,.84fr);gap:64px;align-items:center}\n.eyebrow{display:inline-flex;align-items:center;gap:10px;color:var(--brand-white);font-size:12px;font-weight:600;letter-spacing:.10em;text-transform:uppercase}\n.eyebrow:before{content:\"\";width:42px;height:2px;background:var(--brand-red)}\n.eyebrow i{display:none}\nh1{max-width:900px;margin:24px 0 24px;font-size:clamp(48px,5.8vw,86px);line-height:.98;letter-spacing:-.045em;font-weight:700;text-wrap:balance}\nh1 em{font-style:normal;color:var(--brand-white);text-decoration:underline;text-decoration-color:var(--brand-red);text-decoration-thickness:7px;text-underline-offset:10px}\n.lead{max-width:790px;margin:0;color:rgba(255,255,255,.82);font-size:18px;line-height:1.72;text-align:left}\n.hero-actions{display:flex;gap:14px;flex-wrap:wrap;margin-top:32px}\n.btn{display:inline-flex;align-items:center;justify-content:center;min-height:48px;padding:12px 20px;border:1px solid transparent;border-radius:5px;font-size:14px;font-weight:600;text-decoration:none;cursor:pointer;transition:transform .18s ease,background .18s ease,color .18s ease}\n.btn:hover{transform:translateY(-1px)}\n.btn.primary{background:var(--brand-red);color:var(--brand-white);border-color:var(--brand-red)}\n.btn.primary:hover{background:var(--brand-white);color:var(--brand-burgundy);border-color:var(--brand-white)}\n.btn.ghost{background:transparent;color:var(--brand-white);border-color:rgba(255,255,255,.72)}\n.btn.ghost:hover{background:var(--brand-white);color:var(--brand-black)}\n.orbit{height:430px;position:relative;display:grid;place-items:center}\n.orbit:before,.orbit:after{content:\"\";position:absolute;border-radius:50%;border:1px solid rgba(255,255,255,.25)}\n.orbit:before{width:300px;height:300px}\n.orbit:after{width:390px;height:390px;border-color:rgba(181,24,38,.85)}\n.core{width:184px;height:184px;border-radius:50%;position:relative;display:grid;place-items:center;background:var(--brand-red);border:16px solid var(--brand-burgundy);box-shadow:0 0 0 1px rgba(255,255,255,.52),0 0 0 30px rgba(181,24,38,.16)}\n.core:before{content:\"\";position:absolute;width:76px;height:76px;border-radius:50%;border:1px solid var(--brand-white);left:26px;top:28px;box-shadow:44px 18px 0 -1px var(--brand-red),44px 18px 0 0 var(--brand-white)}\n.core:after{content:\"EVIDENCE\\A LANDSCAPE\";white-space:pre;text-align:center;position:relative;z-index:2;color:var(--brand-white);font-size:11px;font-weight:700;letter-spacing:.12em;line-height:1.55;margin-top:74px}\n.node{position:absolute;min-width:154px;padding:14px 16px;background:var(--brand-white);color:var(--brand-black);border-left:5px solid var(--brand-red);box-shadow:var(--shadow-strong);font-size:12px;line-height:1.35}\n.node b{display:block;color:var(--brand-burgundy);font-size:26px;line-height:1;margin-bottom:5px;font-weight:700}\n.n1{top:20px;left:8px}.n2{top:54px;right:0}.n3{bottom:50px;left:0}.n4{right:26px;bottom:13px}\n.dashboard-shell{max-width:1540px;margin:auto;padding:0 30px 64px}\n.analytics-section{padding:64px 0 10px;scroll-margin-top:130px}\n.analytics-section + .analytics-section{margin-top:18px}\n.section-head{display:grid;grid-template-columns:minmax(260px,.72fr) minmax(360px,1.28fr);gap:42px;align-items:end;margin:0 0 24px;padding-left:18px;border-left:6px solid var(--brand-red)}\n.section-head h2{margin:0;color:var(--brand-black);font-size:clamp(30px,3vw,45px);line-height:1.05;letter-spacing:-.03em;font-weight:700}\n.section-head p{margin:0;color:var(--muted);font-size:15px;line-height:1.7;text-align:left}\n.filters{position:sticky;top:96px;z-index:35;display:grid;grid-template-columns:repeat(6,minmax(135px,1fr));gap:10px;padding:16px;background:var(--brand-white);border:1px solid var(--line);border-top:5px solid var(--brand-red);box-shadow:var(--shadow);border-radius:var(--radius)}\n.filter label{display:block;margin:0 0 7px;color:var(--brand-burgundy);font-size:12px;font-weight:600;letter-spacing:.05em;text-transform:uppercase}\nselect,.search{width:100%;min-height:44px;padding:10px 12px;background:var(--brand-white);color:var(--brand-black);border:1px solid rgba(22,22,23,.24);border-radius:5px;font-size:13px;outline:none}\nselect:focus,.search:focus{border-color:var(--brand-red);box-shadow:0 0 0 3px rgba(181,24,38,.12)}\n.kpis{display:grid;grid-template-columns:repeat(6,1fr);gap:12px;margin:18px 0 16px}\n.card{background:var(--brand-white);border:1px solid var(--line);border-radius:var(--radius);box-shadow:var(--shadow)}\n.kpi{position:relative;overflow:hidden;min-height:148px;padding:20px 18px 18px;border-top:5px solid var(--brand-red)}\n.kpi:after{content:\"\";position:absolute;width:86px;height:86px;right:-28px;bottom:-30px;border-radius:50%;background:var(--glow,rgba(181,24,38,.18))}\n.kpi small{position:relative;z-index:1;color:var(--brand-burgundy);font-size:11px;font-weight:600;letter-spacing:.07em;text-transform:uppercase}\n.kpi strong{position:relative;z-index:1;display:block;margin:13px 0 5px;color:var(--brand-black);font-size:34px;line-height:1;font-weight:700;letter-spacing:-.035em}\n.kpi span{position:relative;z-index:1;color:var(--muted);font-size:12px}\n.grid2{display:grid;grid-template-columns:1.16fr .84fr;gap:16px;margin-top:16px}\n.grid3{display:grid;grid-template-columns:repeat(3,1fr);gap:16px;margin-top:16px}\n.panel{min-height:350px;padding:24px;border-top:5px solid var(--brand-burgundy)}\n.panel h3,.table-top h3{margin:0;color:var(--brand-black);font-size:18px;font-weight:700}\n.sub{margin:5px 0 20px;color:var(--muted);font-size:13px}\n.chart{display:flex;flex-direction:column;gap:12px}\n.bar-row{display:grid;grid-template-columns:minmax(150px,1.4fr) 3fr 52px;gap:12px;align-items:center;font-size:13px}\n.bar-label{overflow:hidden;color:var(--brand-black);white-space:nowrap;text-overflow:ellipsis}\n.bar-track{height:10px;overflow:hidden;background:rgba(101,18,31,.12);border-radius:999px}\n.bar-fill{height:100%;border-radius:999px;background:linear-gradient(90deg,var(--brand-burgundy),var(--brand-red))}\n.bar-value{text-align:right;color:var(--brand-burgundy);font-weight:600}\n.donut-wrap{display:grid;grid-template-columns:200px 1fr;gap:18px;align-items:center}\n.donut{width:188px;height:188px;position:relative;display:grid;place-items:center;border-radius:50%}\n.donut:after{content:\"\";position:absolute;width:122px;height:122px;border-radius:50%;background:var(--brand-white);box-shadow:inset 0 0 0 1px var(--line)}\n.donut div{position:relative;z-index:1;text-align:center}.donut b{display:block;color:var(--brand-burgundy);font-size:30px;line-height:1;font-weight:700}.donut span{display:block;margin-top:6px;color:var(--muted);font-size:10px;line-height:1.35}\n.signal-list{display:flex;flex-direction:column;gap:10px}\n.signal{display:grid;grid-template-columns:36px minmax(0,1fr) auto;gap:12px;align-items:center;padding:13px 14px;background:rgba(181,24,38,.045);border:1px solid rgba(181,24,38,.16);border-radius:7px}\n.rank{width:32px;height:32px;display:grid;place-items:center;border-radius:50%;background:var(--brand-red);color:var(--brand-white);font-size:12px;font-weight:700}\n.signal b{display:block;color:var(--brand-black);font-size:13px;font-weight:600}.signal small{display:block;margin-top:3px;color:var(--muted);font-size:11px}\n.pill{padding:6px 8px;border:1px solid var(--brand-red);border-radius:999px;color:var(--brand-burgundy);background:var(--brand-white);font-size:10px;font-weight:600;white-space:nowrap}\n.matrix{display:grid;gap:7px;overflow:auto;padding-bottom:4px}.matrix-row{display:grid;grid-template-columns:170px repeat(6,minmax(58px,1fr));gap:6px;align-items:center;min-width:780px}.matrix-row>span:first-child{overflow:hidden;color:var(--brand-black);font-size:12px;white-space:nowrap;text-overflow:ellipsis}.cell{height:38px;display:grid;place-items:center;border-radius:4px;border:1px solid rgba(101,18,31,.12);font-size:11px;font-weight:600}\n.table-card{margin-top:16px;overflow:hidden;border-top:5px solid var(--brand-red)}\n.table-top{display:flex;gap:18px;align-items:center;justify-content:space-between;padding:19px 22px;border-bottom:1px solid var(--line)}\n.table-top .search{max-width:390px}\n.table-wrap{max-height:590px;overflow:auto}\ntable{width:100%;min-width:1280px;border-collapse:collapse}\nth{position:sticky;top:0;z-index:2;padding:13px 12px;background:var(--brand-burgundy);color:var(--brand-white);border-bottom:1px solid var(--brand-burgundy);font-size:11px;font-weight:600;letter-spacing:.05em;text-align:left;text-transform:uppercase}\ntd{padding:13px 12px;color:var(--brand-black);border-bottom:1px solid rgba(22,22,23,.09);font-size:12px;line-height:1.5;vertical-align:top}tbody tr:nth-child(even) td{background:rgba(181,24,38,.025)}tbody tr:hover td{background:rgba(181,24,38,.07)}td strong{color:var(--brand-burgundy);font-weight:600}.tag{display:inline-block;padding:5px 7px;background:rgba(181,24,38,.08);color:var(--brand-burgundy);border:1px solid rgba(181,24,38,.20);border-radius:4px;font-size:10px;font-weight:500}.score{font-weight:700}.score.hi{color:var(--brand-red)}.score.mid{color:var(--brand-burgundy)}.score.lo{color:var(--brand-black)}\n.empty{padding:48px 16px;color:var(--muted);font-size:14px;text-align:center}\n.site-footer{margin-top:70px;background:var(--brand-white);border-top:1px solid var(--line)}\n.footer-inner{max-width:1540px;margin:auto;padding:30px;display:grid;grid-template-columns:auto 1fr;gap:34px;align-items:center}\n.footer-copy{padding-left:34px;border-left:1px solid var(--line)}\n.footer-copy strong{display:block;color:var(--brand-black);font-size:14px;font-weight:600}.footer-copy span{display:block;margin-top:4px;color:var(--muted);font-size:12px;line-height:1.6}\n@media(max-width:1180px){.product-label{display:none}.filters{grid-template-columns:repeat(3,1fr)}.kpis{grid-template-columns:repeat(3,1fr)}.grid2,.grid3{grid-template-columns:1fr}.hero-inner{grid-template-columns:1fr}.orbit{max-width:620px;width:100%;margin:0 auto}.section-head{grid-template-columns:1fr;gap:10px}.panel{min-height:0}}\n@media(max-width:760px){html{scroll-padding-top:100px}.coati-navbar{position:relative}.nav-inner{height:auto;min-height:78px;padding:14px 18px;flex-wrap:wrap}.logo-white{width:150px}.navlinks{width:100%;order:3;margin:0;gap:18px;overflow-x:auto;padding-top:2px}.navlinks a{font-size:12px;white-space:nowrap}.hero-inner{min-height:0;padding:58px 18px 48px}.hero{overflow:hidden}h1{font-size:clamp(42px,13vw,62px)}h1 em{text-decoration-thickness:5px}.lead{font-size:16px}.orbit{height:auto;display:grid;grid-template-columns:1fr 1fr;gap:10px;margin-top:10px}.orbit:before,.orbit:after,.core{display:none}.node{position:static;min-width:0}.dashboard-shell{padding:0 18px 40px}.analytics-section{padding-top:48px}.filters{position:static;grid-template-columns:1fr 1fr}.kpis{grid-template-columns:1fr 1fr}.section-head{padding-left:14px}.section-head h2{font-size:32px}.bar-row{grid-template-columns:minmax(120px,1.2fr) 2fr 42px}.donut-wrap{grid-template-columns:1fr}.donut{margin:auto}.table-top{align-items:stretch;flex-direction:column}.table-top .search{max-width:none}.footer-inner{grid-template-columns:1fr;padding:28px 18px}.footer-copy{padding:18px 0 0;border-left:0;border-top:1px solid var(--line)}}\n@media(max-width:480px){.filters,.kpis{grid-template-columns:1fr}.hero-actions{flex-direction:column}.btn{width:100%}.navlinks{gap:15px}.grid2,.grid3{gap:12px}.panel{padding:19px}.bar-row{grid-template-columns:112px 1fr 38px;gap:8px;font-size:11px}}\n\n.coati-credit-bar{background:var(--brand-red);width:100%;display:block;}.coati-credit-inner{max-width:1540px;margin:auto;padding:18px 30px;text-align:center;color:var(--brand-white);font-size:14px;line-height:1.6;font-family:var(--ff);font-weight:400;}.coati-credit-inner a{color:var(--brand-white);text-decoration:underline;font-weight:600;}.coati-credit-inner a:hover{opacity:0.8;}\n\n<\/style>\n\n<header class=\"coati-navbar\">\n  <div class=\"nav-inner\">\n    <a class=\"brand-lockup\" href=\"#top\" aria-label=\"Coati-X dashboard home\"><svg class=\"coati-logo logo-white\" viewBox=\"0 0 533 98\" preserveAspectRatio=\"xMinYMid meet\" role=\"img\" aria-label=\"Coati-X\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 119.183594 78.980469 C 111.605469 71.398438 107.8125 61.800781 107.8125 50.1875 C 107.8125 38.574219 111.605469 28.976562 119.183594 21.394531 C 126.765625 13.816406 136.289062 10.023438 147.753906 10.023438 C 153.820312 10.023438 159.441406 11.207031 164.621094 13.574219 C 169.796875 15.941406 174.140625 19.308594 177.65625 23.671875 C 181.167969 28.035156 183.589844 33.101562 184.921875 38.871094 L 172.050781 38.871094 C 170.203125 33.691406 167.132812 29.644531 162.84375 26.722656 C 158.554688 23.800781 153.523438 22.339844 147.753906 22.339844 C 139.988281 22.339844 133.554688 24.964844 128.449219 30.21875 C 123.347656 35.46875 120.792969 42.144531 120.792969 50.242188 C 120.792969 58.34375 123.347656 65 128.449219 70.214844 C 133.554688 75.429688 139.988281 78.035156 147.753906 78.035156 C 153.671875 78.035156 158.8125 76.464844 163.175781 73.320312 C 167.539062 70.175781 170.574219 65.867188 172.273438 60.394531 L 185.257812 60.394531 C 183.257812 69.492188 178.859375 76.761719 172.050781 82.195312 C 165.246094 87.632812 157.148438 90.351562 147.753906 90.351562 C 136.289062 90.351562 126.765625 86.5625 119.183594 78.980469 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 235.296875 76.207031 C 238.257812 74.542969 240.566406 72.210938 242.234375 69.214844 C 243.894531 66.222656 244.730469 62.835938 244.730469 59.0625 C 244.730469 53.367188 242.898438 48.671875 239.238281 44.972656 C 235.574219 41.273438 230.898438 39.425781 225.199219 39.425781 C 219.507812 39.425781 214.828125 41.273438 211.167969 44.972656 C 207.503906 48.671875 205.675781 53.367188 205.675781 59.0625 C 205.675781 64.761719 207.503906 69.457031 211.167969 73.15625 C 214.828125 76.851562 219.507812 78.703125 225.199219 78.703125 C 228.972656 78.703125 232.339844 77.871094 235.296875 76.207031 M 202.292969 81.53125 C 196.1875 75.578125 193.136719 68.089844 193.136719 59.0625 C 193.136719 53.148438 194.523438 47.785156 197.296875 42.976562 C 200.070312 38.167969 203.917969 34.414062 208.835938 31.714844 C 213.753906 29.015625 219.210938 27.664062 225.199219 27.664062 C 231.191406 27.664062 236.648438 29.015625 241.566406 31.714844 C 246.484375 34.414062 250.332031 38.167969 253.105469 42.976562 C 255.878906 47.785156 257.265625 53.148438 257.265625 59.0625 C 257.265625 68.089844 254.214844 75.578125 248.113281 81.53125 C 242.011719 87.484375 234.375 90.460938 225.199219 90.460938 C 216.027344 90.460938 208.394531 87.484375 202.292969 81.53125 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 312.132812 73.097656 C 315.796875 69.363281 317.625 64.667969 317.625 59.007812 C 317.625 53.351562 315.796875 48.671875 312.132812 44.972656 C 308.472656 41.273438 303.792969 39.425781 298.097656 39.425781 C 294.398438 39.425781 291.054688 40.277344 288.058594 41.976562 C 285.0625 43.679688 282.714844 46.027344 281.011719 49.023438 C 279.3125 52.019531 278.460938 55.363281 278.460938 59.0625 C 278.460938 64.683594 280.328125 69.363281 284.0625 73.097656 C 287.796875 76.835938 292.496094 78.703125 298.15625 78.703125 C 303.8125 78.703125 308.472656 76.835938 312.132812 73.097656 M 330.050781 29.105469 L 330.050781 89.019531 L 320.066406 89.019531 L 318.847656 81.699219 C 313.078125 87.542969 305.867188 90.464844 297.210938 90.464844 C 288.261719 90.464844 280.808594 87.46875 274.855469 81.476562 C 268.902344 75.484375 265.921875 67.996094 265.921875 59.007812 C 265.921875 50.019531 268.902344 42.550781 274.855469 36.597656 C 280.808594 30.640625 288.261719 27.664062 297.210938 27.664062 C 306.011719 27.664062 313.296875 30.625 319.070312 36.542969 L 320.511719 29.105469 Z M 330.050781 29.105469 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 381.09375 77.816406 L 381.09375 89.019531 L 371.996094 89.019531 C 367.632812 89.019531 363.859375 88.171875 360.679688 86.46875 C 357.496094 84.765625 355.058594 82.308594 353.355469 79.089844 C 351.65625 75.875 350.804688 72.082031 350.804688 67.71875 L 350.804688 39.648438 L 340.042969 39.648438 L 340.042969 37.316406 L 360.902344 15.128906 L 363.007812 15.128906 L 363.007812 29.105469 L 380.761719 29.105469 L 380.761719 39.648438 L 363.121094 39.648438 L 363.121094 66.71875 C 363.121094 70.269531 364.082031 73.007812 366.003906 74.929688 C 367.925781 76.851562 370.703125 77.816406 374.324219 77.816406 Z M 381.09375 77.816406 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 393.078125 29.105469 L 405.394531 29.105469 L 405.394531 89.019531 L 393.078125 89.019531 Z M 392.855469 7.140625 L 405.613281 7.140625 L 405.613281 19.789062 L 392.855469 19.789062 Z M 392.855469 7.140625 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 421.480469 51.964844 L 457.097656 51.964844 L 457.097656 63.945312 L 421.480469 63.945312 Z M 421.480469 51.964844 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 512.351562 89.019531 L 493.492188 58.730469 L 474.628906 89.019531 L 460.316406 89.019531 L 485.726562 48.300781 L 462.089844 11.355469 L 476.402344 11.355469 L 493.492188 38.648438 L 510.464844 11.355469 L 524.667969 11.355469 L 501.257812 48.746094 L 526.664062 89.019531 Z M 512.351562 89.019531 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 17.335938 69.878906 C 25.332031 79.089844 43.609375 91.117188 57.457031 87.683594 C 61.183594 86.753906 64.125 83.820312 65.957031 79.1875 C 69.9375 69.136719 67.890625 53.867188 63.402344 46.925781 C 61.804688 44.457031 59.820312 42.21875 57.5 40.28125 C 48.226562 32.527344 35.871094 29.902344 26.011719 33.589844 C 25.996094 33.59375 25.984375 33.601562 25.96875 33.605469 C 15.070312 37.703125 8.371094 50.214844 11.628906 60.378906 C 12.613281 63.441406 14.480469 66.550781 17.335938 69.878906 M 58.984375 88.414062 C 58.578125 88.566406 58.160156 88.695312 57.730469 88.800781 C 43.417969 92.351562 24.644531 80.058594 16.464844 70.632812 L 16.460938 70.628906 C 13.503906 67.183594 11.5625 63.945312 10.535156 60.730469 C 7.097656 50.011719 14.121094 36.832031 25.5625 32.527344 C 25.578125 32.523438 25.59375 32.515625 25.609375 32.511719 C 35.851562 28.679688 48.652344 31.378906 58.238281 39.398438 C 60.648438 41.414062 62.710938 43.734375 64.367188 46.300781 C 69.019531 53.488281 71.253906 68.9375 67.027344 79.609375 C 65.257812 84.085938 62.492188 87.101562 58.984375 88.414062 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 17.902344 69.390625 C 25.777344 78.460938 43.738281 90.320312 57.273438 86.953125 C 60.757812 86.089844 63.519531 83.304688 65.261719 78.910156 C 69.15625 69.066406 67.160156 54.121094 62.773438 47.332031 C 61.21875 44.925781 59.28125 42.746094 57.019531 40.855469 C 47.953125 33.273438 35.886719 30.699219 26.273438 34.292969 C 15.691406 38.273438 9.199219 50.347656 12.34375 60.148438 C 13.296875 63.117188 15.113281 66.136719 17.902344 69.390625 M 52.421875 90.171875 C 38.820312 90.171875 23.195312 79.53125 15.898438 71.125 C 12.867188 67.59375 10.878906 64.269531 9.820312 60.957031 C 6.265625 49.878906 13.5 36.265625 25.300781 31.828125 C 35.835938 27.886719 48.933594 30.636719 58.71875 38.820312 C 61.1875 40.886719 63.300781 43.265625 65 45.894531 C 69.746094 53.234375 72.035156 69 67.726562 79.886719 C 65.886719 84.539062 62.953125 87.730469 59.25 89.117188 C 58.808594 89.28125 58.359375 89.417969 57.910156 89.53125 C 56.140625 89.96875 54.296875 90.171875 52.421875 90.171875 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 46.230469 16.152344 C 36.378906 19.835938 29.136719 30.859375 27.769531 44.253906 C 27.425781 47.613281 27.539062 51.003906 28.105469 54.324219 C 29.8125 64.335938 40.316406 80.574219 50.808594 85.722656 C 54.757812 87.660156 58.265625 87.84375 61.226562 86.261719 C 73.835938 79.546875 78.824219 56.023438 78.226562 42.238281 C 77.984375 37.269531 77.164062 33.1875 75.71875 29.761719 C 70.945312 18.449219 57.1875 12.082031 46.273438 16.136719 C 46.257812 16.140625 46.242188 16.148438 46.230469 16.152344 M 60.527344 87.839844 C 57.503906 88.96875 54.074219 88.609375 50.300781 86.753906 C 39.335938 81.375 28.757812 65.007812 26.96875 54.515625 C 26.386719 51.09375 26.269531 47.601562 26.625 44.136719 C 28.035156 30.3125 35.570312 18.910156 45.828125 15.074219 C 45.84375 15.070312 45.855469 15.0625 45.871094 15.058594 C 57.335938 10.800781 71.777344 17.460938 76.78125 29.316406 C 78.277344 32.867188 79.128906 37.078125 79.375 42.183594 C 79.988281 56.261719 74.816406 80.328125 61.769531 87.28125 C 61.363281 87.496094 60.949219 87.683594 60.527344 87.839844 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 46.09375 15.777344 L 46.230469 16.152344 L 46.105469 15.769531 C 46.101562 15.773438 46.097656 15.773438 46.09375 15.777344 M 46.230469 16.152344 L 46.492188 16.855469 C 36.910156 20.441406 29.855469 31.222656 28.515625 44.328125 C 28.179688 47.625 28.289062 50.945312 28.84375 54.195312 C 30.523438 64.039062 40.839844 79.996094 51.136719 85.046875 C 54.859375 86.875 58.136719 87.0625 60.875 85.601562 C 73.199219 79.035156 78.066406 55.863281 77.476562 42.273438 C 77.238281 37.394531 76.441406 33.398438 75.03125 30.054688 C 70.402344 19.09375 57.089844 12.917969 46.535156 16.839844 Z M 56.925781 89.234375 C 54.742188 89.234375 52.417969 88.628906 49.96875 87.425781 C 38.816406 81.953125 28.050781 65.308594 26.230469 54.640625 C 25.636719 51.152344 25.519531 47.589844 25.878906 44.058594 C 27.320312 29.960938 35.042969 18.304688 45.5625 14.371094 C 57.429688 9.960938 72.320312 16.816406 77.472656 29.027344 C 79.003906 32.660156 79.871094 36.949219 80.125 42.148438 C 80.746094 56.417969 75.453125 80.839844 62.121094 87.941406 C 61.6875 88.171875 61.238281 88.375 60.789062 88.542969 C 59.558594 89.003906 58.269531 89.234375 56.925781 89.234375 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 17.355469 33.902344 C 11.355469 36.144531 8.296875 42.851562 10.542969 48.851562 C 12.785156 54.851562 19.492188 57.90625 25.492188 55.664062 C 31.492188 53.421875 34.546875 46.714844 32.304688 40.710938 C 30.058594 34.714844 23.351562 31.65625 17.355469 33.902344 M 25.894531 56.742188 C 19.300781 59.207031 11.929688 55.847656 9.464844 49.253906 C 6.996094 42.660156 10.355469 35.289062 16.953125 32.824219 C 23.546875 30.355469 30.917969 33.714844 33.382812 40.308594 C 35.847656 46.902344 32.492188 54.273438 25.894531 56.742188 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 17.617188 34.605469 C 12.003906 36.703125 9.144531 42.976562 11.242188 48.589844 C 12.261719 51.304688 14.273438 53.460938 16.917969 54.667969 C 19.566406 55.871094 22.515625 55.976562 25.230469 54.960938 C 30.84375 52.863281 33.699219 46.589844 31.601562 40.976562 C 29.503906 35.363281 23.230469 32.503906 17.617188 34.605469 M 21.429688 58.304688 C 19.519531 58.304688 17.613281 57.894531 15.820312 57.078125 C 12.53125 55.578125 10.023438 52.894531 8.761719 49.519531 C 7.496094 46.140625 7.628906 42.46875 9.125 39.179688 C 10.625 35.890625 13.3125 33.382812 16.6875 32.121094 C 20.066406 30.859375 23.738281 30.988281 27.027344 32.484375 C 30.316406 33.984375 32.820312 36.671875 34.085938 40.046875 C 36.695312 47.027344 33.140625 54.832031 26.160156 57.445312 C 24.621094 58.019531 23.023438 58.304688 21.429688 58.304688 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 35.710938 10.464844 C 26.773438 13.808594 22.21875 23.800781 25.5625 32.734375 C 28.90625 41.675781 38.894531 46.226562 47.835938 42.882812 C 56.773438 39.539062 61.324219 29.550781 57.980469 20.613281 C 54.640625 11.675781 44.648438 7.121094 35.710938 10.464844 M 48.238281 43.960938 C 38.703125 47.527344 28.050781 42.671875 24.484375 33.140625 C 20.917969 23.609375 25.773438 12.953125 35.308594 9.386719 C 44.839844 5.824219 55.492188 10.675781 59.058594 20.207031 C 62.625 29.742188 57.769531 40.398438 48.238281 43.960938 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 41.765625 10.113281 C 39.8125 10.113281 37.855469 10.464844 35.972656 11.167969 C 31.835938 12.714844 28.546875 15.785156 26.714844 19.8125 C 24.878906 23.84375 24.71875 28.339844 26.265625 32.472656 C 29.460938 41.023438 39.019531 45.378906 47.570312 42.179688 C 51.707031 40.632812 54.992188 37.5625 56.828125 33.535156 C 58.664062 29.507812 58.824219 25.007812 57.277344 20.875 C 55.730469 16.738281 52.660156 13.453125 48.632812 11.617188 C 46.4375 10.617188 44.105469 10.113281 41.765625 10.113281 M 41.792969 45.882812 C 34.007812 45.882812 26.664062 41.113281 23.78125 33.402344 C 20.070312 23.484375 25.125 12.394531 35.042969 8.683594 C 44.960938 4.976562 56.050781 10.027344 59.761719 19.945312 C 63.472656 29.867188 58.417969 40.953125 48.5 44.664062 C 46.289062 45.488281 44.023438 45.882812 41.792969 45.882812 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 13.546875 22.378906 C 12.226562 22.871094 11.554688 24.347656 12.050781 25.667969 C 12.542969 26.984375 14.015625 27.65625 15.335938 27.164062 C 16.65625 26.671875 17.328125 25.195312 16.832031 23.878906 C 16.339844 22.558594 14.867188 21.886719 13.546875 22.378906 M 15.738281 28.242188 C 13.824219 28.957031 11.6875 27.980469 10.972656 26.070312 C 10.257812 24.15625 11.230469 22.015625 13.144531 21.300781 C 15.058594 20.585938 17.195312 21.558594 17.910156 23.472656 C 18.625 25.386719 17.652344 27.527344 15.738281 28.242188 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 13.808594 23.082031 C 12.878906 23.429688 12.402344 24.472656 12.75 25.402344 C 12.921875 25.855469 13.253906 26.210938 13.695312 26.414062 C 14.132812 26.613281 14.625 26.628906 15.074219 26.460938 C 16.003906 26.113281 16.480469 25.070312 16.128906 24.140625 C 15.78125 23.207031 14.742188 22.730469 13.808594 23.082031 M 14.441406 29.226562 C 13.8125 29.226562 13.1875 29.09375 12.597656 28.824219 C 11.511719 28.328125 10.683594 27.445312 10.269531 26.332031 C 9.851562 25.21875 9.894531 24.007812 10.390625 22.925781 C 10.882812 21.839844 11.769531 21.015625 12.878906 20.597656 C 15.183594 19.738281 17.753906 20.910156 18.613281 23.210938 C 19.476562 25.511719 18.304688 28.082031 16 28.945312 C 15.496094 29.132812 14.96875 29.226562 14.441406 29.226562 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 16.703125 13.234375 C 15.84375 13.554688 15.40625 14.511719 15.726562 15.371094 C 16.050781 16.230469 17.007812 16.667969 17.867188 16.347656 C 18.726562 16.027344 19.164062 15.066406 18.84375 14.207031 C 18.519531 13.347656 17.5625 12.914062 16.703125 13.234375 M 18.269531 17.425781 C 16.816406 17.96875 15.191406 17.230469 14.648438 15.777344 C 14.105469 14.324219 14.847656 12.699219 16.300781 12.15625 C 17.753906 11.613281 19.375 12.351562 19.921875 13.804688 C 20.464844 15.257812 19.722656 16.882812 18.269531 17.425781 \"\/>\n<path fill-rule=\"nonzero\" fill=\"currentColor\" fill-opacity=\"1\" d=\"M 17.285156 13.878906 C 17.175781 13.878906 17.070312 13.898438 16.964844 13.9375 C 16.738281 14.019531 16.558594 14.191406 16.457031 14.410156 C 16.355469 14.632812 16.347656 14.882812 16.429688 15.109375 C 16.515625 15.339844 16.6875 15.519531 16.90625 15.621094 C 17.128906 15.722656 17.375 15.730469 17.605469 15.644531 C 17.832031 15.5625 18.011719 15.390625 18.113281 15.167969 C 18.214844 14.945312 18.226562 14.699219 18.140625 14.472656 C 18.054688 14.242188 17.886719 14.0625 17.664062 13.960938 C 17.542969 13.90625 17.414062 13.878906 17.285156 13.878906 M 17.289062 18.355469 C 15.84375 18.355469 14.484375 17.46875 13.949219 16.039062 C 13.261719 14.199219 14.195312 12.140625 16.035156 11.453125 C 17.875 10.765625 19.933594 11.703125 20.621094 13.542969 C 21.3125 15.382812 20.375 17.441406 18.53125 18.128906 C 18.121094 18.28125 17.703125 18.355469 17.289062 18.355469 \"\/>\n<\/svg><\/a>\n    <span class=\"product-label\">Market intelligence dashboard<\/span>\n    <nav class=\"navlinks\" aria-label=\"Dashboard sections\">\n      <a href=\"#overview\">Executive view<\/a>\n      <a href=\"#technology\">Technology<\/a>\n      <a href=\"#players\">Competition<\/a>\n      <a href=\"#explorer\">Data explorer<\/a>\n    <\/nav>\n  <\/div>\n<\/header>\n\n<main id=\"top\">\n<section class=\"hero\">\n <div class=\"hero-inner\">\n  <div class=\"hero-copy\">\n    <div class=\"eyebrow\"><i><\/i>Evidence-led market intelligence<\/div>\n    <h1>Bioactive coating intelligence for <em>better strategic decisions.<\/em><\/h1>\n    <p class=\"lead\">Explore the competitive and technology landscape of anticoagulant and antimicrobial medical-device coatings through commercial maturity, evidence quality, chemistry disclosure, regulatory positioning, and strategic threat.<\/p>\n    <div class=\"hero-actions\"><a class=\"btn primary\" href=\"#overview\">Open executive view<\/a><button class=\"btn ghost\" id=\"resetTop\" type=\"button\">Clear selections<\/button><\/div>\n  <\/div>\n  <div class=\"orbit\" aria-label=\"Dataset summary\">\n    <div class=\"core\"><\/div>\n    <div class=\"node n1\"><b id=\"heroRecords\">528<\/b>evidence records<\/div>\n    <div class=\"node n2\"><b id=\"heroPlayers\">88<\/b>organizations<\/div>\n    <div class=\"node n3\"><b id=\"heroCategories\">14<\/b>device segments<\/div>\n    <div class=\"node n4\"><b id=\"heroTech\">\u2014<\/b>chemistry families<\/div>\n  <\/div>\n <\/div>\n<\/section>\n\n<div class=\"dashboard-shell\">\n<section id=\"overview\" class=\"analytics-section\">\n <div class=\"section-head\"><div><h2>Executive market overview<\/h2><\/div><p>Reframe the market by maturity, application, chemistry, function, regulatory stage, or organization. Every metric and visualization updates immediately.<\/p><\/div>\n <div class=\"filters\" aria-label=\"Dashboard filters\">\n  <div class=\"filter\"><label for=\"fMarket\">Market maturity<\/label><select id=\"fMarket\"><\/select><\/div>\n  <div class=\"filter\"><label for=\"fCategory\">Device category<\/label><select id=\"fCategory\"><\/select><\/div>\n  <div class=\"filter\"><label for=\"fChemistry\">Chemistry family<\/label><select id=\"fChemistry\"><\/select><\/div>\n  <div class=\"filter\"><label for=\"fFunction\">Function<\/label><select id=\"fFunction\"><\/select><\/div>\n  <div class=\"filter\"><label for=\"fRegulatory\">Regulatory stage<\/label><select id=\"fRegulatory\"><\/select><\/div>\n  <div class=\"filter\"><label for=\"fPlayer\">Player<\/label><select id=\"fPlayer\"><\/select><\/div>\n <\/div>\n <div class=\"kpis\" id=\"kpis\"><\/div>\n <div class=\"grid2\">\n   <div class=\"card panel\"><h3>Market architecture<\/h3><div class=\"sub\">Distribution of records across maturity layers<\/div><div id=\"marketChart\" class=\"chart\"><\/div><\/div>\n   <div class=\"card panel\"><h3>Evidence vs. competitive pressure<\/h3><div class=\"sub\">Average evidence quality and threat intensity<\/div><div id=\"evidenceDonut\"><\/div><\/div>\n <\/div>\n<\/section>\n\n<section id=\"technology\" class=\"analytics-section\">\n <div class=\"section-head\"><div><h2>Technology landscape<\/h2><\/div><p>Identify chemistry families with meaningful application breadth, commercial traction, and disclosure depth\u2014and locate defensible market white space.<\/p><\/div>\n <div class=\"grid2\">\n   <div class=\"card panel\"><h3>Leading chemistry families<\/h3><div class=\"sub\">Top families by filtered record volume<\/div><div id=\"chemChart\" class=\"chart\"><\/div><\/div>\n   <div class=\"card panel\"><h3>Strategic signals<\/h3><div class=\"sub\">Priority opportunities, competitive alerts, and diligence flags<\/div><div id=\"signals\" class=\"signal-list\"><\/div><\/div>\n <\/div>\n <div class=\"card panel\" style=\"margin-top:16px\"><h3>Application\u2013chemistry intensity map<\/h3><div class=\"sub\">Relative density across the six leading device categories and chemistry families<\/div><div id=\"matrix\" class=\"matrix\"><\/div><\/div>\n<\/section>\n\n<section id=\"players\" class=\"analytics-section\">\n <div class=\"section-head\"><div><h2>Competitive panorama<\/h2><\/div><p>Portfolio breadth is separated from evidence quality and threat level, avoiding the common mistake of treating database frequency as market share.<\/p><\/div>\n <div class=\"grid3\">\n   <div class=\"card panel\"><h3>Top players<\/h3><div class=\"sub\">Filtered portfolio presence<\/div><div id=\"playerChart\" class=\"chart\"><\/div><\/div>\n   <div class=\"card panel\"><h3>High-pressure competitors<\/h3><div class=\"sub\">Records scoring threat level 4\u20135<\/div><div id=\"threatPlayers\" class=\"signal-list\"><\/div><\/div>\n   <div class=\"card panel\"><h3>Disclosure leaders<\/h3><div class=\"sub\">Chemistry and immobilization transparency<\/div><div id=\"disclosurePlayers\" class=\"signal-list\"><\/div><\/div>\n <\/div>\n<\/section>\n\n<section id=\"explorer\" class=\"analytics-section\">\n <div class=\"section-head\"><div><h2>Market explorer<\/h2><\/div><p>A curated evidence register for rapid diligence. Search by company, product, chemistry, active agent, geography, or differentiating claim.<\/p><\/div>\n <div class=\"card table-card\">\n   <div class=\"table-top\"><h3 id=\"resultCount\">Records<\/h3><input class=\"search\" id=\"searchBox\" aria-label=\"Search the evidence dataset\" placeholder=\"Search the selected evidence universe\u2026\"><\/div>\n   <div class=\"table-wrap\"><table><thead><tr><th>Player \/ device<\/th><th>Category<\/th><th>Market level<\/th><th>Function<\/th><th>Chemistry<\/th><th>Regulatory<\/th><th>Evidence<\/th><th>Threat<\/th><th>Strategic signal<\/th><th>Geography<\/th><\/tr><\/thead><tbody id=\"tableBody\"><\/tbody><\/table><\/div>\n <\/div>\n<\/section>\n<\/div>\n<\/main>\n\n<footer class=\"site-footer\">\n <div class=\"footer-inner\">\n  <div><svg class=\"coati-logo logo-color\" viewBox=\"0 0 533 98\" preserveAspectRatio=\"xMinYMid meet\" role=\"img\" aria-label=\"Coati-X\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 119.183594 78.980469 C 111.605469 71.398438 107.8125 61.800781 107.8125 50.1875 C 107.8125 38.574219 111.605469 28.976562 119.183594 21.394531 C 126.765625 13.816406 136.289062 10.023438 147.753906 10.023438 C 153.820312 10.023438 159.441406 11.207031 164.621094 13.574219 C 169.796875 15.941406 174.140625 19.308594 177.65625 23.671875 C 181.167969 28.035156 183.589844 33.101562 184.921875 38.871094 L 172.050781 38.871094 C 170.203125 33.691406 167.132812 29.644531 162.84375 26.722656 C 158.554688 23.800781 153.523438 22.339844 147.753906 22.339844 C 139.988281 22.339844 133.554688 24.964844 128.449219 30.21875 C 123.347656 35.46875 120.792969 42.144531 120.792969 50.242188 C 120.792969 58.34375 123.347656 65 128.449219 70.214844 C 133.554688 75.429688 139.988281 78.035156 147.753906 78.035156 C 153.671875 78.035156 158.8125 76.464844 163.175781 73.320312 C 167.539062 70.175781 170.574219 65.867188 172.273438 60.394531 L 185.257812 60.394531 C 183.257812 69.492188 178.859375 76.761719 172.050781 82.195312 C 165.246094 87.632812 157.148438 90.351562 147.753906 90.351562 C 136.289062 90.351562 126.765625 86.5625 119.183594 78.980469 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 235.296875 76.207031 C 238.257812 74.542969 240.566406 72.210938 242.234375 69.214844 C 243.894531 66.222656 244.730469 62.835938 244.730469 59.0625 C 244.730469 53.367188 242.898438 48.671875 239.238281 44.972656 C 235.574219 41.273438 230.898438 39.425781 225.199219 39.425781 C 219.507812 39.425781 214.828125 41.273438 211.167969 44.972656 C 207.503906 48.671875 205.675781 53.367188 205.675781 59.0625 C 205.675781 64.761719 207.503906 69.457031 211.167969 73.15625 C 214.828125 76.851562 219.507812 78.703125 225.199219 78.703125 C 228.972656 78.703125 232.339844 77.871094 235.296875 76.207031 M 202.292969 81.53125 C 196.1875 75.578125 193.136719 68.089844 193.136719 59.0625 C 193.136719 53.148438 194.523438 47.785156 197.296875 42.976562 C 200.070312 38.167969 203.917969 34.414062 208.835938 31.714844 C 213.753906 29.015625 219.210938 27.664062 225.199219 27.664062 C 231.191406 27.664062 236.648438 29.015625 241.566406 31.714844 C 246.484375 34.414062 250.332031 38.167969 253.105469 42.976562 C 255.878906 47.785156 257.265625 53.148438 257.265625 59.0625 C 257.265625 68.089844 254.214844 75.578125 248.113281 81.53125 C 242.011719 87.484375 234.375 90.460938 225.199219 90.460938 C 216.027344 90.460938 208.394531 87.484375 202.292969 81.53125 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 312.132812 73.097656 C 315.796875 69.363281 317.625 64.667969 317.625 59.007812 C 317.625 53.351562 315.796875 48.671875 312.132812 44.972656 C 308.472656 41.273438 303.792969 39.425781 298.097656 39.425781 C 294.398438 39.425781 291.054688 40.277344 288.058594 41.976562 C 285.0625 43.679688 282.714844 46.027344 281.011719 49.023438 C 279.3125 52.019531 278.460938 55.363281 278.460938 59.0625 C 278.460938 64.683594 280.328125 69.363281 284.0625 73.097656 C 287.796875 76.835938 292.496094 78.703125 298.15625 78.703125 C 303.8125 78.703125 308.472656 76.835938 312.132812 73.097656 M 330.050781 29.105469 L 330.050781 89.019531 L 320.066406 89.019531 L 318.847656 81.699219 C 313.078125 87.542969 305.867188 90.464844 297.210938 90.464844 C 288.261719 90.464844 280.808594 87.46875 274.855469 81.476562 C 268.902344 75.484375 265.921875 67.996094 265.921875 59.007812 C 265.921875 50.019531 268.902344 42.550781 274.855469 36.597656 C 280.808594 30.640625 288.261719 27.664062 297.210938 27.664062 C 306.011719 27.664062 313.296875 30.625 319.070312 36.542969 L 320.511719 29.105469 Z M 330.050781 29.105469 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 381.09375 77.816406 L 381.09375 89.019531 L 371.996094 89.019531 C 367.632812 89.019531 363.859375 88.171875 360.679688 86.46875 C 357.496094 84.765625 355.058594 82.308594 353.355469 79.089844 C 351.65625 75.875 350.804688 72.082031 350.804688 67.71875 L 350.804688 39.648438 L 340.042969 39.648438 L 340.042969 37.316406 L 360.902344 15.128906 L 363.007812 15.128906 L 363.007812 29.105469 L 380.761719 29.105469 L 380.761719 39.648438 L 363.121094 39.648438 L 363.121094 66.71875 C 363.121094 70.269531 364.082031 73.007812 366.003906 74.929688 C 367.925781 76.851562 370.703125 77.816406 374.324219 77.816406 Z M 381.09375 77.816406 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 393.078125 29.105469 L 405.394531 29.105469 L 405.394531 89.019531 L 393.078125 89.019531 Z M 392.855469 7.140625 L 405.613281 7.140625 L 405.613281 19.789062 L 392.855469 19.789062 Z M 392.855469 7.140625 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 421.480469 51.964844 L 457.097656 51.964844 L 457.097656 63.945312 L 421.480469 63.945312 Z M 421.480469 51.964844 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#65121F\" fill-opacity=\"1\" d=\"M 512.351562 89.019531 L 493.492188 58.730469 L 474.628906 89.019531 L 460.316406 89.019531 L 485.726562 48.300781 L 462.089844 11.355469 L 476.402344 11.355469 L 493.492188 38.648438 L 510.464844 11.355469 L 524.667969 11.355469 L 501.257812 48.746094 L 526.664062 89.019531 Z M 512.351562 89.019531 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 17.335938 69.878906 C 25.332031 79.089844 43.609375 91.117188 57.457031 87.683594 C 61.183594 86.753906 64.125 83.820312 65.957031 79.1875 C 69.9375 69.136719 67.890625 53.867188 63.402344 46.925781 C 61.804688 44.457031 59.820312 42.21875 57.5 40.28125 C 48.226562 32.527344 35.871094 29.902344 26.011719 33.589844 C 25.996094 33.59375 25.984375 33.601562 25.96875 33.605469 C 15.070312 37.703125 8.371094 50.214844 11.628906 60.378906 C 12.613281 63.441406 14.480469 66.550781 17.335938 69.878906 M 58.984375 88.414062 C 58.578125 88.566406 58.160156 88.695312 57.730469 88.800781 C 43.417969 92.351562 24.644531 80.058594 16.464844 70.632812 L 16.460938 70.628906 C 13.503906 67.183594 11.5625 63.945312 10.535156 60.730469 C 7.097656 50.011719 14.121094 36.832031 25.5625 32.527344 C 25.578125 32.523438 25.59375 32.515625 25.609375 32.511719 C 35.851562 28.679688 48.652344 31.378906 58.238281 39.398438 C 60.648438 41.414062 62.710938 43.734375 64.367188 46.300781 C 69.019531 53.488281 71.253906 68.9375 67.027344 79.609375 C 65.257812 84.085938 62.492188 87.101562 58.984375 88.414062 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 17.902344 69.390625 C 25.777344 78.460938 43.738281 90.320312 57.273438 86.953125 C 60.757812 86.089844 63.519531 83.304688 65.261719 78.910156 C 69.15625 69.066406 67.160156 54.121094 62.773438 47.332031 C 61.21875 44.925781 59.28125 42.746094 57.019531 40.855469 C 47.953125 33.273438 35.886719 30.699219 26.273438 34.292969 C 15.691406 38.273438 9.199219 50.347656 12.34375 60.148438 C 13.296875 63.117188 15.113281 66.136719 17.902344 69.390625 M 52.421875 90.171875 C 38.820312 90.171875 23.195312 79.53125 15.898438 71.125 C 12.867188 67.59375 10.878906 64.269531 9.820312 60.957031 C 6.265625 49.878906 13.5 36.265625 25.300781 31.828125 C 35.835938 27.886719 48.933594 30.636719 58.71875 38.820312 C 61.1875 40.886719 63.300781 43.265625 65 45.894531 C 69.746094 53.234375 72.035156 69 67.726562 79.886719 C 65.886719 84.539062 62.953125 87.730469 59.25 89.117188 C 58.808594 89.28125 58.359375 89.417969 57.910156 89.53125 C 56.140625 89.96875 54.296875 90.171875 52.421875 90.171875 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 46.230469 16.152344 C 36.378906 19.835938 29.136719 30.859375 27.769531 44.253906 C 27.425781 47.613281 27.539062 51.003906 28.105469 54.324219 C 29.8125 64.335938 40.316406 80.574219 50.808594 85.722656 C 54.757812 87.660156 58.265625 87.84375 61.226562 86.261719 C 73.835938 79.546875 78.824219 56.023438 78.226562 42.238281 C 77.984375 37.269531 77.164062 33.1875 75.71875 29.761719 C 70.945312 18.449219 57.1875 12.082031 46.273438 16.136719 C 46.257812 16.140625 46.242188 16.148438 46.230469 16.152344 M 60.527344 87.839844 C 57.503906 88.96875 54.074219 88.609375 50.300781 86.753906 C 39.335938 81.375 28.757812 65.007812 26.96875 54.515625 C 26.386719 51.09375 26.269531 47.601562 26.625 44.136719 C 28.035156 30.3125 35.570312 18.910156 45.828125 15.074219 C 45.84375 15.070312 45.855469 15.0625 45.871094 15.058594 C 57.335938 10.800781 71.777344 17.460938 76.78125 29.316406 C 78.277344 32.867188 79.128906 37.078125 79.375 42.183594 C 79.988281 56.261719 74.816406 80.328125 61.769531 87.28125 C 61.363281 87.496094 60.949219 87.683594 60.527344 87.839844 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 46.09375 15.777344 L 46.230469 16.152344 L 46.105469 15.769531 C 46.101562 15.773438 46.097656 15.773438 46.09375 15.777344 M 46.230469 16.152344 L 46.492188 16.855469 C 36.910156 20.441406 29.855469 31.222656 28.515625 44.328125 C 28.179688 47.625 28.289062 50.945312 28.84375 54.195312 C 30.523438 64.039062 40.839844 79.996094 51.136719 85.046875 C 54.859375 86.875 58.136719 87.0625 60.875 85.601562 C 73.199219 79.035156 78.066406 55.863281 77.476562 42.273438 C 77.238281 37.394531 76.441406 33.398438 75.03125 30.054688 C 70.402344 19.09375 57.089844 12.917969 46.535156 16.839844 Z M 56.925781 89.234375 C 54.742188 89.234375 52.417969 88.628906 49.96875 87.425781 C 38.816406 81.953125 28.050781 65.308594 26.230469 54.640625 C 25.636719 51.152344 25.519531 47.589844 25.878906 44.058594 C 27.320312 29.960938 35.042969 18.304688 45.5625 14.371094 C 57.429688 9.960938 72.320312 16.816406 77.472656 29.027344 C 79.003906 32.660156 79.871094 36.949219 80.125 42.148438 C 80.746094 56.417969 75.453125 80.839844 62.121094 87.941406 C 61.6875 88.171875 61.238281 88.375 60.789062 88.542969 C 59.558594 89.003906 58.269531 89.234375 56.925781 89.234375 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 17.355469 33.902344 C 11.355469 36.144531 8.296875 42.851562 10.542969 48.851562 C 12.785156 54.851562 19.492188 57.90625 25.492188 55.664062 C 31.492188 53.421875 34.546875 46.714844 32.304688 40.710938 C 30.058594 34.714844 23.351562 31.65625 17.355469 33.902344 M 25.894531 56.742188 C 19.300781 59.207031 11.929688 55.847656 9.464844 49.253906 C 6.996094 42.660156 10.355469 35.289062 16.953125 32.824219 C 23.546875 30.355469 30.917969 33.714844 33.382812 40.308594 C 35.847656 46.902344 32.492188 54.273438 25.894531 56.742188 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 17.617188 34.605469 C 12.003906 36.703125 9.144531 42.976562 11.242188 48.589844 C 12.261719 51.304688 14.273438 53.460938 16.917969 54.667969 C 19.566406 55.871094 22.515625 55.976562 25.230469 54.960938 C 30.84375 52.863281 33.699219 46.589844 31.601562 40.976562 C 29.503906 35.363281 23.230469 32.503906 17.617188 34.605469 M 21.429688 58.304688 C 19.519531 58.304688 17.613281 57.894531 15.820312 57.078125 C 12.53125 55.578125 10.023438 52.894531 8.761719 49.519531 C 7.496094 46.140625 7.628906 42.46875 9.125 39.179688 C 10.625 35.890625 13.3125 33.382812 16.6875 32.121094 C 20.066406 30.859375 23.738281 30.988281 27.027344 32.484375 C 30.316406 33.984375 32.820312 36.671875 34.085938 40.046875 C 36.695312 47.027344 33.140625 54.832031 26.160156 57.445312 C 24.621094 58.019531 23.023438 58.304688 21.429688 58.304688 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 35.710938 10.464844 C 26.773438 13.808594 22.21875 23.800781 25.5625 32.734375 C 28.90625 41.675781 38.894531 46.226562 47.835938 42.882812 C 56.773438 39.539062 61.324219 29.550781 57.980469 20.613281 C 54.640625 11.675781 44.648438 7.121094 35.710938 10.464844 M 48.238281 43.960938 C 38.703125 47.527344 28.050781 42.671875 24.484375 33.140625 C 20.917969 23.609375 25.773438 12.953125 35.308594 9.386719 C 44.839844 5.824219 55.492188 10.675781 59.058594 20.207031 C 62.625 29.742188 57.769531 40.398438 48.238281 43.960938 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 41.765625 10.113281 C 39.8125 10.113281 37.855469 10.464844 35.972656 11.167969 C 31.835938 12.714844 28.546875 15.785156 26.714844 19.8125 C 24.878906 23.84375 24.71875 28.339844 26.265625 32.472656 C 29.460938 41.023438 39.019531 45.378906 47.570312 42.179688 C 51.707031 40.632812 54.992188 37.5625 56.828125 33.535156 C 58.664062 29.507812 58.824219 25.007812 57.277344 20.875 C 55.730469 16.738281 52.660156 13.453125 48.632812 11.617188 C 46.4375 10.617188 44.105469 10.113281 41.765625 10.113281 M 41.792969 45.882812 C 34.007812 45.882812 26.664062 41.113281 23.78125 33.402344 C 20.070312 23.484375 25.125 12.394531 35.042969 8.683594 C 44.960938 4.976562 56.050781 10.027344 59.761719 19.945312 C 63.472656 29.867188 58.417969 40.953125 48.5 44.664062 C 46.289062 45.488281 44.023438 45.882812 41.792969 45.882812 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 13.546875 22.378906 C 12.226562 22.871094 11.554688 24.347656 12.050781 25.667969 C 12.542969 26.984375 14.015625 27.65625 15.335938 27.164062 C 16.65625 26.671875 17.328125 25.195312 16.832031 23.878906 C 16.339844 22.558594 14.867188 21.886719 13.546875 22.378906 M 15.738281 28.242188 C 13.824219 28.957031 11.6875 27.980469 10.972656 26.070312 C 10.257812 24.15625 11.230469 22.015625 13.144531 21.300781 C 15.058594 20.585938 17.195312 21.558594 17.910156 23.472656 C 18.625 25.386719 17.652344 27.527344 15.738281 28.242188 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 13.808594 23.082031 C 12.878906 23.429688 12.402344 24.472656 12.75 25.402344 C 12.921875 25.855469 13.253906 26.210938 13.695312 26.414062 C 14.132812 26.613281 14.625 26.628906 15.074219 26.460938 C 16.003906 26.113281 16.480469 25.070312 16.128906 24.140625 C 15.78125 23.207031 14.742188 22.730469 13.808594 23.082031 M 14.441406 29.226562 C 13.8125 29.226562 13.1875 29.09375 12.597656 28.824219 C 11.511719 28.328125 10.683594 27.445312 10.269531 26.332031 C 9.851562 25.21875 9.894531 24.007812 10.390625 22.925781 C 10.882812 21.839844 11.769531 21.015625 12.878906 20.597656 C 15.183594 19.738281 17.753906 20.910156 18.613281 23.210938 C 19.476562 25.511719 18.304688 28.082031 16 28.945312 C 15.496094 29.132812 14.96875 29.226562 14.441406 29.226562 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 16.703125 13.234375 C 15.84375 13.554688 15.40625 14.511719 15.726562 15.371094 C 16.050781 16.230469 17.007812 16.667969 17.867188 16.347656 C 18.726562 16.027344 19.164062 15.066406 18.84375 14.207031 C 18.519531 13.347656 17.5625 12.914062 16.703125 13.234375 M 18.269531 17.425781 C 16.816406 17.96875 15.191406 17.230469 14.648438 15.777344 C 14.105469 14.324219 14.847656 12.699219 16.300781 12.15625 C 17.753906 11.613281 19.375 12.351562 19.921875 13.804688 C 20.464844 15.257812 19.722656 16.882812 18.269531 17.425781 \"\/>\n<path fill-rule=\"nonzero\" fill=\"#B51826\" fill-opacity=\"1\" d=\"M 17.285156 13.878906 C 17.175781 13.878906 17.070312 13.898438 16.964844 13.9375 C 16.738281 14.019531 16.558594 14.191406 16.457031 14.410156 C 16.355469 14.632812 16.347656 14.882812 16.429688 15.109375 C 16.515625 15.339844 16.6875 15.519531 16.90625 15.621094 C 17.128906 15.722656 17.375 15.730469 17.605469 15.644531 C 17.832031 15.5625 18.011719 15.390625 18.113281 15.167969 C 18.214844 14.945312 18.226562 14.699219 18.140625 14.472656 C 18.054688 14.242188 17.886719 14.0625 17.664062 13.960938 C 17.542969 13.90625 17.414062 13.878906 17.285156 13.878906 M 17.289062 18.355469 C 15.84375 18.355469 14.484375 17.46875 13.949219 16.039062 C 13.261719 14.199219 14.195312 12.140625 16.035156 11.453125 C 17.875 10.765625 19.933594 11.703125 20.621094 13.542969 C 21.3125 15.382812 20.375 17.441406 18.53125 18.128906 C 18.121094 18.28125 17.703125 18.355469 17.289062 18.355469 \"\/>\n<\/svg><\/div>\n  <div class=\"footer-copy\"><strong>Medical Device Coating Intelligence<\/strong><span>Dataset-derived indicators are analytical proxies\u2014not revenue, valuation, or market-share estimates.<\/span><\/div>\n<\/footer>\n<div class=\"coati-credit-bar\">  <div class=\"coati-credit-inner\">    This work was carried out by the <a href=\"https:\/\/www.fre-sci.com\/\" target=\"_blank\" rel=\"noopener\">FRESCI by SCIENCE&amp;STRATEGY SL<\/a> team: Dr.&nbsp;F.&nbsp;Rossi, Ms.&nbsp;F.&nbsp;Solano, Ms.&nbsp;A.&nbsp;Serramitjana and Dr.&nbsp;M.&nbsp;Straccia  <\/div>\n<\/div>\n<script>\nconst DATA=[{\"id\":319,\"player\":\"Abbott\",\"device\":\"CentriMag Acute Circulatory Support System\",\"sku\":\"CentriMag blood pump \/ acute MCS platform\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Validated competitor\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ global by region\",\"claim\":\"Flexible extracorporeal MCS pump with design-led hemocompatibility and recent FDA clearances.\",\"partnership\":\"Abbott internal platform\",\"link\":\"https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/heart-failure\/mechanical-circulatory-support\/centrimag-acute-circulatory-support-system\/about.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P170038S030 | https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/heart-failure\/mechanical-circulatory-support\/centrimag-acute-circulatory-support-system\/about.html | https:\/\/abbott.mediaroom.com\/2023-04-25-Abbotts-Life-Support-System-Receives-New-FDA-Clearances-to-Help-Doctors-Treat-More-Critically-Ill-Patients\"},{\"id\":318,\"player\":\"Abbott\",\"device\":\"HeartMate 3 Left Ventricular Assist System\",\"sku\":\"HeartMate 3 LVAS pump\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Validated competitor\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ global by region\",\"claim\":\"Market-leading durable LVAD with strong evidence and design-led hemocompatibility.\",\"partnership\":\"Abbott internal platform\",\"link\":\"https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/heart-failure\/left-ventricular-assist-devices\/heartmate-3.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=396111 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P160054S031 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160054C.pdf | https:\/\/pubmed.ncbi.nlm.nih.gov\/27195742\/ | https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/heart-failure\/left-ventricular-assist-devices\/heartmate-3.html\"},{\"id\":322,\"player\":\"Abiomed \/ Johnson & Johnson MedTech\",\"device\":\"Impella 5.5 with SmartAssist\",\"sku\":\"Impella 5.5 catheter \/ surgically inserted microaxial pump\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ Europe \/ international by model\",\"claim\":\"High-profile temporary MCS platform; hemocompatibility risk management is not coating-led in public evidence.\",\"partnership\":\"Abiomed internal platform\",\"link\":\"https:\/\/www.abiomed.com\/en-us\/about-us\/news-and-media\/press-releases\/abiomed-receives-fda-pma-approval-impella-55-smartassist-minimally-invasive-forward\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/p140003s004b.pdf | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P140003S071 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P140003S027 | https:\/\/www.abiomed.com\/en-us\/about-us\/news-and-media\/press-releases\/abiomed-receives-fda-pma-approval-impella-55-smartassist-minimally-invasive-forward | https:\/\/www.abiomed.com\/en-us\/about-us\/news-and-media\/press-releases\/abiomed-receives-fda-pma-approval-impella-55-smartassist-minimally-invasive-forward\"},{\"id\":321,\"player\":\"Abiomed \/ Johnson & Johnson MedTech\",\"device\":\"Impella CP with SmartAssist\",\"sku\":\"Impella CP catheter \/ SmartAssist platform\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ Europe \/ international by model\",\"claim\":\"High-profile temporary MCS platform; hemocompatibility risk management is not coating-led in public evidence.\",\"partnership\":\"Abiomed internal platform\",\"link\":\"https:\/\/www.abiomed.com\/en-us\/products-and-services\/impella\/impella-cp-with-smartassist\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/p140003s004b.pdf | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P140003S071 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P140003S027 | https:\/\/www.abiomed.com\/en-us\/products-and-services\/impella\/impella-cp-with-smartassist | https:\/\/www.abiomed.com\/en-us\/about-us\/news-and-media\/press-releases\/abiomed-receives-fda-pma-approval-impella-55-smartassist-minimally-invasive-forward\"},{\"id\":363,\"player\":\"Acandis\",\"device\":\"CARESTO heal Stent\",\"sku\":\"HEAL Technology coated\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"HEAL Technology\",\"supplier\":\"Acandis\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/acandis.com\/en\/ischemic-stroke\/caresto-heal-carotid-stent\/\",\"evidenceChain\":\"https:\/\/acandis.com\/en\/technologies\/heal-technology-en\/ | https:\/\/acandis.com\/en\/ischemic-stroke\/caresto-heal-carotid-stent\/ | https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352492824032240\"},{\"id\":362,\"player\":\"Acandis\",\"device\":\"CREDO heal Stent\",\"sku\":\"HEAL Technology coated\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"HEAL Technology\",\"supplier\":\"Acandis\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/acandis.com\/en\/ischemic-stroke\/credo-heal-stent\/\",\"evidenceChain\":\"https:\/\/acandis.com\/en\/technologies\/heal-technology-en\/ | https:\/\/acandis.com\/en\/ischemic-stroke\/credo-heal-stent\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11832549\/\"},{\"id\":338,\"player\":\"Artivion \/ On-X Life Technologies\",\"device\":\"On-X Aortic Heart Valve\",\"sku\":\"On-X mechanical aortic valve\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Carbon \/ passive surface\",\"signal\":\"Validated competitor\",\"brand\":\"On-X Carbon\",\"supplier\":\"Internal \/ undisclosed\",\"agent\":\"None disclosed\",\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ Canada \/ CE region\",\"claim\":\"Mechanical valve platform with pyrolytic-carbon material and reduced-INR labeling.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/artivion.com\/product\/on-x-aortic\/\",\"evidenceChain\":\"https:\/\/www.onxlti.com\/wp-content\/uploads\/2019\/05\/010122103A-On-X-IFU-Booklet-English-Website-Version.pdf | https:\/\/artivion.com\/product\/on-x-aortic\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11136449\/\"},{\"id\":418,\"player\":\"BD\",\"device\":\"COVERA Vascular Covered Stent\",\"sku\":\"AV access venous-anastomosis \/ AV fistula configurations\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/vascularnews.com\/fda-premarket-approval-covera-covered-haemodialysis\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf17\/P170042B.pdf | https:\/\/vascularnews.com\/fda-premarket-approval-covera-covered-haemodialysis\/\"},{\"id\":417,\"player\":\"BD\",\"device\":\"LifeStream Balloon Expandable Vascular Covered Stent\",\"sku\":\"Iliac artery platform\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.bd.com\/en-in\/products-and-solutions\/products\/product-families\/lifestream-balloon-expandable-vascular-covered-stent\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160024B.pdf | https:\/\/www.bd.com\/en-in\/products-and-solutions\/products\/product-families\/lifestream-balloon-expandable-vascular-covered-stent\"},{\"id\":61,\"player\":\"Baxter \/ Vantive\",\"device\":\"AN69ST membrane\",\"sku\":\"AN69ST membrane with heparin adsorption\/priming\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"oXiris \/ AN69ST\",\"supplier\":\"Vantive \/ Baxter\",\"agent\":\"Heparin (grafted) for oXiris\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"US \/ EU \/ international\",\"claim\":\"CRRT filter with explicit heparin-grafted membrane plus adsorptive layers.\",\"partnership\":null,\"link\":\"https:\/\/pro.vantive.com\/oxiris-set\",\"evidenceChain\":\"https:\/\/pro.vantive.com\/oxiris-set | https:\/\/www.fda.gov\/media\/137267\/download | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6159854\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695587\/\"},{\"id\":430,\"player\":\"Boston Scientific\",\"device\":\"ELUVIA Drug-Eluting Vascular Stent\",\"sku\":\"Sustained-release paclitaxel SFA\/PPA stent\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Validated competitor\",\"brand\":\"ELUVIA \/ Sustend drug-delivery technology\",\"supplier\":\"Boston Scientific\",\"agent\":\"Paclitaxel (antiproliferative, not anticoagulant)\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Drug eluting\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.bostonscientific.com\/content\/dam\/elabeling\/pi\/eluvia-eifu-us\/51574536-01A_ELUVIA_EIFU_US_EN_s.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P180011 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/P180011B.pdf | https:\/\/www.bostonscientific.com\/content\/dam\/elabeling\/pi\/eluvia-eifu-us\/51574536-01A_ELUVIA_EIFU_US_EN_s.pdf | https:\/\/www.bostonscientific.com\/content\/dam\/elabeling\/pi\/eluvia-eifu-us\/51574536-01A_ELUVIA_EIFU_US_EN_s.pdf\"},{\"id\":432,\"player\":\"Boston Scientific\",\"device\":\"Ranger Drug-Coated Balloon\",\"sku\":\"TransPax paclitaxel PTA balloon\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"TransPax coating\",\"supplier\":\"Boston Scientific\",\"agent\":\"Paclitaxel (antiproliferative, not anticoagulant)\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Drug-eluting reservoir\",\"release\":\"Drug eluting\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/P190019B.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/P190019B.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/P190019B.pdf\"},{\"id\":330,\"player\":\"Boston Scientific\",\"device\":\"WATCHMAN FLX Pro Left Atrial Appendage Closure Device\",\"sku\":\"WATCHMAN FLX Pro with HEMOCOAT Technology\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Validated competitor\",\"brand\":\"HEMOCOAT\",\"supplier\":\"Boston Scientific internal \/ undisclosed\",\"agent\":\"None disclosed - non-active, non-eluting coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ Europe \/ selected international markets\",\"claim\":\"One of the clearest commercial structural-heart examples of a named thromboresistant coating with disclosed chemistry.\",\"partnership\":\"Boston Scientific internal coating\",\"link\":\"https:\/\/www.bostonscientific.com\/en-US\/products\/laac-system\/watchman-flx-pro.html\",\"evidenceChain\":\"https:\/\/www.bostonscientific.com\/en-US\/products\/laac-system\/watchman-flx-pro.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130013S080 | https:\/\/acforum.org\/web\/resource_files\/1739291757-34025.pdf | https:\/\/www.watchman.com\/en-us-implanter\/clinical-evidence\/watchman-flx-pro-clinical-data\/watchman-flx-pro-pre-clinical-data.html | https:\/\/www.watchman.com\/en-us-implanter\/device\/watchman-flx-pro.html | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11014679\/\"},{\"id\":431,\"player\":\"Cook Medical\",\"device\":\"Zilver PTX Drug-Eluting Peripheral Stent\",\"sku\":\"Paclitaxel-coated nitinol stent\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Drug-eluting \/ antiproliferative\",\"signal\":\"Validated competitor\",\"brand\":\"Zilver PTX\",\"supplier\":\"Cook Medical\",\"agent\":\"Paclitaxel (antiproliferative, not anticoagulant)\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Physical adsorption\",\"release\":\"Drug eluting\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.cookmedical.com\/peripheral-intervention\/paclitaxel\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P100022 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/p100022b.pdf | https:\/\/www.cookmedical.com\/peripheral-intervention\/paclitaxel\/\"},{\"id\":42,\"player\":\"Eurosets\",\"device\":\"A.L.ONE ECMO Adult\",\"sku\":\"A.L.ONE ECMO Adult PC coated\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":44,\"player\":\"Eurosets\",\"device\":\"A.L.ONE ECMO Newborn\",\"sku\":\"A.L.ONE ECMO Newborn PC coated\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":43,\"player\":\"Eurosets\",\"device\":\"A.L.ONE ECMO Pediatric\",\"sku\":\"A.L.ONE ECMO Pediatric PC coated\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":47,\"player\":\"Eurosets\",\"device\":\"Colibri ECMO\",\"sku\":\"Colibri ECMO PC coated\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":49,\"player\":\"Eurosets\",\"device\":\"ECLS Suite tubing set\",\"sku\":\"ECLS Suite tubing set PC coated\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":45,\"player\":\"Eurosets\",\"device\":\"ECMOlife Adult\",\"sku\":\"ECMOlife Adult PC coated\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":46,\"player\":\"Eurosets\",\"device\":\"ECMOlife Pediatric\",\"sku\":\"ECMOlife Pediatric PC coated\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":50,\"player\":\"Eurosets\",\"device\":\"Eurosets Adult oxygenator\",\"sku\":\"Eurosets Adult oxygenator PC coated\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":51,\"player\":\"Eurosets\",\"device\":\"Eurosets CPB oxygenator\",\"sku\":\"Eurosets CPB oxygenator PC coated\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":48,\"player\":\"Eurosets\",\"device\":\"Landing ECMO\",\"sku\":\"Landing ECMO PC coated\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PC \/ Phosphorylcholine coating\",\"supplier\":\"Eurosets S.r.l.\",\"agent\":\"None disclosed; heparin-free PC biomimetic\/passivating coating\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"European Union\/CE markets; broader geographic availability varies; no FDA clearance confirmed\",\"claim\":\"Heparin-free PC-coated ECMO\/ECLS platform with adult, pediatric and newborn oxygenator options and 30-day validated-use positioning.\",\"partnership\":\"Internal Eurosets PC platform\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT05163925 | https:\/\/pubmed.ncbi.nlm.nih.gov\/23201818\/ | https:\/\/www.btchealth.com.au\/wp-content\/uploads\/ECMOlife-IFU_compressed_compressed-1.pdf | https:\/\/euromed.ch\/wp-content\/uploads\/2023\/02\/ecmolife-brochure_2022.pdf | https:\/\/www.eurosets.com\/en\/ecls-suite\/\"},{\"id\":1,\"player\":\"Getinge\",\"device\":\"HLS Set Advanced\",\"sku\":\"5.0 with BIOLINE Coating\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"TGA Approved\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Europe \/ international; model-specific availability varies\",\"claim\":\"Bioactive heparin-albumin coated extracorporeal support platform with broad Getinge\/Cardiohelp adoption and CE-region extended-use positioning.\",\"partnership\":\"Getinge\/Maquet internal coating platform\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.tga.gov.au\/resources\/artg\/193475 | https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/getingemaquet-cardiohelp-system-potential-insufficient-packaging-sterility-hls-set-advanced-letter | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/journals.sagepub.com\/doi\/10.1177\/0267659118772452\"},{\"id\":2,\"player\":\"Getinge\",\"device\":\"HLS Set Advanced\",\"sku\":\"7.0 with BIOLINE Coating\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"TGA Approved\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Europe \/ international; model-specific availability varies\",\"claim\":\"Bioactive heparin-albumin coated extracorporeal support platform with broad Getinge\/Cardiohelp adoption and CE-region extended-use positioning.\",\"partnership\":\"Getinge\/Maquet internal coating platform\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.tga.gov.au\/resources\/artg\/193475 | https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/getingemaquet-cardiohelp-system-potential-insufficient-packaging-sterility-hls-set-advanced-letter | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/journals.sagepub.com\/doi\/10.1177\/0267659118772452\"},{\"id\":497,\"player\":\"Getinge\",\"device\":\"ROTAFLOW Centrifugal Pump with BIOLINE\",\"sku\":\"RF-32 \/ regional field-action record with BIOLINE\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"Health Canada Licensed\",\"clinical\":3,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial \/ field-action record confirms marketed device; verify current availability and recall status.\",\"geography\":\"Canada \/ international\",\"claim\":\"Coated pump component distinct from oxygenator\/tubing rows.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/recalls-rappels.canada.ca\/en\/alert-recall\/rotaflow-centrifugal-pump-bioline\",\"evidenceChain\":\"https:\/\/recalls-rappels.canada.ca\/en\/alert-recall\/rotaflow-centrifugal-pump-bioline | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":415,\"player\":\"Getinge \/ Atrium Medical\",\"device\":\"iCast Covered Stent System\",\"sku\":\"P120003 iliac \/ 2025 bridging-stent indication\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":\"Established covered stent platform; differentiation is ePTFE encapsulation\/balloon-expandable design rather than anticoagulant coating.\",\"partnership\":null,\"link\":\"https:\/\/ifu.cookmedical.com\/data\/IFU_PDF\/ATRIUM_EL012022_AA.PDF\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf12\/P120003B.pdf | https:\/\/ifu.cookmedical.com\/data\/IFU_PDF\/ATRIUM_EL012022_AA.PDF | https:\/\/www.getinge.com\/us\/company\/news\/press-releases\/2025\/5176617-Getinges-iCast-covered-stent-system-now-available-as\/ | https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/icast-covered-stent-system-p120003\"},{\"id\":32,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"INSPIRE 4 PH.I.S.I.O\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":33,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"INSPIRE 6 PH.I.S.I.O\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":34,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"INSPIRE 8 PH.I.S.I.O\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":37,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"INSPIRE Dual Reservoir PH.I.S.I.O\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":36,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"INSPIRE HVR Dual PH.I.S.I.O\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":35,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"INSPIRE HVR PH.I.S.I.O\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":39,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"INSPIRE adult integrated system PC coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":38,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"INSPIRE oxygenator module PC coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":40,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"INSPIRE pediatric configuration PC coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":41,\"player\":\"LivaNova\",\"device\":\"INSPIRE Oxygenator Family\",\"sku\":\"Sorin\/LivaNova PHISIO CPB circuit pack\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"PH.I.S.I.O. \/ PHISIO PC\",\"supplier\":\"LivaNova \/ Sorin Group Italia\",\"agent\":\"None disclosed; PC biomimetic\/passivating chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/GB and other markets per LivaNova commercial pages\",\"claim\":\"Broad modular INSPIRE adult oxygenator\/reservoir platform with PH.I.S.I.O. PC coating across oxygenator and reservoir blood-contacting surfaces.\",\"partnership\":\"Internal LivaNova\/Sorin PHISIO platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K180448 | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/safety%20info\/im-02628-a_safety-info_inspire-6f-m-8f-m_for-website.pdf?ext=.pdf | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire\"},{\"id\":17,\"player\":\"Medtronic\",\"device\":\"Affinity Fusion Integrated Arterial Filter\",\"sku\":\"Cortiva option\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"Cortiva BioActive Surface\",\"supplier\":\"Medtronic; technology lineage from Carmeda BioActive Surface \/ end-point attached heparin\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; availability also regional\/global per Medtronic commercial materials\",\"claim\":\"High-evidence, FDA-cleared CPB oxygenator\/circuit family with non-leaching end-point attached heparin surface.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf20\/K203111.pdf | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":15,\"player\":\"Medtronic\",\"device\":\"Affinity Fusion Oxygenator\",\"sku\":\"with Balance Biosurface\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Balance Biosurface\",\"supplier\":\"Medtronic; technology licensed under agreement from BioInteractions Limited, United Kingdom\",\"agent\":\"None disclosed; heparin-free polymer surface\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":2,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies\",\"claim\":\"Heparin-free Medtronic\/BioInteractions hydrophilic polymer surface for CPB\/ECLS devices, strategically positioned where heparin surfaces are undesirable.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K240666.pdf | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023 | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\"},{\"id\":14,\"player\":\"Medtronic\",\"device\":\"Affinity Fusion Oxygenator\",\"sku\":\"with Cortiva BioActive Surface\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"Cortiva BioActive Surface\",\"supplier\":\"Medtronic; technology lineage from Carmeda BioActive Surface \/ end-point attached heparin\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; availability also regional\/global per Medtronic commercial materials\",\"claim\":\"High-evidence, FDA-cleared CPB oxygenator\/circuit family with non-leaching end-point attached heparin surface.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf20\/K203111.pdf | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":16,\"player\":\"Medtronic\",\"device\":\"Affinity NT Cardiotomy\/Venous Reservoir\",\"sku\":\"Cortiva option\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"Cortiva BioActive Surface\",\"supplier\":\"Medtronic; technology lineage from Carmeda BioActive Surface \/ end-point attached heparin\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; availability also regional\/global per Medtronic commercial materials\",\"claim\":\"High-evidence, FDA-cleared CPB oxygenator\/circuit family with non-leaching end-point attached heparin surface.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf20\/K203111.pdf | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":12,\"player\":\"Medtronic\",\"device\":\"Affinity NT Oxygenator\",\"sku\":\"with Cortiva BioActive Surface\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"Cortiva BioActive Surface\",\"supplier\":\"Medtronic; technology lineage from Carmeda BioActive Surface \/ end-point attached heparin\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; availability also regional\/global per Medtronic commercial materials\",\"claim\":\"High-evidence, FDA-cleared CPB oxygenator\/circuit family with non-leaching end-point attached heparin surface.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf20\/K203111.pdf | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":13,\"player\":\"Medtronic\",\"device\":\"Affinity NT Oxygenator\",\"sku\":\"with Trillium Biosurface\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"Trillium Biosurface\",\"supplier\":\"Medtronic; technology licensed under agreement from BioInteractions Limited, United Kingdom\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; other regions not verified in Cycle 2A\",\"claim\":\"Legacy heparin-containing endothelium-mimetic Medtronic\/BioInteractions CPB surface with FDA-listed device configurations.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10532432\/ | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":18,\"player\":\"Medtronic\",\"device\":\"Affinity Pixie Oxygenation System\",\"sku\":\"biocompatible surface option\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Cortiva BioActive Surface; Balance Biosurface\",\"supplier\":\"Medtronic; technology licensed under agreement from BioInteractions Limited, United Kingdom\",\"agent\":\"Cortiva: heparin; Balance: none disclosed\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies\",\"claim\":\"Heparin-free Medtronic\/BioInteractions hydrophilic polymer surface for CPB\/ECLS devices, strategically positioned where heparin surfaces are undesirable.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/K100645.pdf | https:\/\/pubmed.ncbi.nlm.nih.gov\/24447948\/ | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\"},{\"id\":21,\"player\":\"Medtronic\",\"device\":\"Cortiva-coated CPB tubing pack\",\"sku\":\"custom pack option\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"Cortiva BioActive Surface\",\"supplier\":\"Medtronic; technology lineage from Carmeda BioActive Surface \/ end-point attached heparin\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; availability also regional\/global per Medtronic commercial materials\",\"claim\":\"High-evidence, FDA-cleared CPB oxygenator\/circuit family with non-leaching end-point attached heparin surface.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf20\/K203111.pdf | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":499,\"player\":\"Medtronic\",\"device\":\"Pipeline Flex Embolization Device with Shield Technology\",\"sku\":\"Pipeline Flex with Shield Technology\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"Shield Technology\",\"supplier\":\"Medtronic proprietary\",\"agent\":\"None disclosed; antithrombogenic PC polymer surface modification rather than eluting anticoagulant.\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed where approved.\",\"geography\":\"United States \/ Europe \/ Australia \/ international where approved\",\"claim\":\"Market-leading flow diverter family with immobilized PC Shield surface modification.\",\"partnership\":\"Medtronic internal\",\"link\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/aneurysm-flow-diverters\/pipeline-flex-with-shield-technology.html\",\"evidenceChain\":\"https:\/\/news.medtronic.com\/2021-04-21-Medtronic-Receives-U-S-FDA-Approval-for-Pipeline-TM-Flex-Embolization-Device-with-Shield-Technology-TM | https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/aneurysm-flow-diverters\/pipeline-flex-with-shield-technology.html | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7788678\/\"},{\"id\":500,\"player\":\"Medtronic\",\"device\":\"Pipeline Vantage Embolization Device with Shield Technology\",\"sku\":\"Pipeline Vantage with Shield Technology\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Validated competitor\",\"brand\":\"Shield Technology\",\"supplier\":\"Medtronic proprietary\",\"agent\":\"None disclosed; antithrombogenic PC polymer surface modification rather than eluting anticoagulant.\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"TGA Approved\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed where approved; note 2025 field safety notice for selected Pipeline Vantage configurations should be reviewed by region.\",\"geography\":\"United States \/ Europe \/ Australia \/ international where approved\",\"claim\":\"Market-leading flow diverter family with immobilized PC Shield surface modification.\",\"partnership\":\"Medtronic internal\",\"link\":\"https:\/\/www.tga.gov.au\/resources\/artg\/357270\",\"evidenceChain\":\"https:\/\/www.tga.gov.au\/resources\/artg\/357270 | https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/aneurysm-flow-diverters\/pipeline-flex-with-shield-technology.html | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7509525\/\"},{\"id\":20,\"player\":\"Medtronic\",\"device\":\"Trillium-coated CPB circuit component\",\"sku\":\"legacy variant\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"Trillium Biosurface\",\"supplier\":\"Medtronic; technology licensed under agreement from BioInteractions Limited, United Kingdom\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; other regions not verified in Cycle 2A\",\"claim\":\"Legacy heparin-containing endothelium-mimetic Medtronic\/BioInteractions CPB surface with FDA-listed device configurations.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10532432\/ | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":502,\"player\":\"Smart Reactors\",\"device\":\"Camouflage Coated Extracorporeal Cardiopulmonary Tubing Set\",\"sku\":\"SR180C FDA 510(k)-cleared CPB tubing set\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":\"Camouflage\",\"supplier\":\"Smart Reactors\",\"agent\":\"None disclosed; heparin-free positioning in company materials.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":2,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"FDA-cleared in 2026; commercial rollout\/availability should be verified.\",\"geography\":\"United States clearance; Ireland\/UK company base; global availability not fully public\",\"claim\":\"Heparin-free proprietary coated CPB tubing with 2026 FDA 510(k) clearance.\",\"partnership\":\"Supplier\/OEM coating and tubing-set commercialization model; partners not fully public.\",\"link\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf26\/K260043.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K260043 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf26\/K260043.pdf | https:\/\/www.smartreactors.com\/camouflageinertsurface\/\"},{\"id\":328,\"player\":\"SynCardia Systems\",\"device\":\"SynCardia temporary Total Artificial Heart\",\"sku\":\"70cc TAH-t System\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ Canada \/ selected centers\",\"claim\":\"Only widely established FDA-approved temporary TAH platform.\",\"partnership\":null,\"link\":\"https:\/\/www.syncardia.com\/syncardia-total-artificial-heart.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P030011S070 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4162530\/ | https:\/\/www.syncardia.com\/syncardia-total-artificial-heart.html\"},{\"id\":26,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"FX Advance FX15 R30 with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K151791 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumocv.com\/doc\/Schiel_CanadianPerfusionCanadienne_11_No2.pdf\"},{\"id\":27,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"FX Advance FX15 R40 with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K151791 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumocv.com\/doc\/Schiel_CanadianPerfusionCanadienne_11_No2.pdf\"},{\"id\":28,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"FX Advance FX25 with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K151791 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumocv.com\/doc\/Schiel_CanadianPerfusionCanadienne_11_No2.pdf\"},{\"id\":29,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"FX Advance Integrated Arterial Filter with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K151791 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumocv.com\/doc\/Schiel_CanadianPerfusionCanadienne_11_No2.pdf\"},{\"id\":358,\"player\":\"Terumo\",\"device\":\"FRED X Flow Diverter\",\"sku\":\"FRED X with X Technology\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"X Technology\",\"supplier\":\"MicroVention \/ Terumo Neuro\",\"agent\":null,\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Material intrinsic\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.terumo.com\/newsrelease\/detail\/20220222\/677\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma_pas.cfm?s=t&sb=dad | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11571132\/ | https:\/\/www.oruen.com\/wp-content\/uploads\/2022\/12\/36-38_Oruen_Vol-8_Issue-2_Digital80.pdf | https:\/\/www.terumo.com\/newsrelease\/detail\/20220222\/677\"},{\"id\":351,\"player\":\"Terumo\",\"device\":\"SOFIA Catheter\",\"sku\":\"SOFIA 5F\/6F\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":3,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.terumoneuro.com\/products\/sofia\/additional-information\/warnings-and-precaution\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/CDRH510K\/K131482.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/6lZb0TsIL7QNCyEaWcP8DA\/1cdbd407289877672aaa5ac66905300c\/SSCP22-0003.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/4gsOdodL7jDZgSUJmhLU7s\/10d8f7072da8a1f1d4e795aace40a872\/IFU100160X2.pdf | https:\/\/www.terumoneuro.com\/products\/sofia\/additional-information\/warnings-and-precaution\"},{\"id\":353,\"player\":\"Terumo\",\"device\":\"SOFIA Catheter\",\"sku\":\"SOFIA EX\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":3,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.terumoneuro.com\/products\/sofia\/additional-information\/warnings-and-precaution\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/CDRH510K\/K131482.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/6lZb0TsIL7QNCyEaWcP8DA\/1cdbd407289877672aaa5ac66905300c\/SSCP22-0003.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/4gsOdodL7jDZgSUJmhLU7s\/10d8f7072da8a1f1d4e795aace40a872\/IFU100160X2.pdf | https:\/\/www.terumoneuro.com\/products\/sofia\/additional-information\/warnings-and-precaution\"},{\"id\":352,\"player\":\"Terumo\",\"device\":\"SOFIA Catheter\",\"sku\":\"SOFIA Plus\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":3,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.terumoneuro.com\/products\/sofia\/additional-information\/warnings-and-precaution\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/CDRH510K\/K131482.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/6lZb0TsIL7QNCyEaWcP8DA\/1cdbd407289877672aaa5ac66905300c\/SSCP22-0003.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/4gsOdodL7jDZgSUJmhLU7s\/10d8f7072da8a1f1d4e795aace40a872\/IFU100160X2.pdf | https:\/\/www.terumoneuro.com\/products\/sofia\/additional-information\/warnings-and-precaution\"},{\"id\":76,\"player\":\"Toray Medical\",\"device\":\"Hydrolink NV Dialyzer\",\"sku\":\"Hydrolink NV series hemodialyzer\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Hydrolink NV\",\"supplier\":\"Toray Medical \/ Nikkiso lineage depending market literature\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan \/ EU \/ international via distributors\",\"claim\":\"Heparin-free hydrophilic polymer dialysis membrane with antithrombogenic positioning.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6159854\/\",\"evidenceChain\":\"https:\/\/iris.unitn.it\/retrieve\/52a58a50-fa58-4e46-9066-208e8151aa8c\/10.5301_ijao.5000608.pdf | https:\/\/www.mddionline.com\/cardiovascular\/antithrombogenic-polymer-membrane-inhibits-platelet-adhesion | https:\/\/www.toray-medical.com\/en\/products\/dialysis\/dia_0030.html\"},{\"id\":72,\"player\":\"Toray Medical\",\"device\":\"Hydrolink NV Dialyzer\",\"sku\":\"Hydrolink NV-U 1.3\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Hydrolink NV\",\"supplier\":\"Toray Medical \/ Nikkiso lineage depending market literature\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan \/ EU \/ international via distributors\",\"claim\":\"Heparin-free hydrophilic polymer dialysis membrane with antithrombogenic positioning.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6159854\/\",\"evidenceChain\":\"https:\/\/iris.unitn.it\/retrieve\/52a58a50-fa58-4e46-9066-208e8151aa8c\/10.5301_ijao.5000608.pdf | https:\/\/www.mddionline.com\/cardiovascular\/antithrombogenic-polymer-membrane-inhibits-platelet-adhesion | https:\/\/www.toray-medical.com\/en\/products\/dialysis\/dia_0030.html\"},{\"id\":73,\"player\":\"Toray Medical\",\"device\":\"Hydrolink NV Dialyzer\",\"sku\":\"Hydrolink NV-U 1.5\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Hydrolink NV\",\"supplier\":\"Toray Medical \/ Nikkiso lineage depending market literature\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan \/ EU \/ international via distributors\",\"claim\":\"Heparin-free hydrophilic polymer dialysis membrane with antithrombogenic positioning.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6159854\/\",\"evidenceChain\":\"https:\/\/iris.unitn.it\/retrieve\/52a58a50-fa58-4e46-9066-208e8151aa8c\/10.5301_ijao.5000608.pdf | https:\/\/www.mddionline.com\/cardiovascular\/antithrombogenic-polymer-membrane-inhibits-platelet-adhesion | https:\/\/www.toray-medical.com\/en\/products\/dialysis\/dia_0030.html\"},{\"id\":74,\"player\":\"Toray Medical\",\"device\":\"Hydrolink NV Dialyzer\",\"sku\":\"Hydrolink NV-U 1.8\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Hydrolink NV\",\"supplier\":\"Toray Medical \/ Nikkiso lineage depending market literature\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan \/ EU \/ international via distributors\",\"claim\":\"Heparin-free hydrophilic polymer dialysis membrane with antithrombogenic positioning.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6159854\/\",\"evidenceChain\":\"https:\/\/iris.unitn.it\/retrieve\/52a58a50-fa58-4e46-9066-208e8151aa8c\/10.5301_ijao.5000608.pdf | https:\/\/www.mddionline.com\/cardiovascular\/antithrombogenic-polymer-membrane-inhibits-platelet-adhesion | https:\/\/www.toray-medical.com\/en\/products\/dialysis\/dia_0030.html\"},{\"id\":75,\"player\":\"Toray Medical\",\"device\":\"Hydrolink NV Dialyzer\",\"sku\":\"Hydrolink NV-U 2.1\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Hydrolink NV\",\"supplier\":\"Toray Medical \/ Nikkiso lineage depending market literature\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan \/ EU \/ international via distributors\",\"claim\":\"Heparin-free hydrophilic polymer dialysis membrane with antithrombogenic positioning.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6159854\/\",\"evidenceChain\":\"https:\/\/iris.unitn.it\/retrieve\/52a58a50-fa58-4e46-9066-208e8151aa8c\/10.5301_ijao.5000608.pdf | https:\/\/www.mddionline.com\/cardiovascular\/antithrombogenic-polymer-membrane-inhibits-platelet-adhesion | https:\/\/www.toray-medical.com\/en\/products\/dialysis\/dia_0030.html\"},{\"id\":104,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE ACUSEAL Vascular Graft\",\"sku\":\"6 mm standard wall\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies\",\"claim\":\"Heparin-surfaced early-cannulation vascular access graft.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/K130215.pdf | https:\/\/accessgudid.nlm.nih.gov\/devices\/00733132626984 | https:\/\/www.goremedical.com\/en-emea\/products\/acuseal-vg | https:\/\/pubmed.ncbi.nlm.nih.gov\/33685277\/ | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/detail.cfm?mdrfoi__id=11369054&pc=DSY\"},{\"id\":105,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE ACUSEAL Vascular Graft\",\"sku\":\"7 mm standard wall\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies\",\"claim\":\"Heparin-surfaced early-cannulation vascular access graft.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/K130215.pdf | https:\/\/accessgudid.nlm.nih.gov\/devices\/00733132626984 | https:\/\/www.goremedical.com\/en-emea\/products\/acuseal-vg | https:\/\/pubmed.ncbi.nlm.nih.gov\/33685277\/ | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/detail.cfm?mdrfoi__id=11369054&pc=DSY\"},{\"id\":106,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE ACUSEAL Vascular Graft\",\"sku\":\"8 mm standard wall\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies\",\"claim\":\"Heparin-surfaced early-cannulation vascular access graft.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/K130215.pdf | https:\/\/accessgudid.nlm.nih.gov\/devices\/00733132626984 | https:\/\/www.goremedical.com\/en-emea\/products\/acuseal-vg | https:\/\/pubmed.ncbi.nlm.nih.gov\/33685277\/ | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/detail.cfm?mdrfoi__id=11369054&pc=DSY\"},{\"id\":107,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE ACUSEAL Vascular Graft\",\"sku\":\"tapered dialysis access configuration\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies\",\"claim\":\"Heparin-surfaced early-cannulation vascular access graft.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/K130215.pdf | https:\/\/accessgudid.nlm.nih.gov\/devices\/00733132626984 | https:\/\/www.goremedical.com\/en-emea\/products\/acuseal-vg | https:\/\/pubmed.ncbi.nlm.nih.gov\/33685277\/ | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/detail.cfm?mdrfoi__id=11369054&pc=DSY\"},{\"id\":88,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Axillobifemoral configuration\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":90,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Dialysis access configuration\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":89,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Fem-pop bypass configuration\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":91,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Peripheral bypass heparin-bonded configuration\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":82,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Ringed 5 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":83,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Ringed 6 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":84,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Ringed 7 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":85,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Ringed 8 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":77,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Straight 4 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":78,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Straight 5 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":79,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Straight 6 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":80,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Straight 7 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":81,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Straight 8 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":86,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Tapered 4-7 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":87,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE PROPATEN Vascular Graft\",\"sku\":\"Tapered 6-8 mm\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ Carmeda CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; global availability varies by SKU\",\"claim\":\"Heparin-bonded ePTFE vascular graft with named CBAS\/PROPATEN luminal bioactive surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/products\/propaten\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K062161 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\/physician-resources | https:\/\/evtoday.com\/articles\/2014-june-supplement\/bound-to-perform-gore-propaten-vascular-graft-and-cbas-heparin-surface-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":414,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE TIGRIS Vascular Stent\",\"sku\":\"SFA\/PPA self-expanding stent\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":\"Peripheral nitinol\/fluoropolymer stent with CBAS heparin surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160004B.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160004D.pdf | https:\/\/www.goremedical.com\/la\/news\/gore-tigris-vascular-stent-fda-approval | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":100,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"10 mm x 5 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":101,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"11 mm x 10 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":102,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"13 mm x 10 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":92,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"5 mm x 2.5 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":93,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"5 mm x 5 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":95,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"6 mm x 10 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":94,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"6 mm x 5 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":97,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"7 mm x 10 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":96,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"7 mm x 5 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":99,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"8 mm x 10 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":98,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"8 mm x 5 cm with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":103,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN Endoprosthesis\",\"sku\":\"SFA\/AV access indication configuration with Heparin Bioactive Surface\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"GORE Heparin Bioactive Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ international varies by indication\",\"claim\":\"Implantable stent graft with heparin bioactive surface and broad clinical use.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130006S099 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/viabahn | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten\"},{\"id\":413,\"player\":\"W. L. Gore & Associates\",\"device\":\"GORE VIABAHN VBX Balloon Expandable Endoprosthesis\",\"sku\":\"VBX iliac\/complex aortoiliac configuration\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Validated competitor\",\"brand\":\"CBAS Heparin Surface \/ Heparin Bioactive Surface\",\"supplier\":\"W. L. Gore & Associates \/ CBAS technology lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":\"Balloon-expandable covered endoprosthesis with CBAS heparin surface.\",\"partnership\":null,\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160021B.pdf | https:\/\/vascularnews.com\/gores-viabahn-vbx-stent-graft-receives-fda-approval\/ | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf\"},{\"id\":361,\"player\":\"phenox\",\"device\":\"p48 LITE Flow Modulation Device\",\"sku\":\"p48 LITE HPC\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"HPC\",\"supplier\":\"phenox\",\"agent\":null,\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/phenox.net\/international\/?arm_dd_file=559&arm_file_id=0\",\"evidenceChain\":\"https:\/\/phenox.net\/international\/?arm_dd_file=559&arm_file_id=0 | https:\/\/phenox.net\/international\/wp-content\/uploads\/2021\/06\/IFU-p64-MW-C.pdf | https:\/\/phenox.net\/international\/uploads\/KIF\/KIF-0117C%20-%20p48%20Lite%20Brochure.pdf\"},{\"id\":360,\"player\":\"phenox\",\"device\":\"p48 MW Flow Modulation Device\",\"sku\":\"p48 MW HPC\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"HPC\",\"supplier\":\"phenox\",\"agent\":null,\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/phenox.net\/international\/?arm_dd_file=559&arm_file_id=0\",\"evidenceChain\":\"https:\/\/phenox.net\/international\/?arm_dd_file=559&arm_file_id=0 | https:\/\/phenox.net\/international\/wp-content\/uploads\/2021\/06\/IFU-p64-MW-C.pdf | https:\/\/phenox.net\/international\/uploads\/KIF\/KIF-0117C%20-%20p48%20Lite%20Brochure.pdf\"},{\"id\":359,\"player\":\"phenox\",\"device\":\"p64 MW Flow Modulation Device\",\"sku\":\"p64 MW HPC\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"HPC\",\"supplier\":\"phenox\",\"agent\":null,\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/phenox.net\/international\/?arm_dd_file=559&arm_file_id=0\",\"evidenceChain\":\"https:\/\/phenox.net\/international\/?arm_dd_file=559&arm_file_id=0 | https:\/\/phenox.net\/international\/wp-content\/uploads\/2021\/06\/IFU-p64-MW-C.pdf | https:\/\/phenox.net\/international\/uploads\/KIF\/KIF-0117C%20-%20p48%20Lite%20Brochure.pdf\"},{\"id\":60,\"player\":\"Baxter \/ Vantive\",\"device\":\"oXiris Set\",\"sku\":\"PrisMax oXiris Set\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"oXiris \/ AN69 oXiris membrane\",\"supplier\":\"Vantive \/ Baxter (legacy Gambro)\",\"agent\":\"Heparin (surface graft)\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States EUA-era; international\/commercial availability per company; verify country-specific authorization\",\"claim\":\"CRRT filter with explicit heparin-grafted membrane plus adsorptive layers.\",\"partnership\":null,\"link\":\"https:\/\/pro.vantive.com\/oxiris-set\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/137267\/download | https:\/\/pro.vantive.com\/oxiris-set | https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01779635 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695587\/ | https:\/\/research.monash.edu\/en\/publications\/the-effect-of-the-an69-st100-versus-oxirissupsup-membrane-on-filt\/\"},{\"id\":59,\"player\":\"Baxter \/ Vantive\",\"device\":\"oXiris Set\",\"sku\":\"Prismaflex oXiris Set\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"oXiris \/ AN69 oXiris membrane\",\"supplier\":\"Vantive \/ Baxter (legacy Gambro)\",\"agent\":\"Heparin (surface graft)\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States EUA-era; international\/commercial availability per company; verify country-specific authorization\",\"claim\":\"CRRT filter with explicit heparin-grafted membrane plus adsorptive layers.\",\"partnership\":null,\"link\":\"https:\/\/pro.vantive.com\/oxiris-set\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/137267\/download | https:\/\/pro.vantive.com\/oxiris-set | https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01779635 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695587\/ | https:\/\/research.monash.edu\/en\/publications\/the-effect-of-the-an69-st100-versus-oxirissupsup-membrane-on-filt\/\"},{\"id\":58,\"player\":\"Baxter \/ Vantive\",\"device\":\"oXiris Set\",\"sku\":\"oXiris ST150\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"oXiris \/ AN69 oXiris membrane\",\"supplier\":\"Vantive \/ Baxter (legacy Gambro)\",\"agent\":\"Heparin (surface graft)\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States EUA-era; international\/commercial availability per company; verify country-specific authorization\",\"claim\":\"CRRT filter with explicit heparin-grafted membrane plus adsorptive layers.\",\"partnership\":null,\"link\":\"https:\/\/pro.vantive.com\/oxiris-set\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/137267\/download | https:\/\/pro.vantive.com\/oxiris-set | https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01779635 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695587\/ | https:\/\/research.monash.edu\/en\/publications\/the-effect-of-the-an69-st100-versus-oxirissupsup-membrane-on-filt\/\"},{\"id\":57,\"player\":\"Baxter \/ Vantive\",\"device\":\"oXiris Set\",\"sku\":\"oXiris Set\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"oXiris \/ AN69 oXiris membrane\",\"supplier\":\"Vantive \/ Baxter (legacy Gambro)\",\"agent\":\"Heparin (surface graft)\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States EUA-era; international\/commercial availability per company; verify country-specific authorization\",\"claim\":\"CRRT filter with explicit heparin-grafted membrane plus adsorptive layers.\",\"partnership\":null,\"link\":\"https:\/\/pro.vantive.com\/oxiris-set\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/137267\/download | https:\/\/pro.vantive.com\/oxiris-set | https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01779635 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695587\/ | https:\/\/research.monash.edu\/en\/publications\/the-effect-of-the-an69-st100-versus-oxirissupsup-membrane-on-filt\/\"},{\"id\":64,\"player\":\"Baxter \/ Vantive\",\"device\":\"oXiris Set\",\"sku\":\"oXiris adsorption hemofilter adult\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"oXiris \/ AN69 oXiris membrane\",\"supplier\":\"Vantive \/ Baxter (legacy Gambro)\",\"agent\":\"Heparin (surface graft)\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States EUA-era; international\/commercial availability per company; verify country-specific authorization\",\"claim\":\"CRRT filter with explicit heparin-grafted membrane plus adsorptive layers.\",\"partnership\":null,\"link\":\"https:\/\/pro.vantive.com\/oxiris-set\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/137267\/download | https:\/\/pro.vantive.com\/oxiris-set | https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01779635 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695587\/ | https:\/\/research.monash.edu\/en\/publications\/the-effect-of-the-an69-st100-versus-oxirissupsup-membrane-on-filt\/\"},{\"id\":62,\"player\":\"Baxter \/ Vantive\",\"device\":\"oXiris Set\",\"sku\":\"oXiris filterset for sepsis-associated AKI\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"oXiris \/ AN69 oXiris membrane\",\"supplier\":\"Vantive \/ Baxter (legacy Gambro)\",\"agent\":\"Heparin (surface graft)\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States EUA-era; international\/commercial availability per company; verify country-specific authorization\",\"claim\":\"CRRT filter with explicit heparin-grafted membrane plus adsorptive layers.\",\"partnership\":null,\"link\":\"https:\/\/pro.vantive.com\/oxiris-set\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/137267\/download | https:\/\/pro.vantive.com\/oxiris-set | https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01779635 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695587\/ | https:\/\/research.monash.edu\/en\/publications\/the-effect-of-the-an69-st100-versus-oxirissupsup-membrane-on-filt\/\"},{\"id\":63,\"player\":\"Baxter \/ Vantive\",\"device\":\"oXiris Set\",\"sku\":\"oXiris hemofilter\/dialyzer EUA-era configuration\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"oXiris \/ AN69 oXiris membrane\",\"supplier\":\"Vantive \/ Baxter (legacy Gambro)\",\"agent\":\"Heparin (surface graft)\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States EUA-era; international\/commercial availability per company; verify country-specific authorization\",\"claim\":\"CRRT filter with explicit heparin-grafted membrane plus adsorptive layers.\",\"partnership\":null,\"link\":\"https:\/\/pro.vantive.com\/oxiris-set\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/137267\/download | https:\/\/pro.vantive.com\/oxiris-set | https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01779635 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695587\/ | https:\/\/research.monash.edu\/en\/publications\/the-effect-of-the-an69-st100-versus-oxirissupsup-membrane-on-filt\/\"},{\"id\":329,\"player\":\"CARMAT\",\"device\":\"Aeson Total Artificial Heart\",\"sku\":\"Aeson bioprosthetic TAH\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Europe \/ CE-recognizing countries; US investigational history\",\"claim\":\"Bioprosthetic TAH differentiates by blood-contacting tissue\/material interface rather than synthetic anticoagulant coating.\",\"partnership\":null,\"link\":\"https:\/\/live.euronext.com\/en\/products\/equities\/company-news\/2025-07-28-carmat-receives-mdr-ce-marking-its-aesonr-artificial\",\"evidenceChain\":\"https:\/\/live.euronext.com\/en\/products\/equities\/company-news\/2025-07-28-carmat-receives-mdr-ce-marking-its-aesonr-artificial | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6906674\/ | https:\/\/www.bioworld.com\/articles\/501756-carmats-artificial-heart-receives-ce-mark\"},{\"id\":67,\"player\":\"Fresenius Medical Care\",\"device\":\"FX CorAL Dialyzer\",\"sku\":\"FX CorAL 100\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Helixone hydro membrane\",\"supplier\":\"Fresenius Medical Care\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ EMEA\",\"claim\":\"High-volume global dialyzer entrant with explicit hemocompatibility positioning.\",\"partnership\":null,\"link\":\"https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243874.pdf | https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/ | https:\/\/www.fresenius.com\/node\/5203 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12113146\/\"},{\"id\":71,\"player\":\"Fresenius Medical Care\",\"device\":\"FX CorAL Dialyzer\",\"sku\":\"FX CorAL 1000\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Helixone hydro membrane\",\"supplier\":\"Fresenius Medical Care\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ EMEA\",\"claim\":\"High-volume global dialyzer entrant with explicit hemocompatibility positioning.\",\"partnership\":null,\"link\":\"https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243874.pdf | https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/ | https:\/\/www.fresenius.com\/node\/5203 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12113146\/\"},{\"id\":68,\"player\":\"Fresenius Medical Care\",\"device\":\"FX CorAL Dialyzer\",\"sku\":\"FX CorAL 120\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Helixone hydro membrane\",\"supplier\":\"Fresenius Medical Care\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ EMEA\",\"claim\":\"High-volume global dialyzer entrant with explicit hemocompatibility positioning.\",\"partnership\":null,\"link\":\"https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243874.pdf | https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/ | https:\/\/www.fresenius.com\/node\/5203 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12113146\/\"},{\"id\":65,\"player\":\"Fresenius Medical Care\",\"device\":\"FX CorAL Dialyzer\",\"sku\":\"FX CorAL 60\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Helixone hydro membrane\",\"supplier\":\"Fresenius Medical Care\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ EMEA\",\"claim\":\"High-volume global dialyzer entrant with explicit hemocompatibility positioning.\",\"partnership\":null,\"link\":\"https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243874.pdf | https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/ | https:\/\/www.fresenius.com\/node\/5203 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12113146\/\"},{\"id\":69,\"player\":\"Fresenius Medical Care\",\"device\":\"FX CorAL Dialyzer\",\"sku\":\"FX CorAL 600\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Helixone hydro membrane\",\"supplier\":\"Fresenius Medical Care\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ EMEA\",\"claim\":\"High-volume global dialyzer entrant with explicit hemocompatibility positioning.\",\"partnership\":null,\"link\":\"https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243874.pdf | https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/ | https:\/\/www.fresenius.com\/node\/5203 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12113146\/\"},{\"id\":66,\"player\":\"Fresenius Medical Care\",\"device\":\"FX CorAL Dialyzer\",\"sku\":\"FX CorAL 80\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Helixone hydro membrane\",\"supplier\":\"Fresenius Medical Care\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ EMEA\",\"claim\":\"High-volume global dialyzer entrant with explicit hemocompatibility positioning.\",\"partnership\":null,\"link\":\"https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243874.pdf | https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/ | https:\/\/www.fresenius.com\/node\/5203 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12113146\/\"},{\"id\":70,\"player\":\"Fresenius Medical Care\",\"device\":\"FX CorAL Dialyzer\",\"sku\":\"FX CorAL 800\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Helixone hydro membrane\",\"supplier\":\"Fresenius Medical Care\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe \/ EMEA\",\"claim\":\"High-volume global dialyzer entrant with explicit hemocompatibility positioning.\",\"partnership\":null,\"link\":\"https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243874.pdf | https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/ | https:\/\/www.fresenius.com\/node\/5203 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12113146\/\"},{\"id\":7,\"player\":\"Getinge\",\"device\":\"HLS Cannulae VA access\",\"sku\":\"HLS Cannulae VA access with BIOLINE\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"CE region; global availability varies\",\"claim\":\"Bioactive heparin-albumin coated extracorporeal support platform with broad Getinge\/Cardiohelp adoption and CE-region extended-use positioning.\",\"partnership\":\"Internal\/Getinge coating platform\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-cannulae\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-cannulae\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/journals.sagepub.com\/doi\/10.1177\/0267659118772452 | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf\"},{\"id\":6,\"player\":\"Getinge\",\"device\":\"HLS Cannulae VV access\",\"sku\":\"HLS Cannulae VV access with BIOLINE\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"CE region; global availability varies\",\"claim\":\"Bioactive heparin-albumin coated extracorporeal support platform with broad Getinge\/Cardiohelp adoption and CE-region extended-use positioning.\",\"partnership\":\"Internal\/Getinge coating platform\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-cannulae\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-cannulae\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/journals.sagepub.com\/doi\/10.1177\/0267659118772452 | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf\"},{\"id\":117,\"player\":\"Medtronic\",\"device\":\"React Aspiration Catheter\",\"sku\":\"React 71\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":\"Distal hydrophilic coating\",\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; other regions vary\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/K182101.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/K182097.pdf | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\"},{\"id\":30,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"CAPIOX Custom Pack Xcoating with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\"},{\"id\":31,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"CAPIOX Pediatric Xcoating with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\"},{\"id\":22,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"FX05 with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\"},{\"id\":23,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"FX15 R30 with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\"},{\"id\":24,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"FX15 R40 with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\"},{\"id\":25,\"player\":\"Terumo\",\"device\":\"CAPIOX FX \/ FX Advance Oxygenator\",\"sku\":\"FX25 with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo Cardiovascular \/ Terumo Corporation\",\"agent\":\"None disclosed; heparin-free biopassive polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":5,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; Europe\/Asia-Pacific commercial pages also available\",\"claim\":\"Heparin-free biopassive amphiphilic polymer coating integrated into high-volume CAPIOX FX\/FX Advance oxygenators with integrated arterial filters.\",\"partnership\":\"Internal Terumo coating\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K140774.pdf | https:\/\/congreso.sectcv.es\/wp-content\/uploads\/2020\/10\/CV228GB-0718-OB-I07.18E_CAPIOX-FX-Advance-Brochure.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\"},{\"id\":332,\"player\":\"Abbott\",\"device\":\"Amplatzer Amulet Left Atrial Appendage Occluder\",\"sku\":\"Amplatzer Amulet LAA Occluder\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States\",\"claim\":\"Established structural-heart\/cardiac implant material platform; relevance depends on material-driven hemocompatibility rather than active coating.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/structural-heart\/structural-interventions\/amplatzer-amulet.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P200049 | https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/structural-heart\/structural-interventions\/amplatzer-amulet.html\"},{\"id\":336,\"player\":\"Abbott\",\"device\":\"MitraClip G4 Transcatheter Mitral Valve Repair System\",\"sku\":\"MitraClip G4 System\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ CE region\",\"claim\":\"Established structural-heart\/cardiac implant material platform; relevance depends on material-driven hemocompatibility rather than active coating.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/structural-heart\/transcatheter-valve-solutions\/mitraclip.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=434446 | https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/structural-heart\/transcatheter-valve-solutions\/mitraclip.html\"},{\"id\":337,\"player\":\"Abbott\",\"device\":\"TriClip Transcatheter Edge-to-Edge Repair System\",\"sku\":\"TriClip G4\/G5 family\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ CE region\",\"claim\":\"Established structural-heart\/cardiac implant material platform; relevance depends on material-driven hemocompatibility rather than active coating.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/abbott.mediaroom.com\/2024-04-02-Abbott-Receives-FDA-Approval-for-TriClip-TM-%2C-First-of-Its-Kind-Device-to-Repair-Leaky-Tricuspid-Heart-Valve\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P230007S009 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P100009S078 | https:\/\/abbott.mediaroom.com\/2024-04-02-Abbott-Receives-FDA-Approval-for-TriClip-TM-%2C-First-of-Its-Kind-Device-to-Repair-Leaky-Tricuspid-Heart-Valve\"},{\"id\":126,\"player\":\"BD\",\"device\":\"Lutonix drug-coated balloon\",\"sku\":\"035 platform\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"Lutonix drug coating\",\"supplier\":\"Undisclosed OEM coating supplier\",\"agent\":\"Paclitaxel\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Drug-eluting reservoir\",\"release\":\"Drug eluting\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":1,\"bench\":1,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States\",\"claim\":\"Included for competitive adjacency and blood-contacting surface\/coating tracking.\",\"partnership\":null,\"link\":\"https:\/\/www.bd.com\/en-us\/products-and-solutions\/products\/product-families\/lutonix-drug-coated-balloon-pta-catheters\",\"evidenceChain\":\"https:\/\/www.bd.com\/en-us\/products-and-solutions\/products\/product-families\/lutonix-drug-coated-balloon-pta-catheters | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf17\/P170003B.pdf | https:\/\/www.fda.gov\/media\/113951\/download\"},{\"id\":331,\"player\":\"Boston Scientific\",\"device\":\"WATCHMAN FLX Left Atrial Appendage Closure Device\",\"sku\":\"WATCHMAN FLX Device with Delivery System\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States\",\"claim\":\"Established structural-heart\/cardiac implant material platform; relevance depends on material-driven hemocompatibility rather than active coating.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/www.bostonscientific.com\/en-US\/products\/laac-system\/watchman-flx-pro.html\",\"evidenceChain\":\"https:\/\/www.bostonscientific.com\/en-US\/products\/laac-system\/watchman-flx-pro.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P130013S080 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P130013S057 | https:\/\/www.watchman.com\/content\/dam\/watchman\/downloads\/download-center\/watchman-flx\/WATCHMAN_FLX_Specsheet.pdf\"},{\"id\":376,\"player\":\"CERENOVUS\",\"device\":\"EMBOTRAP III Revascularization Device\",\"sku\":\"EMBOTRAP III\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":0,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.jnjmedtech.com\/en-US\/products\/neurovascular\/ischemic\/embotrap-iii-revascularization-device\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/K193063.pdf | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K193063 | https:\/\/www.jnjmedtech.com\/en-US\/products\/neurovascular\/ischemic\/embotrap-iii-revascularization-device\/ | https:\/\/pubmed.ncbi.nlm.nih.gov\/34750107\/\"},{\"id\":496,\"player\":\"Getinge\",\"device\":\"PLS Set with BIOLINE Coating\",\"sku\":\"Permanent Life Support set \/ tip-to-tip BIOLINE coating\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed \/ legacy family; verify current SKU availability.\",\"geography\":\"United States \/ Europe \/ international depending SKU\",\"claim\":\"Getinge\/Maquet SKU-level coated oxygenator\/component variants with BIOLINE or SOFTLINE options.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/santair.gr\/wp-content\/uploads\/2024\/05\/50305-PLS_Set_Brochure.pdf\",\"evidenceChain\":\"https:\/\/santair.gr\/wp-content\/uploads\/2024\/05\/50305-PLS_Set_Brochure.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":489,\"player\":\"Getinge\",\"device\":\"QUADROX-i Adult Microporous Membrane Oxygenator\",\"sku\":\"Adult with integrated arterial filter \/ BIOLINE coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed \/ legacy family; verify current SKU availability.\",\"geography\":\"United States \/ Europe \/ international depending SKU\",\"claim\":\"Getinge\/Maquet SKU-level coated oxygenator\/component variants with BIOLINE or SOFTLINE options.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf9\/K090511.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf9\/K090511.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":490,\"player\":\"Getinge\",\"device\":\"QUADROX-i Adult Microporous Membrane Oxygenator\",\"sku\":\"Adult with integrated arterial filter \/ SOFTLINE coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Due diligence flag\",\"brand\":\"SOFTLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed \/ legacy family; verify current SKU availability.\",\"geography\":\"United States \/ Europe \/ international depending SKU\",\"claim\":\"Getinge\/Maquet SKU-level coated oxygenator\/component variants with BIOLINE or SOFTLINE options.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/k101153.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/k101153.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf9\/K090511.pdf\"},{\"id\":492,\"player\":\"Getinge\",\"device\":\"QUADROX-i Neonatal Microporous Membrane Oxygenator\",\"sku\":\"Neonatal with SOFTLINE and\/or BIOLINE coating options\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Due diligence flag\",\"brand\":\"SOFTLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed \/ legacy family; verify current SKU availability.\",\"geography\":\"United States \/ Europe \/ international depending SKU\",\"claim\":\"Getinge\/Maquet SKU-level coated oxygenator\/component variants with BIOLINE or SOFTLINE options.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/K102464.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/K102464.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":491,\"player\":\"Getinge\",\"device\":\"QUADROX-i Small Adult Microporous Membrane Oxygenator\",\"sku\":\"Small Adult with optional BIOLINE coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed \/ legacy family; verify current SKU availability.\",\"geography\":\"United States \/ Europe \/ international depending SKU\",\"claim\":\"Getinge\/Maquet SKU-level coated oxygenator\/component variants with BIOLINE or SOFTLINE options.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\",\"evidenceChain\":\"https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf9\/K090511.pdf\"},{\"id\":493,\"player\":\"Getinge\",\"device\":\"QUADROX-iD Adult Diffusion Membrane Oxygenator\",\"sku\":\"Adult diffusion membrane with BIOLINE coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed \/ legacy family; verify current SKU availability.\",\"geography\":\"United States \/ Europe \/ international depending SKU\",\"claim\":\"Getinge\/Maquet SKU-level coated oxygenator\/component variants with BIOLINE or SOFTLINE options.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/k101153.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/k101153.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":495,\"player\":\"Getinge\",\"device\":\"QUADROX-iD Pediatric Diffusion Membrane Oxygenator\",\"sku\":\"Pediatric diffusion membrane with BIOLINE coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed \/ legacy family; verify current SKU availability.\",\"geography\":\"United States \/ Europe \/ international depending SKU\",\"claim\":\"Getinge\/Maquet SKU-level coated oxygenator\/component variants with BIOLINE or SOFTLINE options.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/K100278.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/K100278.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":127,\"player\":\"Medtronic\",\"device\":\"IN.PACT Admiral drug-coated balloon\",\"sku\":\"Admiral\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Validated competitor\",\"brand\":\"IN.PACT coating\",\"supplier\":\"Undisclosed OEM coating supplier\",\"agent\":\"Paclitaxel\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Drug-eluting reservoir\",\"release\":\"Drug eluting\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":1,\"bench\":1,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States\",\"claim\":\"Included for competitive adjacency and blood-contacting surface\/coating tracking.\",\"partnership\":null,\"link\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/cardiovascular\/peripheral-drug-coated-balloons\/inpact-admiral-drug-coated-balloon.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/cardiovascular\/peripheral-drug-coated-balloons\/inpact-admiral-drug-coated-balloon.html | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/P140010b.pdf | https:\/\/www.fda.gov\/media\/113951\/download\"},{\"id\":354,\"player\":\"Terumo\",\"device\":\"Headway Microcatheter\",\"sku\":\"Headway 17\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/2UmANaKzHoZ9OtqN4Y4cnx\/e06483d028e4ada69268b28130bb262e\/Headway_Wedge_IFU100305X2.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K142449.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/2UmANaKzHoZ9OtqN4Y4cnx\/e06483d028e4ada69268b28130bb262e\/Headway_Wedge_IFU100305X2.pdf | https:\/\/www.terumoneuro.com\/products\/headway\/additional-information\/indications-for-use\"},{\"id\":355,\"player\":\"Terumo\",\"device\":\"Headway Microcatheter\",\"sku\":\"Headway 21\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/2UmANaKzHoZ9OtqN4Y4cnx\/e06483d028e4ada69268b28130bb262e\/Headway_Wedge_IFU100305X2.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K142449.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/2UmANaKzHoZ9OtqN4Y4cnx\/e06483d028e4ada69268b28130bb262e\/Headway_Wedge_IFU100305X2.pdf | https:\/\/www.terumoneuro.com\/products\/headway\/additional-information\/indications-for-use\"},{\"id\":356,\"player\":\"Terumo\",\"device\":\"Headway Microcatheter\",\"sku\":\"Headway 27\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/2UmANaKzHoZ9OtqN4Y4cnx\/e06483d028e4ada69268b28130bb262e\/Headway_Wedge_IFU100305X2.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K142449.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/2UmANaKzHoZ9OtqN4Y4cnx\/e06483d028e4ada69268b28130bb262e\/Headway_Wedge_IFU100305X2.pdf | https:\/\/www.terumoneuro.com\/products\/headway\/additional-information\/indications-for-use\"},{\"id\":357,\"player\":\"Terumo\",\"device\":\"Headway Microcatheter\",\"sku\":\"Headway Duo\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/2UmANaKzHoZ9OtqN4Y4cnx\/e06483d028e4ada69268b28130bb262e\/Headway_Wedge_IFU100305X2.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K142449.pdf | https:\/\/assets.ctfassets.net\/ka7vsj9fzri4\/2UmANaKzHoZ9OtqN4Y4cnx\/e06483d028e4ada69268b28130bb262e\/Headway_Wedge_IFU100305X2.pdf | https:\/\/www.terumoneuro.com\/products\/headway\/additional-information\/indications-for-use\"},{\"id\":120,\"player\":\"Terumo\",\"device\":\"Radifocus Glidewire\",\"sku\":\"M Standard\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Mcoat\",\"supplier\":\"Undisclosed OEM coating supplier\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/international product pages available\",\"claim\":\"Included for competitive adjacency and blood-contacting surface\/coating tracking.\",\"partnership\":null,\"link\":\"https:\/\/tis.terumo.com\/products\/radifocus_guide_wire_m\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf15\/K152740.pdf | https:\/\/tis.terumo.com\/products\/radifocus_guide_wire_m | https:\/\/www.terumo-europe.com\/en\/interventional-systems\/products\/product-type\/guidewires\/radifocus-guidewire-advantage-guide-wire\"},{\"id\":463,\"player\":\"Acandis\",\"device\":\"HEAL Technology\",\"sku\":\"HEAL coating platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"HEAL Technology\",\"supplier\":\"Acandis\",\"agent\":\"Heparin covalently bound to fibrin network\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Endogenous fibrin\/heparin surface that combines antithrombogenicity with endothelialization support.\",\"partnership\":\"Applied to Acandis laser-cut and braided devices; no external OEM relationships captured.\",\"link\":\"https:\/\/acandis.com\/en\/technologies\/heal-technology-en\/\",\"evidenceChain\":\"https:\/\/acandis.com\/en\/technologies\/heal-technology-en\/ | https:\/\/acandis.com\/en\/haemorrhagic-stroke\/derivo-2heal-embolisation-device\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11095352\/ | https:\/\/link.springer.com\/article\/10.1007\/s00270-021-03007-9\"},{\"id\":461,\"player\":\"AngioDynamics\",\"device\":\"Endexo Technology\",\"sku\":\"BioFlo\/Endexo material platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Endexo Technology \/ BioFlo\",\"supplier\":\"AngioDynamics \/ proprietary technology; supplier origins require follow-up\",\"agent\":\"None; no heparin, no coating, no impregnation per public BioFlo brochure\",\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Material-intrinsic thrombus-resistance avoids heparin, coating, or drug release.\",\"partnership\":\"Used in BioFlo PICC, ports, midline and dialysis catheter products; distributors include Spectrum Vascular\/MSA materials.\",\"link\":\"https:\/\/www.angiodynamics.com\/product\/bioflo-ports\/\",\"evidenceChain\":\"https:\/\/www.angiodynamics.com\/product\/bioflo-ports\/ | https:\/\/spectrumvascular.com\/technology\/bioflo-technology\/ | https:\/\/msa.com.au\/wp-content\/uploads\/2024\/06\/BIO1000-BioFlo-PICC-Brochure-MSA-Edit_compressed.pdf | https:\/\/www.tga.gov.au\/resources\/artg\/215418\"},{\"id\":133,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160021B.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160004D.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf\"},{\"id\":132,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160021B.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160004D.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf\"},{\"id\":433,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CBAS platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA BioActive Surface \/ CBAS Heparin Surface\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Mature, non-eluting, end-point attached heparin platform with public device applications and large evidence base.\",\"partnership\":\"Carmeda states CBAS Heparin Surface is the Gore trademarked implementation for Gore vascular devices.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.carmeda.se\/carmeda-bioactive-surface | https:\/\/www.carmeda.se\/coating-technology | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/pubmed.ncbi.nlm.nih.gov\/28042080\/\"},{\"id\":438,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O. \/ PHISIO PC coating\",\"sku\":\"Phosphorylcholine platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O.\",\"supplier\":\"LivaNova \/ Sorin lineage\",\"agent\":\"None disclosed; bio-passive PC chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Heparin-free PC platform integrated into LivaNova oxygenator\/reservoir portfolio.\",\"partnership\":\"Internal LivaNova\/Sorin platform\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/cardiopulmonary\/en-us\/oxygenators\/inspire | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf | https:\/\/pubmed.ncbi.nlm.nih.gov\/20172900\/ | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\"},{\"id\":435,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva BioActive Surface\",\"supplier\":\"Medtronic; technology lineage associated with Carmeda\/Medtronic literature\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Large evidence base in extracorporeal circulation and Medtronic circuit portfolio integration.\",\"partnership\":\"Internal Medtronic cardiopulmonary platform; device-specific incorporation varies.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface\/indications-safety-warnings.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/28042080\/ | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":464,\"player\":\"Medtronic\",\"device\":\"Shield Technology\",\"sku\":\"Pipeline Shield surface modification\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Shield Technology\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Ultra-thin covalently bonded surface modification with major neurovascular market presence.\",\"partnership\":\"Medtronic internal technology on Pipeline family.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/en-us\/e\/healthcare-professionals\/neurological\/pipeline-flow-diverter\/shield-technology.html | https:\/\/www.terumoneuro.com\/newsroom\/press-releases\/microvention-announces-first-u-s-patient-treated-with-fred-tm-x-tm-flow | https:\/\/www.terumo.com\/newsrelease\/detail\/20220222\/677 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12852632\/ | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\"},{\"id\":434,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface\",\"sku\":\"Gore proprietary implementation\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS Heparin Surface \/ PROPATEN Bioactive Surface\",\"supplier\":\"Carmeda AB technology marketed by Gore as CBAS on Gore devices\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":5,\"bench\":5,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Probably the most visible heparin-bonded long-term implant surface in peripheral vascular graft\/stent-graft markets.\",\"partnership\":\"Carmeda technology; Gore-specific marketed implementation.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/core.ac.uk\/download\/pdf\/82378881.pdf | https:\/\/pubmed.ncbi.nlm.nih.gov\/28042080\/ | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf\"},{\"id\":146,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/sites\/default\/files\/resources\/pdf\/2026-02\/22739400-EN-PVG-FAQ-Bro-FNL.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf | https:\/\/www.nice.org.uk\/advice\/mib42\/resources\/propaten-heparinbonded-vascular-graft-for-peripheral-arterial-disease-pdf-63499162702021\"},{\"id\":139,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/sites\/default\/files\/resources\/pdf\/2026-02\/22739400-EN-PVG-FAQ-Bro-FNL.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf | https:\/\/www.nice.org.uk\/advice\/mib42\/resources\/propaten-heparinbonded-vascular-graft-for-peripheral-arterial-disease-pdf-63499162702021\"},{\"id\":147,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/sites\/default\/files\/resources\/pdf\/2026-02\/22739400-EN-PVG-FAQ-Bro-FNL.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf | https:\/\/www.nice.org.uk\/advice\/mib42\/resources\/propaten-heparinbonded-vascular-graft-for-peripheral-arterial-disease-pdf-63499162702021\"},{\"id\":143,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160021B.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160004D.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":138,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/sites\/default\/files\/resources\/pdf\/2026-02\/22739400-EN-PVG-FAQ-Bro-FNL.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf | https:\/\/www.nice.org.uk\/advice\/mib42\/resources\/propaten-heparinbonded-vascular-graft-for-peripheral-arterial-disease-pdf-63499162702021\"},{\"id\":145,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/sites\/default\/files\/resources\/pdf\/2026-02\/22739400-EN-PVG-FAQ-Bro-FNL.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf | https:\/\/www.nice.org.uk\/advice\/mib42\/resources\/propaten-heparinbonded-vascular-graft-for-peripheral-arterial-disease-pdf-63499162702021\"},{\"id\":144,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/sites\/default\/files\/resources\/pdf\/2026-02\/22739400-EN-PVG-FAQ-Bro-FNL.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf | https:\/\/www.nice.org.uk\/advice\/mib42\/resources\/propaten-heparinbonded-vascular-graft-for-peripheral-arterial-disease-pdf-63499162702021\"},{\"id\":140,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/sites\/default\/files\/resources\/pdf\/2026-02\/22739400-EN-PVG-FAQ-Bro-FNL.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf | https:\/\/www.nice.org.uk\/advice\/mib42\/resources\/propaten-heparinbonded-vascular-graft-for-peripheral-arterial-disease-pdf-63499162702021\"},{\"id\":141,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology | https:\/\/www.goremedical.com\/sites\/default\/files\/resources\/pdf\/2026-02\/22739400-EN-PVG-FAQ-Bro-FNL.pdf | https:\/\/www.goremedical.com\/en-emea\/products\/propaten | https:\/\/cdn.clinicaltrials.gov\/large-docs\/04\/NCT03720704\/Prot_000.pdf | https:\/\/www.nice.org.uk\/advice\/mib42\/resources\/propaten-heparinbonded-vascular-graft-for-peripheral-arterial-disease-pdf-63499162702021\"},{\"id\":142,\"player\":\"W. L. Gore & Associates\",\"device\":\"CBAS Heparin Surface Technology\",\"sku\":\"CBAS \/ PROPATEN Bioactive Surface application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CBAS \/ PROPATEN Bioactive Surface\",\"supplier\":\"Gore Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CBAS \/ PROPATEN Bioactive Surface into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232312.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160021B.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160004D.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040037S060c.pdf | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":462,\"player\":\"phenox\",\"device\":\"Hydrophilic Polymer Coating\",\"sku\":\"pHPC \/ HPC platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"HPC \/ pHPC\",\"supplier\":\"phenox\",\"agent\":\"None disclosed\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":4,\"bench\":4,\"evidence\":5,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Neurovascular implant-specific antithrombogenic polymer coating with public clinical and bench evidence.\",\"partnership\":\"Used on phenox p48\/p64 HPC devices; supplier is finished-device manufacturer.\",\"link\":\"https:\/\/phenox.net\/international\/?arm_dd_file=559&arm_file_id=0\",\"evidenceChain\":\"https:\/\/phenox.net\/international\/?arm_dd_file=559&arm_file_id=0 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7645186\/ | https:\/\/jnis.bmj.com\/content\/14\/Suppl_1\/A140.2 | https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03153-8\"},{\"id\":333,\"player\":\"Abbott\",\"device\":\"Amplatzer Septal Occluder\",\"sku\":\"ASO and exchange system\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States\",\"claim\":\"Established structural-heart\/cardiac implant material platform; relevance depends on material-driven hemocompatibility rather than active coating.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/structural-heart\/structural-interventions\/amplatzer-septal.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P000039 | https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/structural-heart\/structural-interventions\/amplatzer-septal.html\"},{\"id\":320,\"player\":\"Abbott\",\"device\":\"CentriMag Adult ECMO \/ Pre-connected Pack\",\"sku\":\"Pre-connected pack with PC-coated tubing (where specified)\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Due diligence flag\",\"brand\":\"PC coating (brand not fully disclosed in public source)\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by CentriMag configuration and region\",\"claim\":\"Adjacent coated circuit component tied to high-relevance acute MCS platform.\",\"partnership\":\"Undisclosed coating supplier\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.cardiovascular.abbott\/us\/en\/hcp\/products\/heart-failure\/mechanical-circulatory-support\/centrimag-acute-circulatory-support-system\/about.html | https:\/\/www.visionarymedicare.com\/pdf\/abbott_centrimag.pdf | https:\/\/abbott.mediaroom.com\/2023-04-25-Abbotts-Life-Support-System-Receives-New-FDA-Clearances-to-Help-Doctors-Treat-More-Critically-Ill-Patients | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":393,\"player\":\"AngioDynamics\",\"device\":\"BioFlo Midline with Endexo Technology\",\"sku\":\"Midline catheter\",\"category\":\"Vascular access\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":\"Endexo Technology\",\"supplier\":\"Interface Biologics \/ AngioDynamics relationship requires verification\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":2,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Permanent non-eluting integral polymer strategy rather than heparin or antimicrobial coating.\",\"partnership\":null,\"link\":\"https:\/\/msa.com.au\/wp-content\/uploads\/2024\/06\/BIO1000-BioFlo-PICC-Brochure-MSA-Edit_compressed.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfres\/res.cfm?id=148878 | https:\/\/investors.angiodynamics.com\/news-releases\/news-release-details\/angiodynamics-earns-fda-clearance-first-vascular-access-product | https:\/\/investors.angiodynamics.com\/news-releases\/news-release-details\/angiodynamics-earns-fda-clearance-ports-bioflo-technology-reduce | https:\/\/msa.com.au\/wp-content\/uploads\/2024\/06\/BIO1000-BioFlo-PICC-Brochure-MSA-Edit_compressed.pdf\"},{\"id\":392,\"player\":\"AngioDynamics\",\"device\":\"BioFlo PICC with Endexo Technology\",\"sku\":\"PICC \/ PASV variants\",\"category\":\"Vascular access\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":\"Endexo Technology\",\"supplier\":\"Interface Biologics \/ AngioDynamics relationship requires verification\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":2,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Permanent non-eluting integral polymer strategy rather than heparin or antimicrobial coating.\",\"partnership\":null,\"link\":\"https:\/\/msa.com.au\/wp-content\/uploads\/2024\/06\/BIO1000-BioFlo-PICC-Brochure-MSA-Edit_compressed.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfres\/res.cfm?id=148878 | https:\/\/investors.angiodynamics.com\/news-releases\/news-release-details\/angiodynamics-earns-fda-clearance-first-vascular-access-product | https:\/\/investors.angiodynamics.com\/news-releases\/news-release-details\/angiodynamics-earns-fda-clearance-ports-bioflo-technology-reduce | https:\/\/msa.com.au\/wp-content\/uploads\/2024\/06\/BIO1000-BioFlo-PICC-Brochure-MSA-Edit_compressed.pdf\"},{\"id\":394,\"player\":\"AngioDynamics\",\"device\":\"BioFlo Port with Endexo Technology\",\"sku\":\"Implantable port catheter\",\"category\":\"Vascular access\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":\"Endexo Technology\",\"supplier\":\"Interface Biologics \/ AngioDynamics relationship requires verification\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":2,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Permanent non-eluting integral polymer strategy rather than heparin or antimicrobial coating.\",\"partnership\":null,\"link\":\"https:\/\/msa.com.au\/wp-content\/uploads\/2024\/06\/BIO1000-BioFlo-PICC-Brochure-MSA-Edit_compressed.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfres\/res.cfm?id=148878 | https:\/\/investors.angiodynamics.com\/news-releases\/news-release-details\/angiodynamics-earns-fda-clearance-first-vascular-access-product | https:\/\/investors.angiodynamics.com\/news-releases\/news-release-details\/angiodynamics-earns-fda-clearance-ports-bioflo-technology-reduce | https:\/\/msa.com.au\/wp-content\/uploads\/2024\/06\/BIO1000-BioFlo-PICC-Brochure-MSA-Edit_compressed.pdf\"},{\"id\":421,\"player\":\"Artivion \/ JOTEC\",\"device\":\"E-ventus BX Peripheral Stent Graft System\",\"sku\":\"Renal\/iliac balloon-expandable stent-graft\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":3,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/vascularnews.com\/jotec-launches-new-e-ventus-bx-stent-graft-configuration\/\",\"evidenceChain\":\"https:\/\/vascularnews.com\/jotec-launches-new-e-ventus-bx-stent-graft-configuration\/ | https:\/\/fsca.swissmedic.ch\/mep\/api\/publications\/Vk_20200928_10\/documents\/3\"},{\"id\":501,\"player\":\"Balt\",\"device\":\"Silk Vista Baby Flow Diverter\",\"sku\":\"Silk Vista Baby low-profile flow diverter \/ CE-marked portfolio\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Balt \/ undisclosed\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":3,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where CE\/UK approvals apply; verify local status.\",\"geography\":\"Europe \/ United Kingdom \/ international distributor-dependent\",\"claim\":\"Low-profile neurovascular flow diverter with hydrophilic polymer coating literature and CE-marked portfolio.\",\"partnership\":null,\"link\":\"https:\/\/selamedical.co.uk\/wp-content\/uploads\/2024\/11\/202006-SILK-VISTA-BABY-1.pdf\",\"evidenceChain\":\"https:\/\/selamedical.co.uk\/wp-content\/uploads\/2024\/11\/202006-SILK-VISTA-BABY-1.pdf | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9131493\/\"},{\"id\":401,\"player\":\"Baxter \/ Vantive\",\"device\":\"Evodial Dialyzer\",\"sku\":\"Evodial 1.0 \/ heparin-grafted membrane\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"HeprAN \/ Evodial\",\"supplier\":\"Vantive \/ Baxter \/ legacy Gambro\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":5,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/renalcare.baxterhealthcare.co.uk\/sites\/g\/files\/ebysai3556\/files\/2023-02\/Evodial_Dialyzer_Brochure.pdf\",\"evidenceChain\":\"https:\/\/www.baxter.ca\/sites\/g\/files\/ebysai1431\/files\/2018-12\/Evodial_ENG.pdf | https:\/\/renalcare.baxterhealthcare.co.uk\/sites\/g\/files\/ebysai3556\/files\/2023-02\/Evodial_Dialyzer_Brochure.pdf | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3681640\/ | https:\/\/www.jms.mk\/jms\/article\/view\/vol6no1-13\"},{\"id\":402,\"player\":\"Baxter \/ Vantive\",\"device\":\"Theranova Dialyzer\",\"sku\":\"Theranova 400\/500 MCO membrane\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"Theranova \/ MCO membrane\",\"supplier\":\"Vantive \/ Baxter\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA De Novo\",\"clinical\":4,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/pro.vantive.com\/sites\/g\/files\/yxicxq156\/files\/resources\/2024-07\/US-RC46-230001-V3.0-Theranova-Datasheet_compressed.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/DEN190042.pdf | https:\/\/www.baxter.com\/baxter-newsroom\/baxter-announces-us-fda-de-novo-authorization-theranova-dialyzers-enabling-hdx | https:\/\/pro.vantive.com\/sites\/g\/files\/yxicxq156\/files\/resources\/2024-07\/US-RC46-230001-V3.0-Theranova-Datasheet_compressed.pdf\"},{\"id\":123,\"player\":\"Boston Scientific\",\"device\":\"Glidewire-type hydrophilic guidewire portfolio\",\"sku\":\"Hydrophilic guidewire\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Hydrophilic coating\",\"supplier\":\"Undisclosed OEM coating supplier\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":1,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; EU\/international product pages available\",\"claim\":\"Included for competitive adjacency and blood-contacting surface\/coating tracking.\",\"partnership\":null,\"link\":\"https:\/\/www.terumois.com\/products\/product-type\/guidewires\/glidewire.html\",\"evidenceChain\":\"https:\/\/www.terumois.com\/products\/product-type\/guidewires\/glidewire.html | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K240818.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf15\/K152740.pdf | https:\/\/www.fda.gov\/media\/113951\/download\"},{\"id\":386,\"player\":\"Boston Scientific\",\"device\":\"OptiCross Coronary\/Peripheral Imaging Catheter\",\"sku\":\"Hybrid hydrophilic distal 3 cm\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.bostonscientific.com\/content\/dam\/bostonscientific\/Interventional%20Cardiology\/MedSpecialty\/homepage-eu\/New_Cardio_Product_Catalogue.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K200733 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K173284 | https:\/\/www.bostonscientific.com\/content\/dam\/bostonscientific\/Interventional%20Cardiology\/MedSpecialty\/homepage-eu\/New_Cardio_Product_Catalogue.pdf\"},{\"id\":375,\"player\":\"CERENOVUS\",\"device\":\"EMBOVAC Aspiration Catheter\",\"sku\":\"Large bore aspiration catheter\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.jnjmedtech.com\/en-EMEA\/product\/embovac-aspiration-catheter\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K191237 | https:\/\/www.jnjmedtech.com\/en-EMEA\/product\/embovac-aspiration-catheter | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/detail.cfm?mdrfoi__id=16915988&pc=NRY | https:\/\/pubmed.ncbi.nlm.nih.gov\/34750107\/\"},{\"id\":487,\"player\":\"Chalice Medical\",\"device\":\"Paragon Adult Maxi PMP Oxygenator\",\"sku\":\"XCMOP405PMP FDA-cleared adult maxi PMP oxygenator\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":5,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where available; coating-specific status not confirmed for this record.\",\"geography\":\"United Kingdom \/ United States \/ international distributor-dependent\",\"claim\":\"UK manufacturer Paragon PMP oxygenator FDA-cleared; included to preserve regional manufacturer coverage.\",\"partnership\":null,\"link\":\"https:\/\/www.chalicemedical.com\/products\/paragon-oxygenators\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/K191246.pdf | https:\/\/www.chalicemedical.com\/products\/paragon-oxygenators\/\"},{\"id\":407,\"player\":\"CytoSorbents\",\"device\":\"CytoSorb 300 mL Adsorber\",\"sku\":\"CytoSorb 300 mL\",\"category\":\"Blood purification \/ filters\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":\"CytoSorb\",\"supplier\":\"CytoSorbents\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":4,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/cytosorbents.com\/regulatory-status\/\",\"evidenceChain\":\"https:\/\/cytosorbents.com\/regulatory-status\/ | https:\/\/www.fda.gov\/media\/136866\/download | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9541789\/\"},{\"id\":334,\"player\":\"Edwards Lifesciences\",\"device\":\"SAPIEN 3 \/ SAPIEN 3 Ultra Transcatheter Heart Valve\",\"sku\":\"Balloon-expandable TAVR valve\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ global by model\",\"claim\":\"Established structural-heart\/cardiac implant material platform; relevance depends on material-driven hemocompatibility rather than active coating.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/www.heartvalves.com\/gb\/edwards-sapien-3-platform\/edwards-sapien-3-ultra-valve\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/p140031b.pdf | https:\/\/www.heartvalves.com\/gb\/edwards-sapien-3-platform\/edwards-sapien-3-ultra-valve\"},{\"id\":403,\"player\":\"Fresenius Medical Care\",\"device\":\"FX CorAL Dialyzer\",\"sku\":\"FX CorAL high-flux dialyzer variants\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"Helixone hydro\",\"supplier\":\"Fresenius Medical Care\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243874.pdf | https:\/\/freseniusmedicalcare.com\/en-us\/products\/disposables\/dialyzers\/fx-coral\/ | https:\/\/www.fresenius.com\/node\/5203\"},{\"id\":5,\"player\":\"Getinge\",\"device\":\"Cardiohelp HLS module \/ set\",\"sku\":\"Cardiohelp HLS module \/ set with BIOLINE\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Australia; United States; CE region referenced in company materials\",\"claim\":\"Bioactive heparin-albumin coated extracorporeal support platform with broad Getinge\/Cardiohelp adoption and CE-region extended-use positioning.\",\"partnership\":\"Internal\/Getinge coating platform\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf\",\"evidenceChain\":\"https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/getingemaquet-cardiohelp-system-potential-insufficient-packaging-sterility-hls-set-advanced-letter | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/journals.sagepub.com\/doi\/10.1177\/0267659118772452 | https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\"},{\"id\":424,\"player\":\"Getinge\",\"device\":\"Intergard Synergy Vascular Graft\",\"sku\":\"Silver acetate + triclosan antimicrobial collagen-coated graft\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Validated competitor\",\"brand\":\"Intergard Synergy\",\"supplier\":null,\"agent\":\"NA - antimicrobial agents, not anticoagulants\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Undisclosed\",\"release\":\"Controlled release\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":\"Antimicrobial-coated vascular graft; not antithrombogenic.\",\"partnership\":null,\"link\":\"https:\/\/www.getinge.com\/int\/products\/intergard-synergy\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/intergard-synergy\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/intergard_synergy_vascular_grafts-54099-en.pdf\"},{\"id\":8,\"player\":\"Getinge\",\"device\":\"PLS Set\",\"sku\":\"PLS Set with BIOLINE\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Australia; United States; CE region referenced in company materials\",\"claim\":\"Bioactive heparin-albumin coated extracorporeal support platform with broad Getinge\/Cardiohelp adoption and CE-region extended-use positioning.\",\"partnership\":\"Internal\/Getinge coating platform\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf\",\"evidenceChain\":\"https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/getingemaquet-cardiohelp-system-potential-insufficient-packaging-sterility-hls-set-advanced-letter | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/journals.sagepub.com\/doi\/10.1177\/0267659118772452 | https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\"},{\"id\":9,\"player\":\"Getinge\",\"device\":\"Quadrox-iD adult oxygenator\",\"sku\":\"Quadrox-iD adult oxygenator with BIOLINE\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Australia; United States; CE region referenced in company materials\",\"claim\":\"Bioactive heparin-albumin coated extracorporeal support platform with broad Getinge\/Cardiohelp adoption and CE-region extended-use positioning.\",\"partnership\":\"Internal\/Getinge coating platform\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf\",\"evidenceChain\":\"https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/getingemaquet-cardiohelp-system-potential-insufficient-packaging-sterility-hls-set-advanced-letter | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/journals.sagepub.com\/doi\/10.1177\/0267659118772452 | https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\"},{\"id\":11,\"player\":\"Getinge\",\"device\":\"Quadrox-iD neonatal oxygenator\",\"sku\":\"Quadrox-iD neonatal oxygenator with BIOLINE\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Australia; United States; CE region referenced in company materials\",\"claim\":\"Bioactive heparin-albumin coated extracorporeal support platform with broad Getinge\/Cardiohelp adoption and CE-region extended-use positioning.\",\"partnership\":\"Internal\/Getinge coating platform\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf\",\"evidenceChain\":\"https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/getingemaquet-cardiohelp-system-potential-insufficient-packaging-sterility-hls-set-advanced-letter | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/journals.sagepub.com\/doi\/10.1177\/0267659118772452 | https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\"},{\"id\":10,\"player\":\"Getinge\",\"device\":\"Quadrox-iD pediatric oxygenator\",\"sku\":\"Quadrox-iD pediatric oxygenator with BIOLINE\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Validated competitor\",\"brand\":\"BIOLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Australia; United States; CE region referenced in company materials\",\"claim\":\"Bioactive heparin-albumin coated extracorporeal support platform with broad Getinge\/Cardiohelp adoption and CE-region extended-use positioning.\",\"partnership\":\"Internal\/Getinge coating platform\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf\",\"evidenceChain\":\"https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/getingemaquet-cardiohelp-system-potential-insufficient-packaging-sterility-hls-set-advanced-letter | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/journals.sagepub.com\/doi\/10.1177\/0267659118772452 | https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\"},{\"id\":370,\"player\":\"Imperative Care\",\"device\":\"Zoom Reperfusion Catheter\",\"sku\":\"Zoom 35\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K202182 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K211476 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K211476.pdf | https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\"},{\"id\":371,\"player\":\"Imperative Care\",\"device\":\"Zoom Reperfusion Catheter\",\"sku\":\"Zoom 45\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K202182 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K211476 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K211476.pdf | https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\"},{\"id\":372,\"player\":\"Imperative Care\",\"device\":\"Zoom Reperfusion Catheter\",\"sku\":\"Zoom 55\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K202182 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K211476 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K211476.pdf | https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\"},{\"id\":373,\"player\":\"Imperative Care\",\"device\":\"Zoom Reperfusion Catheter\",\"sku\":\"Zoom 71\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K202182 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K211476 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K211476.pdf | https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\"},{\"id\":374,\"player\":\"Imperative Care\",\"device\":\"Zoom Reperfusion Catheter\",\"sku\":\"Zoom 7X\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K202182 | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K211476 | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K211476.pdf | https:\/\/imperativecare.com\/stroke\/zoom-stroke-system\/\"},{\"id\":324,\"player\":\"LivaNova\",\"device\":\"ProtekDuo \/ ProtekDuo+ RA-PA Cannula\",\"sku\":\"31 Fr veno-venous \/ RA-PA dual-lumen cannula\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ selected international markets\",\"claim\":\"Single IJ RA-PA cannula enabling ambulation and RV support configurations.\",\"partnership\":\"LivaNova\/CardiacAssist platform\",\"link\":\"https:\/\/www.livanova.com\/advanced-circulatory-support\/en-us\/protekduo-kit\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K160257 | https:\/\/www.livanova.com\/advanced-circulatory-support\/en-us\/protekduo-kit | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10777236\/\"},{\"id\":323,\"player\":\"LivaNova\",\"device\":\"TandemHeart Kit for LV Unloading\",\"sku\":\"TandemHeart transseptal cannula\/pump kit\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ selected international markets\",\"claim\":\"Percutaneous LA-to-arterial high-flow support architecture.\",\"partnership\":\"LivaNova\/CardiacAssist platform\",\"link\":\"https:\/\/www.livanova.com\/advanced-circulatory-support\/en-us\/tandemheart-kit\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=k052570 | https:\/\/www.livanova.com\/advanced-circulatory-support\/en-us\/tandemheart-kit | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1764955\/\"},{\"id\":19,\"player\":\"Medtronic\",\"device\":\"Affinity CP Centrifugal Blood Pump\",\"sku\":\"biocompatible blood path option\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":\"Undisclosed biocompatible blood path option\",\"supplier\":\"Medtronic; supplier not public for this row\",\"agent\":null,\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":5,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"US \/ international\",\"claim\":\"Major CPB device family with named FDA-listed coated variants.\",\"partnership\":\"Internal Medtronic surface technology\",\"link\":\"https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\"},{\"id\":335,\"player\":\"Medtronic\",\"device\":\"Evolut PRO+ \/ Evolut FX TAVR System\",\"sku\":\"Self-expanding TAVR valve system\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA PMA Approved\",\"clinical\":5,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ global by model\",\"claim\":\"Established structural-heart\/cardiac implant material platform; relevance depends on material-driven hemocompatibility rather than active coating.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/cardiovascular\/heart-valves\/transcatheter-systems\/evolut-fx-tavr-system.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/P130021S174D.pdf | https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/cardiovascular\/heart-valves\/transcatheter-systems\/evolut-fx-tavr-system.html\"},{\"id\":344,\"player\":\"Medtronic\",\"device\":\"Phenom Catheter\",\"sku\":\"Phenom 17\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K210230.pdf | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\"},{\"id\":345,\"player\":\"Medtronic\",\"device\":\"Phenom Catheter\",\"sku\":\"Phenom 21\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K210230.pdf | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\"},{\"id\":346,\"player\":\"Medtronic\",\"device\":\"Phenom Catheter\",\"sku\":\"Phenom 27\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K210230.pdf | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\"},{\"id\":347,\"player\":\"Medtronic\",\"device\":\"Phenom Catheter\",\"sku\":\"Phenom Plus\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K210230.pdf | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\"},{\"id\":116,\"player\":\"Medtronic\",\"device\":\"React Aspiration Catheter\",\"sku\":\"React 68\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":\"Distal hydrophilic coating\",\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; other regions vary\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/K180705.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/K182097.pdf | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\"},{\"id\":391,\"player\":\"Merit Medical\",\"device\":\"BioFlo DuraMax Hemodialysis Catheter\",\"sku\":\"DuraMax with Endexo Technology\",\"category\":\"Vascular access\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Validated competitor\",\"brand\":\"Endexo Technology\",\"supplier\":\"Interface Biologics \/ Merit Medical relationship requires verification\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":2,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless noted\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"First dialysis catheter with Endexo material technology per company brochure.\",\"partnership\":null,\"link\":\"https:\/\/www.merit.com\/product\/bioflo-duramax-catheter\/\",\"evidenceChain\":\"https:\/\/investors.angiodynamics.com\/news-releases\/news-release-details\/angiodynamics-earns-fda-clearance-ports-bioflo-technology-reduce | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfres\/res.cfm?id=148878 | https:\/\/www.merit.com\/product\/bioflo-duramax-catheter\/ | https:\/\/mcm-schaublin.ch\/hubfs\/05_MCM%20MEDSYS\/03_Products\/Merit\/bioflo-duramax-brochure.pdf?hsLang=de\"},{\"id\":54,\"player\":\"Nipro\",\"device\":\"BRIZIO Adult Oxygenator E8 coating\",\"sku\":\"Coated\/biocompatible option per regional materials\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"E8 Coating\",\"supplier\":\"Nipro \/ Toyobo development cited in technical catalog\",\"agent\":\"None disclosed; synthetic polymer hemocompatible surface\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan\/Asia and distributor markets; exact authorizations not resolved\",\"claim\":\"PEG-based synthetic heparin-free polymer coating for BRIZIO oxygenator family.\",\"partnership\":null,\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf\",\"evidenceChain\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html | https:\/\/niproinindia.com\/cardiopulmonary\/ | https:\/\/pdf.medicalexpo.com\/pdf\/nipro\/brizio\/94053-221097.html\"},{\"id\":56,\"player\":\"Nipro\",\"device\":\"BRIZIO Infant Oxygenator E8 coating\",\"sku\":\"Coated\/biocompatible option per regional materials\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"E8 Coating\",\"supplier\":\"Nipro \/ Toyobo development cited in technical catalog\",\"agent\":\"None disclosed; synthetic polymer hemocompatible surface\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan\/Asia and distributor markets; exact authorizations not resolved\",\"claim\":\"PEG-based synthetic heparin-free polymer coating for BRIZIO oxygenator family.\",\"partnership\":null,\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf\",\"evidenceChain\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html | https:\/\/niproinindia.com\/cardiopulmonary\/ | https:\/\/pdf.medicalexpo.com\/pdf\/nipro\/brizio\/94053-221097.html\"},{\"id\":55,\"player\":\"Nipro\",\"device\":\"BRIZIO Pediatric Oxygenator E8 coating\",\"sku\":\"Coated\/biocompatible option per regional materials\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Validated competitor\",\"brand\":\"E8 Coating\",\"supplier\":\"Nipro \/ Toyobo development cited in technical catalog\",\"agent\":\"None disclosed; synthetic polymer hemocompatible surface\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan\/Asia and distributor markets; exact authorizations not resolved\",\"claim\":\"PEG-based synthetic heparin-free polymer coating for BRIZIO oxygenator family.\",\"partnership\":null,\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf\",\"evidenceChain\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html | https:\/\/niproinindia.com\/cardiopulmonary\/ | https:\/\/pdf.medicalexpo.com\/pdf\/nipro\/brizio\/94053-221097.html\"},{\"id\":109,\"player\":\"Penumbra\",\"device\":\"RED Reperfusion Catheter\",\"sku\":\"RED 62\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":\"REDglide Technology\",\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States where 510(k) model confirmed; EU\/international per company materials\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K203440 | https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/ | https:\/\/www.penumbrainc.com\/products\/red-72\/ | https:\/\/www.penumbrainc.com\/products\/red-68\/ | https:\/\/www.penumbrainc.com\/products\/\"},{\"id\":111,\"player\":\"Penumbra\",\"device\":\"RED Reperfusion Catheter\",\"sku\":\"RED 72 Silver Label\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":\"REDglide Technology\",\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States where 510(k) model confirmed; EU\/international per company materials\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/\",\"evidenceChain\":\"https:\/\/fda.innolitics.com\/submissions\/NE\/subpart-b%E2%80%94cardiovascular-diagnostic-devices\/NRY\/K242104 | https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/ | https:\/\/www.penumbrainc.com\/products\/red-72\/ | https:\/\/www.penumbrainc.com\/products\/red-68\/ | https:\/\/www.penumbrainc.com\/products\/\"},{\"id\":112,\"player\":\"Penumbra\",\"device\":\"RED Reperfusion Catheter\",\"sku\":\"RED 78\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":\"REDglide Technology\",\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":2,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States where 510(k) model confirmed; EU\/international per company materials\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf22\/K222808.pdf | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K203440 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12773048\/ | https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/ | https:\/\/www.penumbrainc.com\/latest-data-demonstrates-penumbra-system-and-red-reperfusion-catheters-effective-for-broad-stroke-care\/\"},{\"id\":113,\"player\":\"Stryker\",\"device\":\"AXS Catalyst Distal Access Catheter\",\"sku\":\"CAT 5\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; CE\/other regions vary\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-catalyst-7\/resources\/AXS-Cat_DFU_US.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf17\/K173841.pdf | https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-catalyst-7\/resources\/AXS-Cat_DFU_US.pdf\"},{\"id\":114,\"player\":\"Stryker\",\"device\":\"AXS Catalyst Distal Access Catheter\",\"sku\":\"CAT 6\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; CE\/other regions vary\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-catalyst-7\/resources\/AXS-Cat_DFU_US.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf17\/K173841.pdf | https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-catalyst-7\/resources\/AXS-Cat_DFU_US.pdf\"},{\"id\":115,\"player\":\"Stryker\",\"device\":\"AXS Catalyst Distal Access Catheter\",\"sku\":\"CAT 7\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States; CE\/other regions vary\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-catalyst-7\/resources\/AXS-Cat_DFU_US.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf17\/K173841.pdf | https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-catalyst-7\/resources\/AXS-Cat_DFU_US.pdf\"},{\"id\":339,\"player\":\"Stryker\",\"device\":\"AXS Vecta Aspiration Catheter\",\"sku\":\"AXS Vecta 71\/74\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":\"Large bore aspiration catheter with distal hydrophilic coating and Scout Introducer.\",\"partnership\":null,\"link\":\"https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-vecta-71\/resources\/AXS-Vecta-71-74_DFU_US_Dec19.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/K191768.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf20\/K200206.pdf | https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-vecta-71\/resources\/AXS-Vecta-71-74_DFU_US_Dec19.pdf\"},{\"id\":340,\"player\":\"Stryker\",\"device\":\"AXS Vecta Intermediate Catheter\",\"sku\":\"AXS Vecta 46\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.stryker.com\/us\/en\/neurovascular\/products\/axs-vecta-46.html\",\"evidenceChain\":\"https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-vecta-46\/documents\/SNV-4476%20Vecta46%20DFU.pdf | https:\/\/www.stryker.com\/us\/en\/neurovascular\/products\/axs-vecta-46.html\"},{\"id\":343,\"player\":\"Stryker\",\"device\":\"Trevo NXT ProVue Retriever\",\"sku\":\"Trevo NXT ProVue\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":0,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.stryker.com\/us\/en\/neurovascular\/products\/trevo-nxt.html\",\"evidenceChain\":\"https:\/\/www.stryker.com\/us\/en\/neurovascular\/products\/trevo-nxt.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K200117 | https:\/\/www.stryker.com\/cl\/en\/neurovascular\/products\/trevo-nxt.html\"},{\"id\":380,\"player\":\"Terumo\",\"device\":\"Radifocus Glidecath Angiographic Catheter\",\"sku\":\"Glidecath\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.terumois.com\/products\/product-type\/guidewires\/glidewire.html\",\"evidenceChain\":\"https:\/\/www.terumois.com\/products\/product-type\/guidewires\/glidewire.html | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K240818.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf15\/K152740.pdf | https:\/\/www.terumo-europe.com\/en\/interventional-systems\/products\/product-type\/catheters\/radifocus-glidecath-angiographic-catheter\"},{\"id\":382,\"player\":\"Terumo\",\"device\":\"Radifocus Glidewire Advantage\",\"sku\":\"Glidewire Advantage\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":\"Mcoat\",\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.terumois.com\/products\/product-type\/guidewires\/glidewire.html\",\"evidenceChain\":\"https:\/\/www.terumois.com\/products\/product-type\/guidewires\/glidewire.html | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K240818.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf15\/K152740.pdf | https:\/\/www.terumo-europe.com\/en\/interventional-systems\/products\/product-type\/guidewires\/radifocus-glidewire-advantage-guide-wire\"},{\"id\":381,\"player\":\"Terumo\",\"device\":\"Radifocus Guide Wire M\",\"sku\":\"Standard\/Half Stiff\/Stiff\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":\"Mcoat\",\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.terumois.com\/products\/product-type\/guidewires\/glidewire.html\",\"evidenceChain\":\"https:\/\/www.terumois.com\/products\/product-type\/guidewires\/glidewire.html | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K240818.pdf | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf15\/K152740.pdf | https:\/\/www.terumo-europe.com\/en\/interventional-systems\/products\/product-type\/guidewires\/radifocus-guide-wire-m-standard-halfstiff-stiff-type-guide-wires\"},{\"id\":428,\"player\":\"Terumo Aortic\",\"device\":\"Gelweave Vascular Prosthesis\",\"sku\":\"Gelatin-sealed woven polyester family\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":\"Gelweave\",\"supplier\":null,\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/terumoaortic.com\/products\/gelweave\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K241550.pdf | https:\/\/terumoaortic.com\/wp-content\/uploads\/2024\/10\/gelweave-gelsoft-plus-open-surgical-graft-ifu-301-1744%E2%80%93usa.pdf | https:\/\/terumoaortic.com\/products\/gelweave\/\"},{\"id\":409,\"player\":\"Toray Medical\",\"device\":\"Toraymyxin PMX-20R\",\"sku\":\"Polymyxin B immobilized fiber hemoperfusion cartridge\",\"category\":\"Blood purification \/ filters\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Validated competitor\",\"brand\":\"Toraymyxin \/ PMX\",\"supplier\":\"Toray Medical\",\"agent\":null,\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"PMDA Approved \/ Certified\",\"clinical\":4,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/www.toraymyxin.toray\/en\/toraymyxin\/pdf\/instructions_for_use.pdf\",\"evidenceChain\":\"https:\/\/www.toray-medical.com\/en\/products\/emergency\/eme_0010.html | https:\/\/www.toraymyxin.toray\/en\/toraymyxin\/pdf\/instructions_for_use.pdf | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9674082\/\"},{\"id\":467,\"player\":\"Baxter \/ Vantive\",\"device\":\"AN69ST \/ oXiris Heparin-Grafted Membrane Surface\",\"sku\":\"AN69ST \/ oXiris membrane platform\",\"category\":\"Blood purification \/ filters\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"AN69ST \/ oXiris membrane\",\"supplier\":\"Baxter \/ Vantive; historical Gambro\/Hospal lineage\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":4,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Combines CRRT membrane adsorption properties with heparin-grafted hemocompatible surface.\",\"partnership\":\"Internal Baxter\/Vantive technology lineage.\",\"link\":\"https:\/\/pro.vantive.com\/oxiris-set\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10974185\/ | https:\/\/www.baxter.com\/healthcare-professionals\/critical-care\/oxiris | https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9836312\/ | https:\/\/pro.vantive.com\/oxiris-set | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695587\/\"},{\"id\":136,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.carmeda.se\/carmeda-bioactive-surface | https:\/\/www.carmeda.se\/selected-reading | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":129,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.carmeda.se\/carmeda-bioactive-surface | https:\/\/www.carmeda.se\/selected-reading | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":137,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.carmeda.se\/carmeda-bioactive-surface | https:\/\/www.carmeda.se\/selected-reading | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":128,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.carmeda.se\/carmeda-bioactive-surface | https:\/\/www.carmeda.se\/selected-reading | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":135,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.carmeda.se\/carmeda-bioactive-surface | https:\/\/www.carmeda.se\/selected-reading | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":134,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.carmeda.se\/carmeda-bioactive-surface | https:\/\/www.carmeda.se\/selected-reading | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":130,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.carmeda.se\/carmeda-bioactive-surface | https:\/\/www.carmeda.se\/selected-reading | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":131,\"player\":\"Carmeda AB\",\"device\":\"CARMEDA BioActive Surface\",\"sku\":\"CARMEDA \/ CBAS application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CARMEDA \/ CBAS\",\"supplier\":\"Carmeda AB\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands CARMEDA \/ CBAS into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.carmeda.se\/carmeda-bioactive-surface\",\"evidenceChain\":\"https:\/\/www.carmeda.se\/upl\/files\/258588 | https:\/\/www.carmeda.se\/carmeda-bioactive-surface | https:\/\/www.carmeda.se\/selected-reading | https:\/\/www.goremedical.com\/en-emea\/cbas-material-technology\"},{\"id\":441,\"player\":\"Corline Biomedical\",\"device\":\"Corline Heparin Conjugate\",\"sku\":\"CHC platform \/ Renaparin adjacency\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CHC \/ Renaparin \/ CHS\",\"supplier\":\"Corline Biomedical\",\"agent\":\"Heparin\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":3,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Separates Corline's heparin conjugate drug\/biomolecule from CHS surface-coating implementation.\",\"partnership\":null,\"link\":\"https:\/\/www.corline.se\/products\/chc-technology\",\"evidenceChain\":\"https:\/\/www.corline.se\/products\/chc-technology | https:\/\/www.corline.se\/ | https:\/\/a.storyblok.com\/f\/292311\/x\/5ad6ffdeec\/corline_introducing_chs_2021_final.pdf | https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0280069\"},{\"id\":440,\"player\":\"Corline Biomedical\",\"device\":\"Corline Heparin Surface\",\"sku\":\"CHS platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"CHS \/ CHC\",\"supplier\":\"Corline Biomedical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Layer-by-layer assembly\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Macromolecular heparin conjugate platform that can be used as coating or pharmaceutical conjugate.\",\"partnership\":\"Public customers not comprehensively disclosed; Corline markets to device industry.\",\"link\":\"https:\/\/www.corline.se\/products\/chc-technology\",\"evidenceChain\":\"https:\/\/www.corline.se\/products\/chc-technology | https:\/\/www.corline.se\/ | https:\/\/a.storyblok.com\/f\/292311\/x\/5ad6ffdeec\/corline_introducing_chs_2021_final.pdf | https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0280069\"},{\"id\":468,\"player\":\"Eurosets\",\"device\":\"Phosphorylcholine \/ PC coating for ECLS-CPB circuits\",\"sku\":\"Eurosets PC coating platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC coating \/ phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":4,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"European ECMO\/CPB OEM with PC\/bio-passive coating options.\",\"partnership\":\"Eurosets internal platform; GVM group.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/pubmed.ncbi.nlm.nih.gov\/23155172\/ | https:\/\/academic.oup.com\/icvts\/article\/8\/1\/7\/665813 | https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf\"},{\"id\":466,\"player\":\"Fresenius Medical Care\",\"device\":\"Hydrolink \/ Helixone membrane surface technology\",\"sku\":\"Hydrolink NV \/ FX CorAL adjacency\",\"category\":\"Blood purification \/ filters\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Hydrolink \/ Hydrolink NV\",\"supplier\":\"Fresenius Medical Care\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":3,\"bench\":3,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Material-intrinsic membrane hemocompatibility rather than active heparin coating.\",\"partnership\":\"Fresenius internal dialyzer technology.\",\"link\":\"https:\/\/freseniusmedicalcare.com\/en\",\"evidenceChain\":\"https:\/\/freseniusmedicalcare.com\/en | https:\/\/freseniusmedicalcare.com\/it-it | https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10974185\/\"},{\"id\":454,\"player\":\"Hydromer\",\"device\":\"Heparin Antithrombogenic Coating\",\"sku\":\"Heparin coating platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Hydromer Heparin Antithrombogenic Coating \/ Hygea-like marketed offering\",\"supplier\":\"Hydromer\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Commercial heparin and PC coating supplier with broad material\/coating-service offering.\",\"partnership\":\"OEM customers not named in sources.\",\"link\":\"https:\/\/hydromer.com\/anti-thrombogenic-coatings\/\",\"evidenceChain\":\"https:\/\/hydromer.com\/anti-thrombogenic-coatings\/ | https:\/\/hydromer.com\/heparin-pc-coatings-for-blood-contacting-devices\/?nocache=1 | https:\/\/hydromer.com\/medical-device-coatings\/ | https:\/\/openurl.ebsco.com\/fulltext\/gcd%3A174977377\"},{\"id\":156,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":149,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":157,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":153,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":148,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":155,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":154,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":150,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":151,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":152,\"player\":\"Medtronic\",\"device\":\"Cortiva BioActive Surface\",\"sku\":\"Cortiva application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Cortiva\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"End-point covalent attachment\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Cortiva into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/cortiva-bioactive-surface.html | https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/static.livemedia.gr\/livemedia\/documents\/al2782_u84_20210610080640271_cortiva20brochure.pdf\"},{\"id\":437,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium Biosurface\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Endothelial-like heparin\/polymer CPB surface in Medtronic portfolio.\",\"partnership\":\"Medtronic internal platform\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface\/indications-safety-warnings.html | https:\/\/www.theaacp.com\/wp-content\/uploads\/2020\/04\/Spring_2020_Newsletter_Hackworth_Schwartz_Darban.pdf | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":439,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"PMEA\/X Coating platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"PMEA amphiphilic biopassive alternative to heparin or PC surfaces in CPB.\",\"partnership\":\"Terumo internal platform\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumo-europe.com\/Relevant%20Product%20Info\/P_CapioxRX_Family_Brochure_CV143GB-1114FK-11%2811.14%29E.pdf | https:\/\/www.cardion.cz\/file\/390\/brozura-x-coating.pdf | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4680762\/ | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":364,\"player\":\"Acandis\",\"device\":\"NeuroSlider DLC Microcatheter\",\"sku\":\"Dual-layer hydrophilic coating\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/acandis.com\/en\/access-and-delivery\/neuroslider-dlc-microcatheter-en\/\",\"evidenceChain\":\"https:\/\/acandis.com\/en\/access-and-delivery\/neuroslider-dlc-microcatheter-en\/\"},{\"id\":365,\"player\":\"Acandis\",\"device\":\"NeuroSpeed PTA Balloon Catheter\",\"sku\":\"Dual-layer hydrophilic coating\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/acandis.com\/en\/ischemic-stroke\/neurospeed-pta-balloon-catheter\/\",\"evidenceChain\":\"https:\/\/acandis.com\/en\/ischemic-stroke\/neurospeed-pta-balloon-catheter\/\"},{\"id\":503,\"player\":\"Asahi Kasei Medical\",\"device\":\"APS Series Dialyzer\",\"sku\":\"APS-SA \/ APS series hydrophilic gel-layer membrane\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"APS hydrophilic gel layer\",\"supplier\":\"Asahi Kasei Medical\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed where available.\",\"geography\":\"Japan \/ international\",\"claim\":\"Japanese dialyzer membrane surface using hydrophilic gel layer for hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/www.asahi-kasei.co.jp\/medical\/en\/dialysis\/product\/aps-series\/feature04.html\",\"evidenceChain\":\"https:\/\/www.asahi-kasei.co.jp\/medical\/en\/dialysis\/product\/aps-series\/feature04.html\"},{\"id\":400,\"player\":\"B. Braun\",\"device\":\"Certofix protect CVC\",\"sku\":null,\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Standard monitoring\",\"brand\":\"Certofix protect\",\"supplier\":\"B. Braun\",\"agent\":\"NA unless specific antithrombotic agent is disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Combination infection-prevention and\/or thrombus-resistance access device; claims vary by product family.\",\"partnership\":null,\"link\":\"https:\/\/www.bbraun.com\/en\/products-and-solutions\/therapies\/vascular-access\/central-venous-catheter-certofix-.html\",\"evidenceChain\":\"https:\/\/www.bbraun.com\/en\/products-and-solutions\/therapies\/vascular-access\/central-venous-catheter-certofix-.html | https:\/\/docs.exhausmed.com\/DOCS\/BRAUN\/2012\/CATALOGUES\/CERTOFIX%20PROTEX.PDF | https:\/\/clinicaltrials.gov\/study\/NCT00555282\"},{\"id\":429,\"player\":\"B. Braun\",\"device\":\"Uni-Graft K DV Vascular Graft\",\"sku\":\"Knitted double velour gelatin-impregnated graft\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"Uni-Graft K DV\",\"supplier\":null,\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"TGA Approved\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.bbraun.be\/content\/dam\/catalog\/bbraun\/bbraunProductCatalog\/S\/AEM2015\/fr-be\/b276\/uni-graft-k-dv-theknittedimpregnatedvasculargraft.pdf\",\"evidenceChain\":\"https:\/\/www.tga.gov.au\/resources\/artg\/135041 | https:\/\/www.bbraun.be\/content\/dam\/catalog\/bbraun\/bbraunProductCatalog\/S\/AEM2015\/fr-be\/b276\/uni-graft-k-dv-theknittedimpregnatedvasculargraft.pdf\"},{\"id\":420,\"player\":\"Bentley InnoMed\",\"device\":\"BeGraft Peripheral PLUS Stent Graft\",\"sku\":\"PLUS bridging \/ BEVAR study variant\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":3,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.bentley.global\/en\/products\/discover-stents\/begraft\",\"evidenceChain\":\"https:\/\/clinicaltrials.gov\/study\/NCT04023370 | https:\/\/hevi.hr\/pdf\/Inspiremed.pdf | https:\/\/www.bentley.global\/en\/products\/discover-stents\/begraft\"},{\"id\":419,\"player\":\"Bentley InnoMed\",\"device\":\"BeGraft Peripheral Stent Graft\",\"sku\":\"Peripheral \/ FEVAR bridging configurations\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDD Legacy)\",\"clinical\":3,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.bentley.global\/en\/products\/discover-stents\/begraft\",\"evidenceChain\":\"https:\/\/www.bentley.global\/en\/products\/discover-stents\/begraft | https:\/\/hevi.hr\/pdf\/Inspiremed.pdf | https:\/\/clinicaltrials.gov\/study\/NCT04023370\"},{\"id\":399,\"player\":\"Cook Medical\",\"device\":\"Spectrum Central Venous Catheter\",\"sku\":null,\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Standard monitoring\",\"brand\":\"Spectrum Technology\",\"supplier\":\"Cook Medical \/ Spectrum Vascular\",\"agent\":\"NA unless specific antithrombotic agent is disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Combination infection-prevention and\/or thrombus-resistance access device; claims vary by product family.\",\"partnership\":null,\"link\":\"https:\/\/www.cookmedical.com\/products\/12eee5a3-ccf0-476c-a180-054be6accdd0\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf8\/K081113.pdf | https:\/\/www.cookmedical.com\/products\/12eee5a3-ccf0-476c-a180-054be6accdd0\/\"},{\"id\":3,\"player\":\"Getinge\",\"device\":\"HIT Set Advanced\",\"sku\":\"5.0 with SOFTLINE Coating\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Due diligence flag\",\"brand\":\"SOFTLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"None disclosed; heparin-free positioning for HIT-susceptible patients\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Europe \/ international; model-specific availability varies\",\"claim\":\"Heparin-free coated HIT Set variant in Getinge Cardiohelp\/HLS ecosystem.\",\"partnership\":\"Getinge\/Maquet internal coating platform\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.tga.gov.au\/resources\/artg\/193475 | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":4,\"player\":\"Getinge\",\"device\":\"HIT Set Advanced\",\"sku\":\"7.0 with SOFTLINE Coating\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Due diligence flag\",\"brand\":\"SOFTLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"None disclosed; heparin-free positioning for HIT-susceptible patients\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Europe \/ international; model-specific availability varies\",\"claim\":\"Heparin-free coated HIT Set variant in Getinge Cardiohelp\/HLS ecosystem.\",\"partnership\":\"Getinge\/Maquet internal coating platform\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.tga.gov.au\/resources\/artg\/193475 | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":427,\"player\":\"Getinge\",\"device\":\"Hemashield Platinum Woven Double Velour Vascular Graft\",\"sku\":\"Collagen-impregnated polyester graft\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"Hemashield Platinum\",\"supplier\":null,\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.getinge.com\/int\/products\/hemashield-platinum-woven-double-velour\/\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf5\/k052302.pdf | https:\/\/www.getinge.com\/int\/products\/hemashield-platinum-woven-double-velour\/\"},{\"id\":426,\"player\":\"Getinge\",\"device\":\"Intergard Woven Vascular Graft\",\"sku\":\"Collagen-coated woven polyester graft\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"Intergard\",\"supplier\":null,\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"TGA Approved\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.getinge.com\/en-ca\/products\/intergard-woven\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/en-ca\/products\/intergard-woven\/ | https:\/\/www.tga.gov.au\/resources\/artg\/145380\"},{\"id\":494,\"player\":\"Getinge\",\"device\":\"QUADROX-iD Adult Diffusion Membrane Oxygenator\",\"sku\":\"Adult diffusion membrane with SOFTLINE coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Due diligence flag\",\"brand\":\"SOFTLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed \/ legacy family; verify current SKU availability.\",\"geography\":\"United States \/ Europe \/ international depending SKU\",\"claim\":\"Getinge\/Maquet SKU-level coated oxygenator\/component variants with BIOLINE or SOFTLINE options.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/k101153.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/k101153.pdf\"},{\"id\":325,\"player\":\"Getinge\",\"device\":\"Sensation 7 Fr IAB Catheter\",\"sku\":\"Sensation 7 Fr fiber optic IAB catheter\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":1,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ Europe \/ international by model\",\"claim\":\"Established counterpulsation technology; not an antithrombogenic coating competitor based on public evidence.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/sensation-7fr.-iab-catheter\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K063525 | https:\/\/www.getinge.com\/int\/products\/sensation-7fr.-iab-catheter | https:\/\/www.getinge.com\/int\/products-and-solutions\/cardiovascular-procedures\/iabp-counterpulsation\/iabp-product-information\/\"},{\"id\":326,\"player\":\"Getinge\",\"device\":\"Sensation Plus IAB Catheter\",\"sku\":\"Sensation Plus 7.5 Fr \/ 8 Fr IAB catheter\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":1,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ Europe \/ international by model\",\"claim\":\"Established counterpulsation technology; not an antithrombogenic coating competitor based on public evidence.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/www.getinge.com\/it\/prodotti\/sensation-plus-7.5-fr.-8fr.-iab-catheters\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K063525 | https:\/\/www.getinge.com\/it\/prodotti\/sensation-plus-7.5-fr.-8fr.-iab-catheters | https:\/\/www.getinge.com\/int\/products-and-solutions\/cardiovascular-procedures\/iabp-counterpulsation\/iabp-product-information\/\"},{\"id\":416,\"player\":\"Getinge \/ Atrium Medical\",\"device\":\"Advanta V12 Balloon Expandable Covered Stent\",\"sku\":\"International Advanta V12 platform\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":4,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.getinge.com\/int\/products\/advanta-v12-balloon-expandable-covered-stent\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/advanta-v12-balloon-expandable-covered-stent\/ | https:\/\/evtoday.com\/articles\/2011-apr\/covered-stents-for-treating-aortoiliac-occlusive-disease | https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf12\/P120003B.pdf\"},{\"id\":389,\"player\":\"Mozarc Medical\",\"device\":\"Palindrome Precision H Chronic Catheter\",\"sku\":\"Palindrome Precision H \/ chronic hemodialysis catheter\",\"category\":\"Vascular access\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Standard monitoring\",\"brand\":\"Palindrome Precision H heparin coating\",\"supplier\":\"Mozarc Medical \/ legacy Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":2,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Named heparin-coated chronic dialysis catheter in a high-volume access segment.\",\"partnership\":null,\"link\":\"https:\/\/mozarcmedical.com\/products\/us\/dialysis-access\/chronic-hd\/catheters\/palindrome-coatings\/\",\"evidenceChain\":\"https:\/\/mozarcmedical.com\/products\/us\/dialysis-access\/chronic-hd\/catheters\/palindrome-coatings\/ | https:\/\/www.medline.com\/product\/Palindrome-H-Heparin-Coated-Dialysis-Catheters\/Z05-PF68509\"},{\"id\":108,\"player\":\"Penumbra\",\"device\":\"RED Reperfusion Catheter\",\"sku\":\"RED 43\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":\"REDglide Technology\",\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States where 510(k) model confirmed; EU\/international per company materials\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/\",\"evidenceChain\":\"https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/ | https:\/\/www.penumbrainc.com\/products\/red-72\/ | https:\/\/www.penumbrainc.com\/products\/red-68\/ | https:\/\/www.penumbrainc.com\/products\/\"},{\"id\":110,\"player\":\"Penumbra\",\"device\":\"RED Reperfusion Catheter\",\"sku\":\"RED 68\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":\"REDglide Technology\",\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"United States where 510(k) model confirmed; EU\/international per company materials\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/\",\"evidenceChain\":\"https:\/\/www.penumbrainc.com\/products\/red-reperfusion-catheters\/ | https:\/\/www.penumbrainc.com\/products\/red-72\/ | https:\/\/www.penumbrainc.com\/products\/red-68\/ | https:\/\/www.penumbrainc.com\/products\/\"},{\"id\":369,\"player\":\"Route 92 Medical\",\"device\":\"HiPoint Reperfusion System\",\"sku\":\"HiPoint \/ FreeClimb family\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243601.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243601.pdf\"},{\"id\":327,\"player\":\"Teleflex\",\"device\":\"Arrow FiberOptix \/ UltraFlex IAB Catheter\",\"sku\":\"Arrow FiberOptix and UltraFlex catheter kits\",\"category\":\"Mechanical circulatory support\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":null,\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":1,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed\",\"geography\":\"United States \/ Europe \/ international by model\",\"claim\":\"Established counterpulsation technology; not an antithrombogenic coating competitor based on public evidence.\",\"partnership\":\"Internal platform \/ NA\",\"link\":\"https:\/\/www.teleflex.com\/emea\/en\/product-areas\/interventional\/cardiac-assist\/intra-aortic-balloon-catheters\/index.html\",\"evidenceChain\":\"https:\/\/www.fda.gov\/medical-devices\/medical-device-recalls-and-early-alerts\/teleflexarrow-international-recall-arrow-fiberoptix-and-ultraflex-intra-aortic-balloon-iab-catheter | https:\/\/www.teleflex.com\/emea\/en\/product-areas\/interventional\/cardiac-assist\/intra-aortic-balloon-catheters\/index.html | https:\/\/www.fda.gov\/medical-devices\/medical-device-recalls-and-early-alerts\/teleflexarrow-international-recall-arrow-fiberoptix-and-ultraflex-intra-aortic-balloon-iab-catheter\"},{\"id\":396,\"player\":\"Teleflex\",\"device\":\"Arrow JACC with Chlorag+ard Technology\",\"sku\":null,\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Standard monitoring\",\"brand\":\"Chlorag+ard Technology\",\"supplier\":\"Teleflex\",\"agent\":\"NA unless specific antithrombotic agent is disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Combination infection-prevention and\/or thrombus-resistance access device; claims vary by product family.\",\"partnership\":null,\"link\":\"https:\/\/interventionalnews.com\/teleflex-receives-us-fda-clearance-for-arrow-and-tighttrack-tunneler\/\",\"evidenceChain\":\"https:\/\/interventionalnews.com\/teleflex-receives-us-fda-clearance-for-arrow-and-tighttrack-tunneler\/\"},{\"id\":397,\"player\":\"Teleflex\",\"device\":\"Arrow Midline with Chlorag+ard Technology\",\"sku\":null,\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Standard monitoring\",\"brand\":\"Chlorag+ard Technology\",\"supplier\":\"Teleflex\",\"agent\":\"NA unless specific antithrombotic agent is disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Combination infection-prevention and\/or thrombus-resistance access device; claims vary by product family.\",\"partnership\":null,\"link\":\"https:\/\/www.medicaldevice-network.com\/news\/newsteleflex-secures-fda-510k-clearance-for-arrow-midline-with-chloragard-technology-5034935\/\",\"evidenceChain\":\"https:\/\/www.medicaldevice-network.com\/news\/newsteleflex-secures-fda-510k-clearance-for-arrow-midline-with-chloragard-technology-5034935\/\"},{\"id\":395,\"player\":\"Teleflex\",\"device\":\"Arrow PICC with Chlorag+ard Technology\",\"sku\":null,\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Standard monitoring\",\"brand\":\"Chlorag+ard Technology\",\"supplier\":\"Teleflex\",\"agent\":\"NA unless specific antithrombotic agent is disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Combination infection-prevention and\/or thrombus-resistance access device; claims vary by product family.\",\"partnership\":null,\"link\":\"https:\/\/www.biospace.com\/teleflex-incorporated-gets-fda-510k-clearance-for-antithrombogenic-claims-on-arrow-picc\",\"evidenceChain\":\"https:\/\/www.biospace.com\/teleflex-incorporated-gets-fda-510k-clearance-for-antithrombogenic-claims-on-arrow-picc\"},{\"id\":398,\"player\":\"Teleflex\",\"device\":\"Arrowg+ard Blue Plus CVC\",\"sku\":null,\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Standard monitoring\",\"brand\":\"Arrowg+ard Blue Plus\",\"supplier\":\"Teleflex\",\"agent\":\"NA unless specific antithrombotic agent is disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Combination infection-prevention and\/or thrombus-resistance access device; claims vary by product family.\",\"partnership\":null,\"link\":\"https:\/\/www.teleflexvascular.com\/files\/ifu\/S-45703-124A.pdf\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=k993691 | https:\/\/www.teleflexvascular.com\/files\/ifu\/S-45703-124A.pdf\"},{\"id\":505,\"player\":\"Toray Medical\",\"device\":\"Filtryzer NF-U Series\",\"sku\":\"NF-U PMMA dialyzer \/ hydrophilic polymer surface modification\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Filtryzer NF-U\",\"supplier\":\"Toray Medical\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed where available.\",\"geography\":\"Japan \/ international\",\"claim\":\"PMMA dialyzer surface positioned for antithrombogenicity\/platelet-adhesion suppression.\",\"partnership\":null,\"link\":\"https:\/\/www.chiefmedical.com\/wp-content\/uploads\/2021\/02\/NF-U_Brochure.pdf\",\"evidenceChain\":\"https:\/\/www.chiefmedical.com\/wp-content\/uploads\/2021\/02\/NF-U_Brochure.pdf | https:\/\/www.toray-medical.com\/en\/products\/dialysis\/dia_0030.html\"},{\"id\":366,\"player\":\"Acandis\",\"device\":\"APERIO Hybrid17|21 Thrombectomy Device\",\"sku\":\"Hybrid17|21\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Due diligence flag\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"Approved \/ internationally marked\",\"regLabel\":\"CE Marked (MDR)\",\"clinical\":4,\"bench\":0,\"evidence\":2,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/acandis.com\/en\/ischemic-stroke\/aperio-hybrid1721-thrombectomy-device\/\",\"evidenceChain\":\"https:\/\/acandis.com\/en\/ischemic-stroke\/aperio-hybrid1721-thrombectomy-device\/\"},{\"id\":423,\"player\":\"Artivion \/ JOTEC\",\"device\":\"E-tegra Stent Graft System\",\"sku\":\"Aortic stent-graft system\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":0,\"evidence\":2,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/artivion.com\/product\/e-tegra\/\",\"evidenceChain\":\"https:\/\/artivion.com\/product\/e-tegra\/\"},{\"id\":390,\"player\":\"Mozarc Medical\",\"device\":\"Palindrome HSI Dialysis Catheter\",\"sku\":\"Heparin coated + silver ion antimicrobial sleeve\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Standard monitoring\",\"brand\":\"Palindrome HSI\",\"supplier\":\"Mozarc Medical \/ legacy Medtronic\",\"agent\":\"Heparin; silver ion antimicrobial component is not anticoagulant\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":2,\"bench\":2,\"evidence\":2,\"threat\":4,\"threatBand\":\"High (4\u20135)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed unless noted\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Combination antimicrobial-antithrombogenic dialysis catheter product.\",\"partnership\":null,\"link\":\"https:\/\/bostonmedix.com\/supply\/catalog\/VTH0048_Palindrome_Family_F.pdf\",\"evidenceChain\":\"https:\/\/livoworld.com\/products\/medical-equipment\/dialysis-catheters\/chronic-hemodialysis-catheters\/23-palindrome%E2%84%A2-hsi%E2%80%93heparin-coated-silver-ion-antimicrobial-dialysis-catheter | https:\/\/bostonmedix.com\/supply\/catalog\/VTH0048_Palindrome_Family_F.pdf\"},{\"id\":406,\"player\":\"ExThera Medical\",\"device\":\"Seraph 100 Microbind Affinity Blood Filter\",\"sku\":\"Seraph 100\",\"category\":\"Blood purification \/ filters\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Standard monitoring\",\"brand\":\"Microbind Affinity \/ Seraph 100\",\"supplier\":\"ExThera Medical\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":4,\"evidence\":5,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/www.fda.gov\/media\/137101\/download\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/137101\/download | https:\/\/www.federalregister.gov\/documents\/2026\/02\/19\/2026-03250\/revocation-of-authorization-of-emergency-use-of-exthera-medical-corporation-seraph-100-microbind | https:\/\/clinicaltrials.gov\/study\/NCT04413955 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8169409\/\"},{\"id\":482,\"player\":\"Senko Medical Instrument Mfg. \/ MERA\",\"device\":\"MERA Exelung Binding Prim\",\"sku\":\"HPO-15H-C legacy silicone-coated oxygenator\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Standard monitoring\",\"brand\":\"Ultra-thin silicone coating\",\"supplier\":\"Senko Medical \/ MERA internal\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Legacy \/ historical product; current availability not confirmed\",\"geography\":\"Japan \/ international distributor-dependent\",\"claim\":\"Japanese MERA oxygenator\/reservoir family with silicone\/heparin or silicone legacy hemocompatibility surface.\",\"partnership\":null,\"link\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9360143\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9360143\/ | https:\/\/www.mera.co.jp\/en\/medical\/product-info\/category\/artificial-heart-lung\/artificial-lungs-and-blood-reservoirs\/\"},{\"id\":483,\"player\":\"Senko Medical Instrument Mfg. \/ MERA\",\"device\":\"MERA Exelung Binding Prim\",\"sku\":\"HPO-25H-C legacy silicone-coated oxygenator\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Standard monitoring\",\"brand\":\"Ultra-thin silicone coating\",\"supplier\":\"Senko Medical \/ MERA internal\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":4,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Legacy \/ historical product; current availability not confirmed\",\"geography\":\"Japan \/ international distributor-dependent\",\"claim\":\"Japanese MERA oxygenator\/reservoir family with silicone\/heparin or silicone legacy hemocompatibility surface.\",\"partnership\":null,\"link\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9360143\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9360143\/ | https:\/\/www.mera.co.jp\/en\/medical\/product-info\/category\/artificial-heart-lung\/artificial-lungs-and-blood-reservoirs\/\"},{\"id\":412,\"player\":\"Terumo Blood and Cell Technologies\",\"device\":\"Spectra Optia Apheresis Tubing Sets\",\"sku\":\"Therapeutic apheresis disposable tubing sets\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":4,\"bench\":0,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/www.terumobct.com\/en\/gl\/products-services\/therapeutic-apheresis\/therapeutic-apheresis-products--indications--and-protocols\/spectra-optia-apheresis-system.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/CDRH510K\/K132429.pdf | https:\/\/www.terumobct.com\/en\/gl\/products-services\/therapeutic-apheresis\/therapeutic-apheresis-products--indications--and-protocols\/spectra-optia-apheresis-system.html | https:\/\/www.terumobct.com\/content\/dam\/terumo-bct\/local-documents\/learning\/1000036875A-web-ENUS_rls8-15-24.pdf\"},{\"id\":453,\"player\":\"Aurorium\",\"device\":\"PC Technology Hemocompatible Surface Technology\",\"sku\":\"PC Technology platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC Technology\",\"supplier\":\"Aurorium\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":3,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"PC biomimetic surface positioned as multi-functional blood-contacting device surface.\",\"partnership\":\"Public device partners not captured in Cycle 2F source set.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.aurorium.com\/industry-solutions\/healthcare\/medical-devices\/hemocompatible-surface-technology | https:\/\/med-techinsights.com\/2022\/09\/14\/how-is-pc-technology-different-to-other-hemocompatible-coatings\/ | https:\/\/patents.google.com\/patent\/US9468706B2\/en | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":448,\"player\":\"Biocoat\",\"device\":\"HYDAK Hydrophilic Coating Technology\",\"sku\":\"Thermal-cure HYDAK\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"HYDAK\",\"supplier\":\"Biocoat\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Dip-coating\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"HYDAK emphasizes lubricity\/durability\/particulate balance with UV and thermal process choices.\",\"partnership\":\"Biocoat reports HYDAK UV used on two FDA-cleared devices; specific customers not public in available sources.\",\"link\":\"https:\/\/biocoat.com\/hydak\/\",\"evidenceChain\":\"https:\/\/biocoat.com\/hydak\/ | https:\/\/biocoat.com\/metals\/ | https:\/\/www.prnewswire.com\/news-releases\/biocoat-inc-introduces-innovative-uv-curable-hydrophilic-coating-for-medical-devices-300999246.html | https:\/\/patents.google.com\/patent\/US20110200828A1\/en\"},{\"id\":449,\"player\":\"Biocoat\",\"device\":\"HYDAK UV\",\"sku\":\"UV-cure HYDAK\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"HYDAK UV\",\"supplier\":\"Biocoat\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Photochemical immobilization\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"UV-cure process expands manufacturing integration and supports high-volume catheter coating.\",\"partnership\":\"Two FDA-cleared device customers reported but not named.\",\"link\":\"https:\/\/biocoat.com\/hydak\/\",\"evidenceChain\":\"https:\/\/www.prnewswire.com\/news-releases\/biocoat-inc-introduces-innovative-uv-curable-hydrophilic-coating-for-medical-devices-300999246.html | https:\/\/www.mddionline.com\/manufacturing\/biocoat-takes-bold-steps-in-coating-market-with-hydak-uv-technology | https:\/\/www.biospace.com\/biocoat-incorporated-hydak-uv-now-in-use-on-two-unique-fda-510-k-cleared-devices | https:\/\/biocoat.com\/hydak\/\"},{\"id\":226,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":219,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":227,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":223,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":218,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":225,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":224,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":220,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":221,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":222,\"player\":\"Eurosets\",\"device\":\"PC coating platform\",\"sku\":\"PC \/ Phosphorylcholine application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PC \/ Phosphorylcholine\",\"supplier\":\"Eurosets\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PC \/ Phosphorylcholine into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/\",\"evidenceChain\":\"https:\/\/www.eurosets.com\/en\/ecls-suite\/ | https:\/\/www.eurosets.com\/en\/product\/ecmo-oxygenators\/ | https:\/\/www.eurosets.com\/wp-content\/uploads\/2026\/02\/ECMO-MM3EOMBE07-Digital-Ordering-Guide.pdf | https:\/\/www.eurosets.com\/wp-content\/uploads\/2025\/05\/Ordering-Guide-ECMO-brochure-REV06.pdf | https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02190-9\"},{\"id\":206,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":199,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":207,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":203,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":198,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":205,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":204,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":200,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":201,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":202,\"player\":\"Getinge\",\"device\":\"BIOLINE Coating\",\"sku\":\"BIOLINE application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"BIOLINE\",\"supplier\":\"Getinge\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands BIOLINE into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf\",\"evidenceChain\":\"https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_set_advanced_brochure-32283-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/cardiohelp_system_-_brochure_int-32076-en.pdf | https:\/\/www.cardiomedic.com.ar\/Brochure\/Brochure%20BIOLINE%20COATING.PDF\"},{\"id\":455,\"player\":\"Hydromer\",\"device\":\"Phosphorylcholine Hemocompatible Coating\",\"sku\":\"PC coating platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Hydromer PC coating\",\"supplier\":\"Hydromer\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Combined PC and heparin coating supplier offering under one OEM service model.\",\"partnership\":\"OEM customers not public.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/hydromer.com\/anti-thrombogenic-coatings\/ | https:\/\/hydromer.com\/heparin-pc-coatings-for-blood-contacting-devices\/?nocache=1 | https:\/\/hydromer.com\/medical-device-coatings\/ | https:\/\/openurl.ebsco.com\/fulltext\/gcd%3A174977377 | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\"},{\"id\":186,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":179,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":187,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":183,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":178,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":185,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":184,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":180,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":181,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":182,\"player\":\"LivaNova\",\"device\":\"PH.I.S.I.O PC coating\",\"sku\":\"PH.I.S.I.O application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PH.I.S.I.O\",\"supplier\":\"LivaNova\",\"agent\":\"None disclosed; phosphorylcholine surface treatment.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands PH.I.S.I.O into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":176,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":169,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":177,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":173,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":168,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":175,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":174,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":170,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":171,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":172,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance\",\"supplier\":\"Medtronic\",\"agent\":\"None disclosed; heparin-free coating.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Balance into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/affinity-fusion-oxygenation-system.html | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":436,\"player\":\"Medtronic\",\"device\":\"Balance Biosurface\",\"sku\":\"Balance platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Balance Biosurface\",\"supplier\":\"BioInteractions Limited licensed to Medtronic per Medtronic source\",\"agent\":\"None disclosed; heparin-free platform\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":3,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Heparin-free alternative surface in CPB for users seeking non-heparin coating strategy.\",\"partnership\":\"Medtronic states technology licensed from BioInteractions Limited, UK.\",\"link\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface.html | https:\/\/www.medtronic.com\/content\/dam\/medtronic-wide\/public\/united-states\/products\/cardiac-vascular\/cardiovascular\/extracorporeal-membrane-oxygenation\/mdt-balance-biosurface.pdf | https:\/\/www.medtronic.com\/it-it\/operatori-sanitari\/products\/cardiovascular\/cardiopulmonary\/balance-biosurface\/indications-safety-warnings.html | https:\/\/academic.oup.com\/icvts\/article\/18\/6\/763\/646023\"},{\"id\":166,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":159,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":167,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":163,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":158,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":165,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":164,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":160,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":161,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":162,\"player\":\"Medtronic\",\"device\":\"Trillium Biosurface\",\"sku\":\"Trillium application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Trillium\",\"supplier\":\"Medtronic\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Trillium into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?id=K183490 | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/affinity-nt-cardiotomy-venous-reservoir.html | https:\/\/www.medtronic.com\/se-sv\/healthcare-professionals\/products\/cardiovascular\/cardiopulmonary\/trillium-biosurface.html | https:\/\/pubmed.ncbi.nlm.nih.gov\/10585155\/\"},{\"id\":465,\"player\":\"MicroVention \/ Terumo Neuro\",\"device\":\"X Technology\",\"sku\":\"FRED X surface treatment\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"X Technology\",\"supplier\":\"MicroVention \/ Terumo Neuro\",\"agent\":\"None disclosed\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":4,\"bench\":3,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Major neurovascular OEM surface modification competitor to Shield\/HPC\/HEAL.\",\"partnership\":\"Internal MicroVention\/Terumo Neuro technology.\",\"link\":\"https:\/\/www.terumoneuro.com\/newsroom\/press-releases\/microvention-announces-first-u-s-patient-treated-with-fred-tm-x-tm-flow\",\"evidenceChain\":\"https:\/\/www.terumoneuro.com\/newsroom\/press-releases\/microvention-announces-first-u-s-patient-treated-with-fred-tm-x-tm-flow | https:\/\/www.terumo.com\/newsrelease\/detail\/20220222\/677 | https:\/\/www.oruen.com\/wp-content\/uploads\/2022\/12\/36-38_Oruen_Vol-8_Issue-2_Digital80.pdf | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12852632\/\"},{\"id\":229,\"player\":\"Nipro\",\"device\":\"E8 Coating\",\"sku\":\"E8 application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"E8\",\"supplier\":\"Nipro\",\"agent\":\"None disclosed; synthetic non-biological hydrophilic copolymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands E8 into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf\",\"evidenceChain\":\"https:\/\/niproinindia.com\/cardiopulmonary\/ | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html | https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf | https:\/\/pdf.medicalexpo.com\/pdf\/nipro\/brizio\/94053-221097.html\"},{\"id\":228,\"player\":\"Nipro\",\"device\":\"E8 Coating\",\"sku\":\"E8 application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"E8\",\"supplier\":\"Nipro\",\"agent\":\"None disclosed; synthetic non-biological hydrophilic copolymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands E8 into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf\",\"evidenceChain\":\"https:\/\/niproinindia.com\/cardiopulmonary\/ | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html | https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf | https:\/\/pdf.medicalexpo.com\/pdf\/nipro\/brizio\/94053-221097.html\"},{\"id\":230,\"player\":\"Nipro\",\"device\":\"E8 Coating\",\"sku\":\"E8 application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"E8\",\"supplier\":\"Nipro\",\"agent\":\"None disclosed; synthetic non-biological hydrophilic copolymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands E8 into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf\",\"evidenceChain\":\"https:\/\/niproinindia.com\/cardiopulmonary\/ | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html | https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf | https:\/\/pdf.medicalexpo.com\/pdf\/nipro\/brizio\/94053-221097.html\"},{\"id\":231,\"player\":\"Nipro\",\"device\":\"E8 Coating\",\"sku\":\"E8 application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"E8\",\"supplier\":\"Nipro\",\"agent\":\"None disclosed; synthetic non-biological hydrophilic copolymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands E8 into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf\",\"evidenceChain\":\"https:\/\/niproinindia.com\/cardiopulmonary\/ | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html | https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf | https:\/\/pdf.medicalexpo.com\/pdf\/nipro\/brizio\/94053-221097.html\"},{\"id\":232,\"player\":\"Nipro\",\"device\":\"E8 Coating\",\"sku\":\"E8 application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"E8\",\"supplier\":\"Nipro\",\"agent\":\"None disclosed; synthetic non-biological hydrophilic copolymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands E8 into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf\",\"evidenceChain\":\"https:\/\/niproinindia.com\/cardiopulmonary\/ | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html | https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/brizio_delux_cat.pdf | https:\/\/pdf.medicalexpo.com\/pdf\/nipro\/brizio\/94053-221097.html\"},{\"id\":445,\"player\":\"Surmodics\",\"device\":\"PhotoLink Surface Modification Technology\",\"sku\":\"PhotoLink platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"PhotoLink\",\"supplier\":\"Surmodics\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Photochemical immobilization\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":3,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"One of the dominant outsourced hydrophilic coating technology platforms for intravascular devices.\",\"partnership\":\"Surmodics is an OEM supplier; device partners usually confidential unless publicly disclosed.\",\"link\":\"https:\/\/www.surmodics.com\/performance-coatings\",\"evidenceChain\":\"https:\/\/www.surmodics.com\/performance-coatings | https:\/\/www.surmodics.com\/preside | https:\/\/surmodics.gcs-web.com\/news-releases\/news-release-details\/surmodics-announces-launch-serener-single-coat-sc-solutions | https:\/\/hen-carnation-jcsf.squarespace.com\/s\/Surmodics-Serene-Hydrophilic-Coatings-Brochure-SRDX-MD-223-A.pdf\"},{\"id\":196,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":189,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":197,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":193,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":188,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":195,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":194,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":190,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":191,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":192,\"player\":\"Terumo\",\"device\":\"Xcoating\",\"sku\":\"Xcoating application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"Xcoating\",\"supplier\":\"Terumo\",\"agent\":\"None disclosed; non-heparin PMEA biopassive polymer.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands Xcoating into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=801&groupId=1 | https:\/\/www.terumo-europe.com\/en\/cardiovascular\/products\/product-types\/perfusion-circuits\/capiox-fx-advance | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/tubing-set\/documents\/x-coating-brochure.pdf | https:\/\/www.terumo-europe.com\/content\/dam\/terumo-dam\/internet-cms\/en-emea\/cv\/capiox-fx\/documents\/capiox-fxfamily-brochure.pdf\"},{\"id\":452,\"player\":\"dsm-firmenich Biomedical\",\"device\":\"VitroStealth Non-Biofouling Coating\",\"sku\":\"VitroStealth platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"VitroStealth\",\"supplier\":\"DSM Biomedical \/ dsm-firmenich\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":4,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"PEG\/nanoparticle non-fouling platform adjacent to hemocompatible sensor and blood-sampling surfaces.\",\"partnership\":null,\"link\":\"https:\/\/cleanroomtechnology.com\/dsm-unveils-vitrostealth-coating-technology-53022\",\"evidenceChain\":\"https:\/\/cleanroomtechnology.com\/dsm-unveils-vitrostealth-coating-technology-53022 | https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/193229681300700223 | https:\/\/www.iscst.com\/wp-content\/uploads\/2015\/05\/2.wyman_.pdf\"},{\"id\":460,\"player\":\"jMedtech\",\"device\":\"jHemo PC Phosphorylcholine Hemocompatible Coating\",\"sku\":\"jHemo PC platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Licensing \/ OEM opportunity\",\"brand\":\"jHemo PC\",\"supplier\":\"jMedtech\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"PC coating from catheter CDMO with high-volume tubing\/coating capabilities.\",\"partnership\":\"Hydromer\/jMedtech strategic context; other partners not public.\",\"link\":\"https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf\",\"evidenceChain\":\"https:\/\/jmedtech.com\/ | https:\/\/jmedtech.com\/heparin-antithrombogenic-coating.html | https:\/\/jmedtech.com\/phosphorylcholine-hemocompatible-coating.html | https:\/\/www.livanova.com\/getcontentasset\/05e60b51-0de6-4c0a-bd48-f99c3ab0f439\/dfc3d011-8f63-43f6-9ed8-4b444333a1d0\/im-7300170-cp-b-inspire-family-brochures-6-8-final-v01.pdf | https:\/\/assets.livanova.com\/media\/com\/documents\/therapeutic%20areas\/cardiopulmonary\/brochures\/livanova_inspire_8_broch_09295-130-b.pdf?ext=.pdf\"},{\"id\":521,\"player\":\"Silq Technologies\",\"device\":\"Zwitterionic surface treatment for implantable medical devices\",\"sku\":\"NuSil silicone-device collaboration \/ implantable devices\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antimicrobial focus\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":\"Silq\",\"supplier\":\"Silq Technologies; NuSil collaboration for silicone devices\",\"agent\":\"None; zwitterionic non-fouling surface\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Announced \/ Not Yet Released\",\"clinical\":2,\"bench\":4,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercial surface-treatment company; blood-contacting use not confirmed as finished device.\",\"geography\":\"United States; OEM\/global potential\",\"claim\":\"Scalable zwitterionic treatment with NuSil collaboration for silicone implant manufacturing.\",\"partnership\":\"2025 collaboration with NuSil Technology LLC \/ Avantor to apply Silq treatment to NuSil silicone medical devices\",\"link\":\"https:\/\/www.silq.tech\/technology\",\"evidenceChain\":\"https:\/\/www.businesswire.com\/news\/home\/20250219365843\/en\/Silq-Technologies-Corp.-and-NuSil-Technology-LLC-Announce-Collaboration-Agreement-to-Drive-Broad-based-Adoption-of-Silqs-Novel-Surface-Treatment-Technology | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9153982\/ | https:\/\/www.silq.tech\/ | https:\/\/www.silq.tech\/technology\"},{\"id\":512,\"player\":\"University of Michigan \/ NOReL ECLS research\",\"device\":\"Immobilized argatroban hemocompatible coating\",\"sku\":\"Extracorporeal life support device surface prototype\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic research group\",\"agent\":\"Argatroban direct thrombin inhibitor\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"United States\",\"claim\":\"Heparin-free direct thrombin inhibitor surface rather than heparin or passive coating.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4957704\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4957704\/ | https:\/\/asaio.org\/conference\/program\/2024\/BIO2.cgi\"},{\"id\":504,\"player\":\"Asahi Kasei Medical\",\"device\":\"APS-HE Dialyzer\",\"sku\":\"APS-HE high-flux \/ HDF-suitable series\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"APS\",\"supplier\":\"Asahi Kasei Medical\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed where available.\",\"geography\":\"Japan \/ international\",\"claim\":\"APS high-flux\/HDF-suitable variant with biocompatible membrane surface positioning.\",\"partnership\":null,\"link\":\"https:\/\/www.asahi-kasei.co.jp\/medical\/en\/dialysis\/product\/apsh\/\",\"evidenceChain\":\"https:\/\/www.asahi-kasei.co.jp\/medical\/en\/dialysis\/product\/apsh\/ | https:\/\/www.asahi-kasei.co.jp\/medical\/en\/dialysis\/product\/aps-series\/feature04.html\"},{\"id\":387,\"player\":\"BD\",\"device\":\"Halo One Thin-Walled Guiding Sheath\",\"sku\":\"Hydrophilic-coated variants\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/eu.bd.com\/events\/lib\/asset\/78.pdf\",\"evidenceChain\":\"https:\/\/eu.bd.com\/events\/lib\/asset\/78.pdf\"},{\"id\":388,\"player\":\"BD\",\"device\":\"UltraScore Scoring Balloon Catheter\",\"sku\":\".014 hydrophilic-coated variants\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/eu.bd.com\/emea-peripheral-interventions\/lib\/asset\/215.pdf\",\"evidenceChain\":\"https:\/\/eu.bd.com\/emea-peripheral-interventions\/lib\/asset\/215.pdf\"},{\"id\":385,\"player\":\"Boston Scientific\",\"device\":\"CHOICE Floppy Guidewire\",\"sku\":\"Hydrophilic-coated polymer sleeve\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.bostonscientific.com\/en-US\/products\/guidewires.html\",\"evidenceChain\":\"https:\/\/www.bostonscientific.com\/en-US\/products\/guidewires.html\"},{\"id\":383,\"player\":\"Boston Scientific\",\"device\":\"NaviPro Hydrophilic Guidewire\",\"sku\":\"NaviPro\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.bostonscientific.com\/en-US\/products\/guidewires\/navipro-guidewire.html\",\"evidenceChain\":\"https:\/\/www.bostonscientific.com\/en-US\/products\/guidewires\/navipro-guidewire.html\"},{\"id\":384,\"player\":\"Boston Scientific\",\"device\":\"Transend Guidewire\",\"sku\":\"ICE hydrophilic coating\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"ICE\",\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.bostonscientific.com\/content\/dam\/bostonscientific\/pi\/portfolio-group\/embolization\/truselect\/microcatheter-guidewire-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.bostonscientific.com\/content\/dam\/bostonscientific\/pi\/portfolio-group\/embolization\/truselect\/microcatheter-guidewire-brochure.pdf\"},{\"id\":488,\"player\":\"Chalice Medical\",\"device\":\"Paragon PMP ECMO Range\",\"sku\":\"Complete ECMO set with coated ParagonPMP oxygenator and optional Rheopak tubing pack\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"Rheopak\",\"supplier\":\"Chalice Medical proprietary\",\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed \/ custom ECMO packs available; verify current regional availability.\",\"geography\":\"United Kingdom \/ international distributor-dependent\",\"claim\":\"UK ECMO circuit option with proprietary Rheopak surface coating.\",\"partnership\":null,\"link\":\"https:\/\/www.visionarymedicare.com\/pdf\/ecmo-brochure.pdf\",\"evidenceChain\":\"https:\/\/www.visionarymedicare.com\/pdf\/ecmo-brochure.pdf | https:\/\/www.chalicemedical.com\/products\/paragon-oxygenators\/\"},{\"id\":379,\"player\":\"Cordis\",\"device\":\"RAIN Sheath Introducer\",\"sku\":\"RAIN Sheath\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/cordis.com\/uploads\/files\/100558351-3-Radial-Portfolio-Brochure-RAIN-Sheath-3.0-Update-12-2021-FINAL.pdf\",\"evidenceChain\":\"https:\/\/cordis.com\/uploads\/files\/100558351-3-Radial-Portfolio-Brochure-RAIN-Sheath-3.0-Update-12-2021-FINAL.pdf\"},{\"id\":378,\"player\":\"Cordis\",\"device\":\"SABER 0.018 PTA Dilatation Catheter\",\"sku\":\"0.018 PTA\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/cordis.com\/apac\/products\/intervene\/endovascular\/pta-balloons\/saber-0-018-pta-dilatation-catheter\",\"evidenceChain\":\"https:\/\/cordis.com\/apac\/products\/intervene\/endovascular\/pta-balloons\/saber-0-018-pta-dilatation-catheter\"},{\"id\":377,\"player\":\"Cordis\",\"device\":\"TEMPO AQUA Hydrophilic Angiographic Catheter\",\"sku\":\"TEMPO AQUA\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/cordis.com\/apac\/products\/diagnose\/endovascular\/tempo-aqua-hydrophilic-coated-angiographic-catheter\",\"evidenceChain\":\"https:\/\/cordis.com\/apac\/products\/diagnose\/endovascular\/tempo-aqua-hydrophilic-coated-angiographic-catheter\"},{\"id\":408,\"player\":\"CytoSorbents\",\"device\":\"DrugSorb-ATR\",\"sku\":\"DrugSorb-ATR investigational cartridge\",\"category\":\"Blood purification \/ filters\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"DrugSorb-ATR\",\"supplier\":\"CytoSorbents\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Regulatory Submission Pending\",\"clinical\":3,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/cytosorbents.com\/regulatory-status\/\",\"evidenceChain\":\"https:\/\/www.prnewswire.com\/news-releases\/cytosorbents-provides-us-fda-and-health-canada-regulatory-update-for-drugsorb-atr-302496461.html | https:\/\/www.stocktitan.net\/sec-filings\/CTSO\/10-k-cytosorbents-corp-files-annual-report-7e126b7f2914.html | https:\/\/www.mdpi.com\/2075-1729\/15\/7\/1065\"},{\"id\":498,\"player\":\"Getinge\",\"device\":\"PLEGIOX Cardioplegia Heat Exchanger\",\"sku\":\"BIO-CHX 30 with SOFTLINE coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE Coating\",\"supplier\":\"Getinge \/ Maquet Cardiopulmonary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":3,\"bench\":5,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Legacy \/ current availability not confirmed.\",\"geography\":\"United States \/ Europe \/ international depending SKU\",\"claim\":\"Getinge\/Maquet SKU-level coated oxygenator\/component variants with BIOLINE or SOFTLINE options.\",\"partnership\":\"Getinge \/ Maquet internal platform\",\"link\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K090555\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K090555\"},{\"id\":477,\"player\":\"JMS Co., Ltd.\",\"device\":\"oxia AC-N\",\"sku\":\"AC-N MPC Legacoat oxygenator\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Standard monitoring\",\"brand\":\"Legacoat\",\"supplier\":\"JMS \/ internal\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed in JMS oxygenator portfolio\",\"geography\":\"Japan; international availability via JMS\",\"claim\":\"Japanese CPB oxygenator using named MPC Legacoat surface.\",\"partnership\":null,\"link\":\"https:\/\/www.jms.cc\/english\/products\/5_1membrane_oxygenator.html\",\"evidenceChain\":\"https:\/\/www.jms.cc\/english\/products\/5_1membrane_oxygenator.html\"},{\"id\":478,\"player\":\"JMS Co., Ltd.\",\"device\":\"oxia IC-N\",\"sku\":\"IC-N MPC Legacoat oxygenator\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Phosphorylcholine \/ MPC\",\"signal\":\"Standard monitoring\",\"brand\":\"Legacoat\",\"supplier\":\"JMS \/ internal\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed in JMS oxygenator portfolio\",\"geography\":\"Japan; international availability via JMS\",\"claim\":\"Japanese CPB oxygenator using named MPC Legacoat surface.\",\"partnership\":null,\"link\":\"https:\/\/www.jms.cc\/english\/products\/5_1membrane_oxygenator.html\",\"evidenceChain\":\"https:\/\/www.jms.cc\/english\/products\/5_1membrane_oxygenator.html\"},{\"id\":410,\"player\":\"Jafron Biomedical\",\"device\":\"HA330 Hemoperfusion Cartridge\",\"sku\":\"HA330 disposable hemoperfusion cartridge\",\"category\":\"Blood purification \/ filters\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"HA330\",\"supplier\":\"Jafron Biomedical\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/www.jafroninternational.com\/xby\/uploadfile\/202412\/dbb6af69a0afb4d.pdf\",\"evidenceChain\":\"https:\/\/www.jafroninternational.com\/xby\/uploadfile\/202412\/dbb6af69a0afb4d.pdf | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10075046\/\"},{\"id\":411,\"player\":\"Jafron Biomedical\",\"device\":\"HA380 Hemoperfusion Cartridge\",\"sku\":\"HA380 disposable hemoperfusion cartridge\",\"category\":\"Blood purification \/ filters\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"HA380\",\"supplier\":\"Jafron Biomedical\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/www.renalpharma.com\/product\/intensyvi-terapija-en\/ha380\/\",\"evidenceChain\":\"https:\/\/www.renalpharma.com\/product\/intensyvi-terapija-en\/ha380\/ | https:\/\/www.mdpi.com\/2306-5354\/12\/4\/400 | https:\/\/www.doh.gov.ae\/-\/media\/Feature\/Research\/Technology-status\/HA330-HA380.ashx\"},{\"id\":350,\"player\":\"Medtronic\",\"device\":\"Mirage Hydrophilic Guidewire\",\"sku\":\"Mirage\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/guidewires\/mirage-hydrophilic-guidewire.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/guidewires\/mirage-hydrophilic-guidewire.html | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\"},{\"id\":349,\"player\":\"Medtronic\",\"device\":\"Rebar Microcatheter\",\"sku\":\"Rebar family\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/catheters\/micro-catheters\/rebar-micro-catheter.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/catheters\/micro-catheters\/rebar-micro-catheter.html | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\"},{\"id\":348,\"player\":\"Medtronic\",\"device\":\"Rist Radial Access Guide Catheter\",\"sku\":\"Hydrophilic distal 25 cm\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/catheters\/radial-access-catheters\/rist-radial-access-guide-catheter.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/catheters\/radial-access-catheters\/rist-radial-access-guide-catheter.html | https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/neurological\/access-delivery-nv.html\"},{\"id\":405,\"player\":\"Nikkiso Medical\",\"device\":\"PEPA \/ FDX-Series Dialyzer\",\"sku\":\"PEPA membrane FDX-Series\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"PEPA\",\"supplier\":\"Nikkiso Medical\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":2,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/nikkisomedical.com\/wp-content\/uploads\/2017\/06\/pepa_EN_ausgabe2016-04_vers4pkt3.pdf\",\"evidenceChain\":\"https:\/\/nikkisomedical.com\/wp-content\/uploads\/2017\/06\/pepa_EN_ausgabe2016-04_vers4pkt3.pdf | https:\/\/nikkisomedical.eu\/en\/products\"},{\"id\":486,\"player\":\"Nipro\",\"device\":\"BIOCUBE Oxygenator\",\"sku\":\"BIOCUBE C 2800P with TNC coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"TNC coating\",\"supplier\":\"Nipro internal\",\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where available; verify local availability.\",\"geography\":\"Japan \/ international\",\"claim\":\"Nipro BIOCUBE TNC-coated oxygenator variant, distinct from BRIZIO E8 and VITAL\/THYMUS families.\",\"partnership\":null,\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/biocube.pdf\",\"evidenceChain\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/biocube.pdf | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html\"},{\"id\":485,\"player\":\"Nipro\",\"device\":\"BIOCUBE Oxygenator\",\"sku\":\"BIOCUBE C 4500P with TNC coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"TNC coating\",\"supplier\":\"Nipro internal\",\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where available; verify local availability.\",\"geography\":\"Japan \/ international\",\"claim\":\"Nipro BIOCUBE TNC-coated oxygenator variant, distinct from BRIZIO E8 and VITAL\/THYMUS families.\",\"partnership\":null,\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/biocube.pdf\",\"evidenceChain\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/biocube.pdf | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html\"},{\"id\":484,\"player\":\"Nipro\",\"device\":\"BIOCUBE Oxygenator\",\"sku\":\"BIOCUBE C 6000P with TNC coating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"TNC coating\",\"supplier\":\"Nipro internal\",\"agent\":\"None disclosed\",\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where available; verify local availability.\",\"geography\":\"Japan \/ international\",\"claim\":\"Nipro BIOCUBE TNC-coated oxygenator variant, distinct from BRIZIO E8 and VITAL\/THYMUS families.\",\"partnership\":null,\"link\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/biocube.pdf\",\"evidenceChain\":\"https:\/\/www.nipro.co.jp\/en\/assets\/document\/business\/biocube.pdf | https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html\"},{\"id\":368,\"player\":\"Route 92 Medical\",\"device\":\"FreeClimb Catheter System\",\"sku\":\"FreeClimb 88\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.route92medical.com\/route-92-medical-announces-commercial-launch-of-freeclimb-88-catheter-system\/\",\"evidenceChain\":\"https:\/\/www.route92medical.com\/route-92-medical-announces-commercial-launch-of-freeclimb-88-catheter-system\/\"},{\"id\":367,\"player\":\"Route 92 Medical\",\"device\":\"FreeClimb Reperfusion System\",\"sku\":\"FreeClimb 70\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"US FDA approved \/ cleared\",\"regLabel\":\"FDA Cleared (510k)\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K223530\",\"evidenceChain\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K223530\"},{\"id\":480,\"player\":\"Senko Medical Instrument Mfg. \/ MERA\",\"device\":\"MERA NHP Exelung TPC\",\"sku\":\"HPO-23H-CP double-coated oxygenator\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Standard monitoring\",\"brand\":\"NHP double coating\",\"supplier\":\"Senko Medical \/ MERA internal\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed where available\",\"geography\":\"Japan \/ international distributor-dependent\",\"claim\":\"Japanese MERA oxygenator\/reservoir family with silicone\/heparin or silicone legacy hemocompatibility surface.\",\"partnership\":null,\"link\":\"https:\/\/www.mera.co.jp\/en\/medical\/product-info\/category\/artificial-heart-lung\/artificial-lungs-and-blood-reservoirs\/\",\"evidenceChain\":\"https:\/\/www.mera.co.jp\/en\/medical\/product-info\/category\/artificial-heart-lung\/artificial-lungs-and-blood-reservoirs\/\"},{\"id\":479,\"player\":\"Senko Medical Instrument Mfg. \/ MERA\",\"device\":\"MERA NHP Exelung TPC\",\"sku\":\"HPO-23RHF-CP double-coated oxygenator\/reservoir\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Standard monitoring\",\"brand\":\"NHP double coating\",\"supplier\":\"Senko Medical \/ MERA internal\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed where available\",\"geography\":\"Japan \/ international distributor-dependent\",\"claim\":\"Japanese MERA oxygenator\/reservoir family with silicone\/heparin or silicone legacy hemocompatibility surface.\",\"partnership\":null,\"link\":\"https:\/\/www.mera.co.jp\/en\/medical\/product-info\/category\/artificial-heart-lung\/artificial-lungs-and-blood-reservoirs\/\",\"evidenceChain\":\"https:\/\/www.mera.co.jp\/en\/medical\/product-info\/category\/artificial-heart-lung\/artificial-lungs-and-blood-reservoirs\/\"},{\"id\":481,\"player\":\"Senko Medical Instrument Mfg. \/ MERA\",\"device\":\"MERA NHP Venous Reservoir\",\"sku\":\"HVR-4NFP polymer-coated reservoir pairing\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"MERA polymer-coated SEC \/ NHP surface pairing\",\"supplier\":\"Senko Medical \/ MERA internal\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where available\",\"geography\":\"Japan \/ international distributor-dependent\",\"claim\":\"Japanese MERA oxygenator\/reservoir family with silicone\/heparin or silicone legacy hemocompatibility surface.\",\"partnership\":null,\"link\":\"https:\/\/www.mera.co.jp\/en\/medical\/product-info\/category\/artificial-heart-lung\/artificial-lungs-and-blood-reservoirs\/\",\"evidenceChain\":\"https:\/\/www.mera.co.jp\/en\/medical\/product-info\/category\/artificial-heart-lung\/artificial-lungs-and-blood-reservoirs\/\"},{\"id\":342,\"player\":\"Stryker\",\"device\":\"AXS Infinity LS Plus Long Sheath\",\"sku\":\"Hydrophilic distal coating\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.stryker.com\/ro\/en\/neurovascular\/products\/axs-infinity-plus.html\",\"evidenceChain\":\"https:\/\/www.stryker.com\/ro\/en\/neurovascular\/products\/axs-infinity-plus.html | https:\/\/www.stryker.com\/us\/en\/neurovascular\/products\/axs-infinity-ls.html\"},{\"id\":341,\"player\":\"Stryker\",\"device\":\"AXS Offset Delivery Assist Catheter\",\"sku\":\"Distal 80 cm hydrophilic coated\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Manufacturer internal \/ undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially marketed where approved\",\"geography\":\"Varies by country \/ region\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-offset\/resources\/AXS-Offset_DFU_US_Jun17.pdf\",\"evidenceChain\":\"https:\/\/www.stryker.com\/content\/dam\/stryker\/neurovascular\/products\/axs-offset\/resources\/AXS-Offset_DFU_US_Jun17.pdf\"},{\"id\":404,\"player\":\"Toray Medical\",\"device\":\"Filtryzer NF-H\",\"sku\":\"PMMA NF-H high flux hemodialyzer\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"PMMA Filtryzer NF-H\",\"supplier\":\"Toray Medical\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":3,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed unless regulatory status states investigational\/discontinued\",\"geography\":\"Varies by geography; verify model-specific availability\",\"claim\":\"Blood-treatment device with coating\/material\/surface technology relevant to clotting, adsorption, or hemocompatibility.\",\"partnership\":null,\"link\":\"https:\/\/www.toray-medical.com\/en\/products\/dialysis\/dia_0030.html\",\"evidenceChain\":\"https:\/\/www.toray-medical.com\/en\/products\/dialysis\/dia_0030.html | https:\/\/www.estor.it\/en\/therapareas\/pmma-filtryzer\/\"},{\"id\":442,\"player\":\"BioInteractions Ltd\",\"device\":\"AstutePlus Advanced Antithrombogenic\",\"sku\":\"AstutePlus \/ Astute platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Standard monitoring\",\"brand\":\"AstutePlus \/ Astute\",\"supplier\":\"BioInteractions Ltd\",\"agent\":\"Heparin functional groups claimed in secondary source; exact formulation not public\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":2,\"bench\":3,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Heparin-containing\/functionalized but non-leaching long-term implant coating distinct from lubricity-only coatings.\",\"partnership\":\"Medtronic Balance is separately stated by Medtronic to be licensed from BioInteractions, but AstutePlus device partners not fully public.\",\"link\":\"https:\/\/biointeractions.com\/products\/astute\/\",\"evidenceChain\":\"https:\/\/biointeractions.com\/products\/astute\/ | https:\/\/biointeractions.com\/wp-content\/uploads\/2023\/02\/BioInteractions%20-%20Astute.pdf | https:\/\/medical-technology.nridigital.com\/medical_technology_jun19\/biointeractions\"},{\"id\":216,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - Blood Purification \/ Filter\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into Blood Purification \/ Filter use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":209,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - Cardiopulmonary Bypass\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into Cardiopulmonary Bypass use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":217,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - Combination Antimicrobial-Antithrombogenic\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into Combination Antimicrobial-Antithrombogenic use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":213,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - Coronary \/ Peripheral Intervention\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into Coronary \/ Peripheral Intervention use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":208,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - ECMO \/ ECLS\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into ECMO \/ ECLS use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":215,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - Guidewire \/ Catheter \/ Sheath\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into Guidewire \/ Catheter \/ Sheath use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":214,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - Hemodialysis \/ CRRT \/ Apheresis\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into Hemodialysis \/ CRRT \/ Apheresis use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":210,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - Neurovascular\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into Neurovascular use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":211,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - Vascular Access\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into Vascular Access use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":212,\"player\":\"Getinge\",\"device\":\"SOFTLINE Coating\",\"sku\":\"SOFTLINE application pairing - Vascular Graft \/ Endograft\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":\"SOFTLINE\",\"supplier\":\"Getinge\",\"agent\":\"None disclosed; marketed as a heparin-free HIT-susceptible patient option.\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercial OEM platform or commercial internal coating where cited.\",\"geography\":\"Global OEM availability; final device geography varies.\",\"claim\":\"Platform pairing expands SOFTLINE into Vascular Graft \/ Endograft use cases while preserving claim separation.\",\"partnership\":\"OEM\/customer relationships often confidential unless public in finished device evidence.\",\"link\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/int\/products\/hls-set-advanced\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/mcp-dms-_2014678-v6-ifu__hls_set_advanced__g-660__us-102001-en.pdf | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/hls_cannulae_brochure-32284-en.pdf\"},{\"id\":456,\"player\":\"Hydromer\",\"device\":\"Hydrophilic Medical Device Coatings\",\"sku\":\"UV-curable hydrophilic platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Hydromer hydrophilic coating\",\"supplier\":\"Hydromer\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Photochemical immobilization\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Broad hydrophilic coating services plus equipment\/supplier model.\",\"partnership\":\"Hydromer reported strategic investment by jMedtech to build global coating platform.\",\"link\":\"https:\/\/hydromer.com\/medical-device-coatings\/\",\"evidenceChain\":\"https:\/\/hydromer.com\/medical-device-coatings\/ | https:\/\/hydromer.com\/hydromer-reports-strategic-investment-by-jmedtech\/ | https:\/\/hydromer.com\/can-hydrophilic-coatings-reduce-issues-in-medical-procedures\/\"},{\"id\":447,\"player\":\"Surmodics\",\"device\":\"Preside Hydrophilic Coatings\",\"sku\":\"Preside platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Preside\",\"supplier\":\"Surmodics\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Photochemical immobilization\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":3,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Next-generation hydrophilic option for demanding neurovascular and CTO\/peripheral applications.\",\"partnership\":\"OEM partners not disclosed in supplier sources.\",\"link\":\"https:\/\/www.surmodics.com\/preside\",\"evidenceChain\":\"https:\/\/www.surmodics.com\/performance-coatings | https:\/\/www.surmodics.com\/preside | https:\/\/surmodics.gcs-web.com\/news-releases\/news-release-details\/surmodics-announces-launch-serener-single-coat-sc-solutions | https:\/\/hen-carnation-jcsf.squarespace.com\/s\/Surmodics-Serene-Hydrophilic-Coatings-Brochure-SRDX-MD-223-A.pdf\"},{\"id\":446,\"player\":\"Surmodics\",\"device\":\"Serene Hydrophilic Coatings\",\"sku\":\"Serene SC \/ CX family\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Serene\",\"supplier\":\"Surmodics\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Photochemical immobilization\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":3,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Established hydrophilic coating platform with process integration advantages.\",\"partnership\":\"OEM relationships typically confidential.\",\"link\":\"https:\/\/surmodics.gcs-web.com\/news-releases\/news-release-details\/surmodics-announces-launch-serener-single-coat-sc-solutions\",\"evidenceChain\":\"https:\/\/www.surmodics.com\/performance-coatings | https:\/\/www.surmodics.com\/preside | https:\/\/surmodics.gcs-web.com\/news-releases\/news-release-details\/surmodics-announces-launch-serener-single-coat-sc-solutions | https:\/\/hen-carnation-jcsf.squarespace.com\/s\/Surmodics-Serene-Hydrophilic-Coatings-Brochure-SRDX-MD-223-A.pdf\"},{\"id\":451,\"player\":\"dsm-firmenich Biomedical\",\"device\":\"ComfortCoat Dual-Action Vascular\",\"sku\":\"DAV hemocompatibility data summary\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"ComfortCoat DAV\",\"supplier\":\"dsm-firmenich Biomedical\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":3,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Hydrophilic vascular coating with explicit hemocompatibility data positioning beyond lubricity-only performance.\",\"partnership\":\"OEM-specific partners not named.\",\"link\":\"https:\/\/www.dsm-firmenich.com\/content\/dam\/dsm-firmenich\/protected\/biomedical\/english\/ComfortCoat-Technical-Hemocompatibility-Data-Summary_Final-%281%29.pdf\",\"evidenceChain\":\"https:\/\/www.dsm-firmenich.com\/content\/dam\/dsm-firmenich\/protected\/biomedical\/english\/ComfortCoat-Technical-Hemocompatibility-Data-Summary_Final-%281%29.pdf | https:\/\/www.dsm-firmenich.com\/en\/businesses\/health-nutrition-care\/segments\/biomedical\/biomaterials-solutions\/hydrophilic-coatings.html\"},{\"id\":450,\"player\":\"dsm-firmenich Biomedical\",\"device\":\"ComfortCoat Hydrophilic Lubricious Coatings\",\"sku\":\"ComfortCoat platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"ComfortCoat\",\"supplier\":\"dsm-firmenich Biomedical\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Large biomaterials supplier with high-volume hydrophilic coating offering.\",\"partnership\":\"OEM customers not named in public page.\",\"link\":\"https:\/\/www.dsm-firmenich.com\/en\/businesses\/health-nutrition-care\/segments\/biomedical\/biomaterials-solutions\/hydrophilic-coatings.html\",\"evidenceChain\":\"https:\/\/www.dsm-firmenich.com\/en\/businesses\/health-nutrition-care\/segments\/biomedical\/biomaterials-solutions\/hydrophilic-coatings.html | https:\/\/www.dsm.com\/content\/dam\/dsm\/biomedical\/en_us\/documents\/document-comfortcoat-product-sheet.pdf | https:\/\/www.dsm-firmenich.com\/content\/dam\/dsm-firmenich\/protected\/biomedical\/english\/ComfortCoat-Technical-Hemocompatibility-Data-Summary_Final-%281%29.pdf\"},{\"id\":307,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"CPB oxygenator\/reservoir application\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":311,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"CRRT hemofilter membrane application\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":310,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"Dialysis catheter lumen application\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":305,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"ECMO oxygenator hollow fibers application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":306,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"ECMO tubing loop application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":314,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"Neurovascular aspiration catheter distal shaft application\",\"category\":\"Neurovascular\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":313,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"Peripheral stent surface application\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":312,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"Vascular graft lumen application\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":317,\"player\":\"Academic \/ zwitterionic polymer researchers\",\"device\":\"Ultrathin zwitterionic polymer coating\",\"sku\":\"ECMO oxygenator hollow fibers application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic polymer researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Polymer brush grafting\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/ | https:\/\/www.nature.com\/articles\/s41467-022-33081-7\"},{\"id\":422,\"player\":\"Artivion \/ JOTEC\",\"device\":\"E-liac Stent Graft System\",\"sku\":\"Iliac branch device system\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":3,\"bench\":0,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/artivion.com\/product\/e-liac\/\",\"evidenceChain\":\"https:\/\/artivion.com\/product\/e-liac\/\"},{\"id\":425,\"player\":\"Getinge\",\"device\":\"Intergard Silver Vascular Graft\",\"sku\":\"Silver acetate antimicrobial collagen-coated graft\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Standard monitoring\",\"brand\":\"Intergard Silver\",\"supplier\":null,\"agent\":\"NA - antimicrobial silver, not anticoagulant\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Undisclosed\",\"release\":\"Controlled release\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":2,\"bench\":2,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed\",\"geography\":\"Varies by market\",\"claim\":null,\"partnership\":null,\"link\":\"https:\/\/www.getinge.com\/it\/prodotti\/intergard-silver\/\",\"evidenceChain\":\"https:\/\/www.getinge.com\/it\/prodotti\/intergard-silver\/ | https:\/\/www.getinge.com\/dam\/hospital\/documents\/english\/intergard_synergy_vascular_grafts-54099-en.pdf\"},{\"id\":118,\"player\":\"Medtronic\",\"device\":\"APRO Catheter\",\"sku\":\"APRO 55\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":3,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"US \/ EU \/ international varies\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/catheters\/support-catheters\/apro-55-intermediate-catheter.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/aspiration\/apro-70-aspiration-catheter.html | https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/catheters\/support-catheters\/apro-55-intermediate-catheter.html\"},{\"id\":119,\"player\":\"Medtronic\",\"device\":\"APRO Catheter\",\"sku\":\"APRO 70\",\"category\":\"Neurovascular\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Device manufacturer \/ OEM coating supplier undisclosed\",\"agent\":null,\"modality\":\"Undisclosed \/ other\",\"immobilization\":\"Undisclosed\",\"release\":\"Undisclosed\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":3,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"US \/ EU \/ international varies\",\"claim\":\"Large-bore neurovascular catheter with hydrophilic\/trackability surface claims.\",\"partnership\":\"OEM coating supplier not public\",\"link\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/aspiration\/apro-70-aspiration-catheter.html\",\"evidenceChain\":\"https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/aspiration\/apro-70-aspiration-catheter.html | https:\/\/www.medtronic.com\/en-us\/healthcare-professionals\/products\/neurological\/neurovascular\/catheters\/support-catheters\/apro-55-intermediate-catheter.html\"},{\"id\":53,\"player\":\"Nipro\",\"device\":\"THYMUS Oxygenator\",\"sku\":\"Coated\/biocompatible option per regional materials\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":1,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan \/ India \/ international varies\",\"claim\":\"Regional oxygenator competitor with coating claim.\",\"partnership\":null,\"link\":\"https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html\",\"evidenceChain\":\"https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html\"},{\"id\":52,\"player\":\"Nipro\",\"device\":\"VITAL Adult Oxygenator\",\"sku\":\"Coated\/biocompatible option per regional materials\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Undisclosed \/ no active coating\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":null,\"agent\":null,\"modality\":\"Undisclosed \/ other\",\"immobilization\":null,\"release\":null,\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":1,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"Japan \/ India \/ international varies\",\"claim\":\"Regional oxygenator competitor with coating claim.\",\"partnership\":null,\"link\":\"https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html\",\"evidenceChain\":\"https:\/\/www.nipro.co.jp\/en\/business\/device\/cardiopulmonary_oxygenator.html\"},{\"id\":444,\"player\":\"BioInteractions Ltd\",\"device\":\"Assist Hydrophilic Surface Treatment\",\"sku\":\"Assist platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Assist\",\"supplier\":\"BioInteractions Ltd\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Part of BioInteractions Surface-Active Systems portfolio adjacent to AstutePlus\/TridAnt.\",\"partnership\":null,\"link\":\"https:\/\/biointeractions.com\/press-release\/biointeractions-launches-surface-active-systems-a-new-standard-in-long-term-medical-device-performance\/\",\"evidenceChain\":\"https:\/\/biointeractions.com\/press-release\/biointeractions-launches-surface-active-systems-a-new-standard-in-long-term-medical-device-performance\/ | https:\/\/www.medicaldesignbriefs.com\/component\/content\/article\/54338-elevating-antimicrobial-coatings-to-a-new-standard-introducing-surface-active-systems\"},{\"id\":443,\"player\":\"BioInteractions Ltd\",\"device\":\"TridAnt Enhanced Antimicrobial Coating\",\"sku\":\"TridAnt platform\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Antimicrobial agent \/ surface\",\"signal\":\"Standard monitoring\",\"brand\":\"TridAnt\",\"supplier\":\"BioInteractions Ltd\",\"agent\":\"None disclosed in located public TridAnt materials.\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Undisclosed\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Low \u2014 neither disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Non-leaching antimicrobial coating with protein-deposition inhibition positioning.\",\"partnership\":\"Specific device partners not public in source set.\",\"link\":\"https:\/\/www.medica.de\/vis-content\/event-compamed2025\/exh-compamed2025.3040853\/COMPAMED-2025-BioInteractions-Ltd.-Product-compamed2025.3040853-ClU9IQwzQUuSqRx2HhOJlA.pdf\",\"evidenceChain\":\"https:\/\/biointeractions.com\/products\/tridant\/ | https:\/\/medical-technology.nridigital.com\/medical_technology_nov22\/biointeractions_company_insight | https:\/\/www.medica.de\/vis-content\/event-compamed2025\/exh-compamed2025.3040853\/COMPAMED-2025-BioInteractions-Ltd.-Product-compamed2025.3040853-ClU9IQwzQUuSqRx2HhOJlA.pdf | https:\/\/biointeractions.com\/press-release\/biointeractions-launches-surface-active-systems-a-new-standard-in-long-term-medical-device-performance\/\"},{\"id\":458,\"player\":\"Harland Medical Systems\",\"device\":\"Lubricent Hydrophilic Coatings\",\"sku\":\"Lubricent \/ Lubricent Ultra\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Lubricent \/ Lubricent Ultra\",\"supplier\":\"Harland Medical Systems\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Photochemical immobilization\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Integrated coating solutions, equipment and testing ecosystem for OEMs.\",\"partnership\":\"Harland markets to neurology, cardiology and peripheral vascular OEMs; specific device partners not public.\",\"link\":\"https:\/\/harlandmedical.com\/markets\/peripheral-vascular\/\",\"evidenceChain\":\"https:\/\/harlandmedical.com\/the-impact-of-hydrophilic-medical-device-coatings-on-patients-2\/ | https:\/\/harlandmedical.com\/markets\/peripheral-vascular\/ | https:\/\/insights.globalspec.com\/article\/5480\/low-particulate-hydrophilic-coating-for-medical-devices\"},{\"id\":457,\"player\":\"Surface Solutions Group\",\"device\":\"AquaGlide Hydrophilic Coating\",\"sku\":\"AquaGlide family\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"AquaGlide\",\"supplier\":\"Surface Solutions Group\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Dip-coating\",\"release\":\"Surface passivation only\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Contract hydrophilic coating provider with multiple substrate variants.\",\"partnership\":\"OEM customers not public.\",\"link\":\"https:\/\/surfacesolutionsgroup.com\/wp-content\/uploads\/2021\/01\/SSG-Tech-Sheet-AquaGlide.pdf\",\"evidenceChain\":\"https:\/\/surfacesolutionsgroup.com\/applications\/hydrophilic\/ | https:\/\/surfacesolutionsgroup.com\/wp-content\/uploads\/2021\/01\/SSG-Tech-Sheet-AquaGlide.pdf\"},{\"id\":459,\"player\":\"jMedtech\",\"device\":\"Hygea Heparin Antithrombogenic Coating\",\"sku\":\"Hygea platform\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"OEM \/ enabling platform\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Standard monitoring\",\"brand\":\"Hygea\",\"supplier\":\"jMedtech\",\"agent\":\"Heparin\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Photochemical immobilization\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"OEM platform \u2014 device-specific authorization\",\"regLabel\":\"OEM Platform - Device-Specific Authorization Required\",\"clinical\":1,\"bench\":2,\"evidence\":2,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Commercially offered to OEMs\",\"geography\":\"Global \/ varies by supplier\",\"claim\":\"Heparin coating supplier paired with catheter CDMO capabilities.\",\"partnership\":\"Hydromer\/jMedtech strategic investment creates broader coating platform footprint.\",\"link\":\"https:\/\/jmedtech.com\/heparin-antithrombogenic-coating.html\",\"evidenceChain\":\"https:\/\/jmedtech.com\/ | https:\/\/jmedtech.com\/heparin-antithrombogenic-coating.html | https:\/\/jmedtech.com\/phosphorylcholine-hemocompatible-coating.html\"},{\"id\":122,\"player\":\"Cook Medical\",\"device\":\"Flexor Introducer Sheath\",\"sku\":\"Hydrophilic coated\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Hydrophilic coating\",\"supplier\":\"Undisclosed OEM coating supplier\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":1,\"evidence\":1,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"US \/ EU \/ international varies\",\"claim\":\"Included for competitive adjacency and blood-contacting surface\/coating tracking.\",\"partnership\":null,\"link\":\"https:\/\/www.fda.gov\/media\/113951\/download\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/113951\/download\"},{\"id\":125,\"player\":\"Cordis\",\"device\":\"BRITE TIP sheath\",\"sku\":\"Hydrophilic coated variant\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Hydrophilic coating\",\"supplier\":\"Undisclosed OEM coating supplier\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":1,\"evidence\":1,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"US \/ EU \/ international varies\",\"claim\":\"Included for competitive adjacency and blood-contacting surface\/coating tracking.\",\"partnership\":null,\"link\":\"https:\/\/www.fda.gov\/media\/113951\/download\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/113951\/download\"},{\"id\":124,\"player\":\"Merit Medical\",\"device\":\"Prelude IDeal hydrophilic sheath\",\"sku\":\"Hydrophilic coated\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Hydrophilic coating\",\"supplier\":\"Undisclosed OEM coating supplier\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":1,\"evidence\":1,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"US \/ EU \/ international varies\",\"claim\":\"Included for competitive adjacency and blood-contacting surface\/coating tracking.\",\"partnership\":null,\"link\":\"https:\/\/www.fda.gov\/media\/113951\/download\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/113951\/download\"},{\"id\":121,\"player\":\"Terumo\",\"device\":\"Destination Guiding Sheath\",\"sku\":\"6F hydrophilic coated\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Standard monitoring\",\"brand\":\"Hydrophilic coating\",\"supplier\":\"Undisclosed OEM coating supplier\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":1,\"evidence\":1,\"threat\":3,\"threatBand\":\"Medium (3)\",\"transparency\":\"Partial\",\"availability\":\"Commercially available or marketed where cited; verify local availability.\",\"geography\":\"US \/ EU \/ international varies\",\"claim\":\"Included for competitive adjacency and blood-contacting surface\/coating tracking.\",\"partnership\":null,\"link\":\"https:\/\/www.fda.gov\/media\/113951\/download\",\"evidenceChain\":\"https:\/\/www.fda.gov\/media\/113951\/download\"},{\"id\":259,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"CPB oxygenator\/reservoir application\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":263,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"CRRT hemofilter membrane application\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":262,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"Dialysis catheter lumen application\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":257,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"ECMO oxygenator hollow fibers application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":258,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"ECMO tubing loop application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":267,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"Guidewire hydrophilic shaft application\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":260,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"LVAD blood-contacting surface application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":266,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"Neurovascular aspiration catheter distal shaft application\",\"category\":\"Neurovascular\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":265,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"Peripheral stent surface application\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":261,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"RVAD temporary pump\/cannula application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":268,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"Structural heart implant surface application\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":264,\"player\":\"Academic \/ cardiovascular biomaterials\",\"device\":\"NO-generating catalytic stent coating\",\"sku\":\"Vascular graft lumen application\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ cardiovascular biomaterials\",\"agent\":\"Nitric oxide generated from endogenous species\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/\"},{\"id\":247,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"CPB oxygenator\/reservoir application\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":251,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"CRRT hemofilter membrane application\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":250,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"Dialysis catheter lumen application\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":245,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"ECMO oxygenator hollow fibers application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":246,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"ECMO tubing loop application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":255,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"Guidewire hydrophilic shaft application\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":248,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"LVAD blood-contacting surface application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":254,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"Neurovascular aspiration catheter distal shaft application\",\"category\":\"Neurovascular\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":253,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"Peripheral stent surface application\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":249,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"RVAD temporary pump\/cannula application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":256,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"Structural heart implant surface application\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":252,\"player\":\"Academic \/ membrane research\",\"device\":\"Endogenous NO-releasing microgel coating on PMP fibers\",\"sku\":\"Vascular graft lumen application\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ membrane research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.mdpi.com\/2077-0375\/12\/1\/73\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\"},{\"id\":235,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"CPB oxygenator\/reservoir application\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":239,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"CRRT hemofilter membrane application\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":238,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"Dialysis catheter lumen application\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":233,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"ECMO oxygenator hollow fibers application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":234,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"ECMO tubing loop application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":243,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"Guidewire hydrophilic shaft application\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":236,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"LVAD blood-contacting surface application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":242,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"Neurovascular aspiration catheter distal shaft application\",\"category\":\"Neurovascular\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":241,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"Peripheral stent surface application\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":237,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"RVAD temporary pump\/cannula application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":244,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"Structural heart implant surface application\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":240,\"player\":\"Academic \/ multicenter ECMO surface research\",\"device\":\"NO-releasing extracorporeal circuit coating\",\"sku\":\"Vascular graft lumen application\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ multicenter ECMO surface research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8083987\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8779597\/\"},{\"id\":271,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"CPB oxygenator\/reservoir application\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":275,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"CRRT hemofilter membrane application\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":274,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"Dialysis catheter lumen application\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":269,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"ECMO oxygenator hollow fibers application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":270,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"ECMO tubing loop application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":279,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"Guidewire hydrophilic shaft application\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":272,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"LVAD blood-contacting surface application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":278,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"Neurovascular aspiration catheter distal shaft application\",\"category\":\"Neurovascular\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":277,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"Peripheral stent surface application\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":273,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"RVAD temporary pump\/cannula application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":280,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"Structural heart implant surface application\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":276,\"player\":\"Academic \/ vascular graft biomaterials\",\"device\":\"NO-releasing vascular graft surface\",\"sku\":\"Vascular graft lumen application\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ vascular graft biomaterials\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6256321\/ | https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2020.00578\/full\"},{\"id\":517,\"player\":\"Academic endothelial-biomimetic coating researchers\",\"device\":\"Thrombomodulin \/ EPCR endothelial-mimetic coating\",\"sku\":\"TM\/EPCR immobilized biomaterial surface\",\"category\":\"Research \/ emerging technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic research\",\"agent\":\"Thrombomodulin \/ activated protein C pathway cofactor; EPCR\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research only\",\"geography\":\"Academic \/ not commercialized\",\"claim\":\"Endothelial anticoagulant pathway mimic rather than heparin or passive non-fouling surface.\",\"partnership\":null,\"link\":\"https:\/\/oamonitor.ireland.openaire.eu\/national\/search\/publication?pid=10.1016%2Fj.actbio.2011.03.015\",\"evidenceChain\":\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S014296120301161X | https:\/\/oamonitor.ireland.openaire.eu\/national\/search\/publication?pid=10.1016%2Fj.actbio.2011.03.015\"},{\"id\":518,\"player\":\"Case Western Reserve University \/ glycocalyx-mimetic research\",\"device\":\"Dextran-modified poly(vinyl amine) glycocalyx-mimetic coating\",\"sku\":\"Medical-grade polycarbonate surface prototype\",\"category\":\"Research \/ emerging technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic research\",\"agent\":\"None; glycocalyx-mimetic carbohydrate passivation\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Physical adsorption\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research only\",\"geography\":\"United States\",\"claim\":\"Carbohydrate-rich glycocalyx mimic rather than heparin, PC or NO-release surface.\",\"partnership\":null,\"link\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16460796\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16460796\/ | https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0142961206000111\"},{\"id\":508,\"player\":\"Cerulean Scientific \/ Wyss Institute\",\"device\":\"Thin-layer perfluorocarbon \/ SLIPS non-stick medical-device coating\",\"sku\":\"Catheter\/tubing\/implant prototype platform\",\"category\":\"Research \/ emerging technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":\"TLP \/ SLIPS-derived coating\",\"supplier\":\"Cerulean Scientific \/ Wyss Institute\",\"agent\":\"None; lubricant\/passive omniphobic surface\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Pre-commercial \/ translational\",\"geography\":\"United States\",\"claim\":\"Non-drug omniphobic\/liquid-infused anti-thrombotic and anti-biofouling coating with spinout path.\",\"partnership\":\"Wyss Institute technology licensed\/used by Cerulean Scientific\",\"link\":\"https:\/\/wyss.harvard.edu\/technology\/tlp-a-non-stick-coating-for-medical-devices\/\",\"evidenceChain\":\"https:\/\/wyss.harvard.edu\/technology\/tlp-a-non-stick-coating-for-medical-devices\/ | https:\/\/aizenberglab.seas.harvard.edu\/publications\/bioinspired-omniphobic-surface-coating-medical-devices-prevents-thrombosis-and | https:\/\/www.medicaldesignbriefs.com\/component\/content\/article\/20851-medical-device-coating-repels-bacteria\"},{\"id\":526,\"player\":\"Russian vascular scaffold research group\",\"device\":\"Anti-thrombogenic drug coating for biodegradable porous vascular prostheses\",\"sku\":\"Unfractionated heparin + iloprost biodegradable graft coating\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Heparin \/ heparinoids\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic research\",\"agent\":\"Unfractionated heparin; iloprost\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Drug-eluting reservoir\",\"release\":\"Drug eluting\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"Russia \/ academic\",\"claim\":\"Combination anticoagulant + antiplatelet drug coating on biodegradable vascular graft scaffold.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8596239\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8596239\/ | https:\/\/pubmed.ncbi.nlm.nih.gov\/34796013\/\"},{\"id\":283,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"CPB oxygenator\/reservoir application\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":287,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"CRRT hemofilter membrane application\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":286,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"Dialysis catheter lumen application\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":281,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"ECMO oxygenator hollow fibers application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":282,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"ECMO tubing loop application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":291,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"Guidewire hydrophilic shaft application\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":284,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"LVAD blood-contacting surface application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":290,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"Neurovascular aspiration catheter distal shaft application\",\"category\":\"Neurovascular\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":289,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"Peripheral stent surface application\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":285,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"RVAD temporary pump\/cannula application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":292,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"Structural heart implant surface application\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":288,\"player\":\"University of British Columbia \/ Centre for Blood Research\",\"device\":\"Blood-vessel-like antithrombotic coating\",\"sku\":\"Vascular graft lumen application\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of British Columbia \/ Centre for Blood Research\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11961369\/ | https:\/\/www.med.ubc.ca\/news\/blood-vessel-like-coating-could-make-medical-devices-safer-for-patients\/\"},{\"id\":510,\"player\":\"University of Georgia \/ Handa Lab\",\"device\":\"Nitric oxide-releasing vascular catheter coating\",\"sku\":\"NO donor catheter prototype\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"University of Georgia \/ Hitesh Handa lab\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"United States\",\"claim\":\"Endothelium-mimetic NO delivery with combined antimicrobial and antithrombotic intent.\",\"partnership\":null,\"link\":\"https:\/\/research.uga.edu\/research-insights\/prevention-of-catheter-related-infections-via-photoactive-nitric-oxide-delivery-device\/\",\"evidenceChain\":\"https:\/\/research.uga.edu\/research-insights\/prevention-of-catheter-related-infections-via-photoactive-nitric-oxide-delivery-device\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6013312\/ | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7946114\/ | https:\/\/patents.google.com\/patent\/US7811600B2\/en\"},{\"id\":525,\"player\":\"University of Michigan \/ NO-releasing catheter research\",\"device\":\"SNAP-doped Elast-eon E2As NO-releasing catheter\",\"sku\":\"7-day sheep venous catheter prototype\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":\"SNAP\/E2As\",\"supplier\":\"Academic research\",\"agent\":\"Nitric oxide released from SNAP\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"United States\",\"claim\":\"Large-animal catheter evidence with NO donor embedded in clinically relevant catheter elastomer.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4326019\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4326019\/ | https:\/\/patents.google.com\/patent\/WO2014124125A2\/sv\"},{\"id\":295,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"CPB oxygenator\/reservoir application\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":299,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"CRRT hemofilter membrane application\",\"category\":\"Hemodialysis \/ CRRT \/ apheresis\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":298,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"Dialysis catheter lumen application\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":293,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"ECMO oxygenator hollow fibers application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":294,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"ECMO tubing loop application\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":303,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"Guidewire hydrophilic shaft application\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":296,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"LVAD blood-contacting surface application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":302,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"Neurovascular aspiration catheter distal shaft application\",\"category\":\"Neurovascular\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":301,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"Peripheral stent surface application\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":297,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"RVAD temporary pump\/cannula application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":304,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"Structural heart implant surface application\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":300,\"player\":\"Wyss Institute \/ Harvard\",\"device\":\"SLIPS bioinspired blood-repellent coating\",\"sku\":\"Vascular graft lumen application\",\"category\":\"Vascular grafts \/ endografts\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Fluorinated \/ liquid-infused\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Wyss Institute \/ Harvard\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Material intrinsic\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":4,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25306244\/ | https:\/\/wyss.harvard.edu\/news\/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria\/ | https:\/\/www.rsc.org\/images\/loc\/2014\/PDFs\/Papers\/030_0069.pdf\"},{\"id\":469,\"player\":\"Terumo\",\"device\":\"CAPIOX RX Oxygenator\",\"sku\":\"RX05 Baby RX 1CX*RX05REA left-outlet hardshell reservoir with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Standard monitoring\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo proprietary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed \/ legacy family; verify local catalogue availability by geography.\",\"geography\":\"United States and Asia-Pacific product pages; historic Europe\/international brochures\",\"claim\":\"Prior-generation\/alternate CAPIOX RX Xcoating SKU distinct from CAPIOX FX integrated-filter family.\",\"partnership\":null,\"link\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1 | https:\/\/terumo-asiapacific.com\/cvs\/wp-content\/uploads\/sites\/3\/2022\/06\/RX_Family_Brochure_2017.pdf\"},{\"id\":470,\"player\":\"Terumo\",\"device\":\"CAPIOX RX Oxygenator\",\"sku\":\"RX05 Baby RX 1CX*RX05RWA right-outlet hardshell reservoir with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Standard monitoring\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo proprietary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed \/ legacy family; verify local catalogue availability by geography.\",\"geography\":\"United States and Asia-Pacific product pages; historic Europe\/international brochures\",\"claim\":\"Prior-generation\/alternate CAPIOX RX Xcoating SKU distinct from CAPIOX FX integrated-filter family.\",\"partnership\":null,\"link\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1 | https:\/\/terumo-asiapacific.com\/cvs\/wp-content\/uploads\/sites\/3\/2022\/06\/RX_Family_Brochure_2017.pdf\"},{\"id\":471,\"player\":\"Terumo\",\"device\":\"CAPIOX RX Oxygenator\",\"sku\":\"RX15 1CX*RX15E oxygenator with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Standard monitoring\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo proprietary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed \/ legacy family; verify local catalogue availability by geography.\",\"geography\":\"United States and Asia-Pacific product pages; historic Europe\/international brochures\",\"claim\":\"Prior-generation\/alternate CAPIOX RX Xcoating SKU distinct from CAPIOX FX integrated-filter family.\",\"partnership\":null,\"link\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1 | https:\/\/terumo-asiapacific.com\/cvs\/wp-content\/uploads\/sites\/3\/2022\/06\/RX_Family_Brochure_2017.pdf\"},{\"id\":472,\"player\":\"Terumo\",\"device\":\"CAPIOX RX Oxygenator\",\"sku\":\"RX15 3CX*RX15RE30 reservoir 3000 mL with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Standard monitoring\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo proprietary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed \/ legacy family; verify local catalogue availability by geography.\",\"geography\":\"United States and Asia-Pacific product pages; historic Europe\/international brochures\",\"claim\":\"Prior-generation\/alternate CAPIOX RX Xcoating SKU distinct from CAPIOX FX integrated-filter family.\",\"partnership\":null,\"link\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1 | https:\/\/terumo-asiapacific.com\/cvs\/wp-content\/uploads\/sites\/3\/2022\/06\/RX_Family_Brochure_2017.pdf\"},{\"id\":473,\"player\":\"Terumo\",\"device\":\"CAPIOX RX Oxygenator\",\"sku\":\"RX15 3CX*RX15RE40 reservoir 4000 mL with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Standard monitoring\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo proprietary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed \/ legacy family; verify local catalogue availability by geography.\",\"geography\":\"United States and Asia-Pacific product pages; historic Europe\/international brochures\",\"claim\":\"Prior-generation\/alternate CAPIOX RX Xcoating SKU distinct from CAPIOX FX integrated-filter family.\",\"partnership\":null,\"link\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1 | https:\/\/terumo-asiapacific.com\/cvs\/wp-content\/uploads\/sites\/3\/2022\/06\/RX_Family_Brochure_2017.pdf\"},{\"id\":474,\"player\":\"Terumo\",\"device\":\"CAPIOX RX Oxygenator\",\"sku\":\"RX15 3CX*RX15RW30 reservoir 3000 mL right-outlet with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Standard monitoring\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo proprietary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed \/ legacy family; verify local catalogue availability by geography.\",\"geography\":\"United States and Asia-Pacific product pages; historic Europe\/international brochures\",\"claim\":\"Prior-generation\/alternate CAPIOX RX Xcoating SKU distinct from CAPIOX FX integrated-filter family.\",\"partnership\":null,\"link\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1 | https:\/\/terumo-asiapacific.com\/cvs\/wp-content\/uploads\/sites\/3\/2022\/06\/RX_Family_Brochure_2017.pdf\"},{\"id\":475,\"player\":\"Terumo\",\"device\":\"CAPIOX RX Oxygenator\",\"sku\":\"RX15 3CX*RX15RW40 reservoir 4000 mL right-outlet with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Standard monitoring\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo proprietary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed \/ legacy family; verify local catalogue availability by geography.\",\"geography\":\"United States and Asia-Pacific product pages; historic Europe\/international brochures\",\"claim\":\"Prior-generation\/alternate CAPIOX RX Xcoating SKU distinct from CAPIOX FX integrated-filter family.\",\"partnership\":null,\"link\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1 | https:\/\/terumo-asiapacific.com\/cvs\/wp-content\/uploads\/sites\/3\/2022\/06\/RX_Family_Brochure_2017.pdf\"},{\"id\":476,\"player\":\"Terumo\",\"device\":\"CAPIOX RX Oxygenator\",\"sku\":\"RX25 adult oxygenator with Xcoating\",\"category\":\"Cardiopulmonary bypass\",\"market\":\"Commercial \/ regulated\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"PMEA \/ amphiphilic polymer\",\"signal\":\"Standard monitoring\",\"brand\":\"Xcoating \/ X Coating\",\"supplier\":\"Terumo proprietary\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Commercial \u2014 pathway not public\",\"regLabel\":\"Commercial Device - Regulatory Pathway Not Public\",\"clinical\":1,\"bench\":2,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Commercially marketed \/ legacy family; verify local catalogue availability by geography.\",\"geography\":\"United States and Asia-Pacific product pages; historic Europe\/international brochures\",\"claim\":\"Prior-generation\/alternate CAPIOX RX Xcoating SKU distinct from CAPIOX FX integrated-filter family.\",\"partnership\":null,\"link\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1\",\"evidenceChain\":\"https:\/\/www.terumocv.com\/products\/ProductDetail.aspx?country=1&familyID=1&groupId=1 | https:\/\/terumo-asiapacific.com\/cvs\/wp-content\/uploads\/sites\/3\/2022\/06\/RX_Family_Brochure_2017.pdf\"},{\"id\":315,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"Guidewire hydrophilic shaft application\",\"category\":\"Guidewires \/ catheters \/ introducers\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":2,\"bench\":4,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":308,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"LVAD blood-contacting surface application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":309,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"RVAD temporary pump\/cannula application\",\"category\":\"Mechanical circulatory support\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":316,\"player\":\"Academic \/ zwitterionic hydrogel researchers\",\"device\":\"Microgel reinforced zwitterionic hydrogel coating\",\"sku\":\"Structural heart implant surface application\",\"category\":\"Structural heart \/ cardiac implants\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic \/ zwitterionic hydrogel researchers\",\"agent\":null,\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Hydrogel entrapment\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":4,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not commercially available as a finished device in captured evidence.\",\"geography\":\"Research geography \/ global publication\",\"claim\":\"Potential next-generation chemistry beyond conventional heparin\/hydrophilic coatings.\",\"partnership\":\"NA or undisclosed\",\"link\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7\",\"evidenceChain\":\"https:\/\/www.nature.com\/articles\/s41467-022-33081-7 | https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11823456\/\"},{\"id\":528,\"player\":\"Academic NO-textured catheter researchers\",\"device\":\"Dual-function submicron-textured nitric oxide polyurethane catheter\",\"sku\":\"Textured NO PU catheter prototype\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic research\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Surface texturing \/ micro-nano structuring\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"Academic \/ not commercialized\",\"claim\":\"Combines surface topography with NO chemistry in a catheter-specific prototype.\",\"partnership\":null,\"link\":\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S174270612400182X\",\"evidenceChain\":\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S174270612400182X\"},{\"id\":520,\"player\":\"Penn State \/ Siedlecki-Allcock-Xu research group\",\"device\":\"Fluorinated polyphosphazene blood-contact coating\",\"sku\":\"Blood-contacting device material prototype\",\"category\":\"Research \/ emerging technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic research\",\"agent\":\"None; polymer surface chemistry\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Dip-coating\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"United States\",\"claim\":\"Polyphosphazene family potentially adjacent to PzF with newer in vivo biocompatibility data.\",\"partnership\":null,\"link\":\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1742706125005586\",\"evidenceChain\":\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1742706125005586\"},{\"id\":527,\"player\":\"Shandong University \/ zwitterionic brush researchers\",\"device\":\"High-density zwitterionic polymer brush coating\",\"sku\":\"Blood-contacting medical-device surface prototype\",\"category\":\"Research \/ emerging technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Pipeline to monitor\",\"brand\":null,\"supplier\":\"Academic research\",\"agent\":\"None; non-fouling hydration-layer surface\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Polymer brush grafting\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"China \/ academic\",\"claim\":\"Polymer-brush density\/lubricity emphasis for blood-contacting device coatings.\",\"partnership\":null,\"link\":\"https:\/\/faculty.sdu.edu.cn\/liujianing2\/en\/lwcg\/854959\/content\/449382.htm\",\"evidenceChain\":\"https:\/\/www.researchgate.net\/publication\/378540301_High-Density_Zwitterionic_Polymer_Brushes_Exhibit_Robust_Lubrication_Properties_and_High_Antithrombotic_Efficacy_in_Blood-Contacting_Medical_Devices | https:\/\/faculty.sdu.edu.cn\/liujianing2\/en\/lwcg\/854959\/content\/449382.htm | https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2590183423000431\"},{\"id\":509,\"player\":\"Sharklet Technologies\",\"device\":\"Sharklet micropatterned CVC surface\",\"sku\":\"Thermoplastic polyurethane CVC-relevant surface prototype\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Pipeline to monitor\",\"brand\":\"Sharklet\",\"supplier\":\"Sharklet Technologies\",\"agent\":null,\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Surface texturing \/ micro-nano structuring\",\"release\":\"Material intrinsic\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Not confirmed as blood-contacting CVC product; research\/pipeline row.\",\"geography\":\"United States\",\"claim\":\"Drug-free microtopography rather than leachable antithrombotic coating.\",\"partnership\":null,\"link\":\"https:\/\/www.sharklet.com\/category\/publications\/page\/2\/\",\"evidenceChain\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25852825\/ | https:\/\/www.sharklet.com\/category\/publications\/page\/2\/\"},{\"id\":523,\"player\":\"Surmodics\",\"device\":\"Thromboresistant coating patent family\",\"sku\":\"Hydrophilic\/hydrophobic thromboresistant coating for medical devices\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Hydrophilic \/ hydrogel\",\"signal\":\"Pipeline to monitor\",\"brand\":\"Surmodics hemocompatible coating \/ patent-stage thromboresistant coating\",\"supplier\":\"Surmodics\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Announced \/ Not Yet Released\",\"clinical\":0,\"bench\":3,\"evidence\":3,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Surmodics coatings commercial; patent-specific thromboresistant coating not confirmed as launched.\",\"geography\":\"Global OEM\",\"claim\":\"Large established OEM coating supplier with hydrophilic\/drug-delivery\/hemocompatible capabilities and patent activity.\",\"partnership\":\"OEM coating supplier; specific partners often confidential\",\"link\":\"https:\/\/www.surmodics.com\/performance-coatings\",\"evidenceChain\":\"https:\/\/www.surmodics.com\/performance-coatings | https:\/\/www.medicaldevice-network.com\/data-insights\/surmodics-files-patent-for-thromboresistant-coating-for-medical-devices\/\"},{\"id\":515,\"player\":\"Academic CVC biomaterials researchers\",\"device\":\"Zwitterionic block polymer-armored NO-generating CVC coating\",\"sku\":\"Central venous catheter surface prototype\",\"category\":\"Vascular access\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Academic research\",\"agent\":\"Nitric oxide generated locally\",\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Material intrinsic\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":2,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"Academic \/ not commercialized\",\"claim\":\"Dual passive zwitterionic and active NO-generating mechanism.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11290871\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11290871\/\"},{\"id\":507,\"player\":\"Alta Biomed\",\"device\":\"PzF thin-film antithrombotic coating\",\"sku\":\"Vascular and blood-contacting OEM coating service\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"PzF\",\"supplier\":\"Alta Biomed\",\"agent\":\"None disclosed; drug-free polymer coating\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Dip-coating\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":2,\"evidence\":2,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Available as coating service \/ development platform; not a finished regulated anticoagulant device.\",\"geography\":\"United States \/ global OEM potential\",\"claim\":\"Drug-free polyphosphazene thin-film coating for broad blood-contacting device classes.\",\"partnership\":\"Partnership\/co-development opportunities offered to OEMs.\",\"link\":\"https:\/\/www.altabiomed.com\/coating\",\"evidenceChain\":\"https:\/\/www.altabiomed.com\/coating | https:\/\/www.altabiomed.com\/education\/what-is-pzf | https:\/\/www.altabiomed.com\/ | https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1742706125005586\"},{\"id\":522,\"player\":\"Bactiguard\",\"device\":\"Noble-metal coating thrombo-inflammatory stent study\",\"sku\":\"Experimental coated stent surface\",\"category\":\"Combined antimicrobial\u2013antithrombogenic\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Dual antimicrobial + antithrombotic\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"Bactiguard coating\",\"supplier\":\"Bactiguard\",\"agent\":\"None disclosed; metal surface\",\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Material intrinsic\",\"release\":\"Material intrinsic\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":2,\"evidence\":2,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Antimicrobial coating platform commercial in some devices; antithrombotic stent use remains research\/pipeline.\",\"geography\":\"Europe \/ global licensing potential\",\"claim\":\"Antimicrobial noble-metal surface with emerging thrombo-inflammatory evidence.\",\"partnership\":\"Bactiguard coating licensing model; row-specific stent partner not confirmed\",\"link\":\"https:\/\/ir.bactiguard.com\/release\/bactiguards-coating-reduces-thrombo-inflammatory-reactions-and-acute-stent-thrombosis-new-study-published\/\",\"evidenceChain\":\"https:\/\/ir.bactiguard.com\/release\/bactiguards-coating-reduces-thrombo-inflammatory-reactions-and-acute-stent-thrombosis-new-study-published\/\"},{\"id\":506,\"player\":\"LipoCoat BV\",\"device\":\"Bio-inspired lipid-based coating platform\",\"sku\":\"Catheter product pipeline \/ OEM coating service\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Antimicrobial focus\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"LipoCoat\",\"supplier\":\"LipoCoat BV\",\"agent\":\"None disclosed; drug-less\/passive surface\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Undisclosed\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":2,\"evidence\":2,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Startup\/pipeline coating platform; not listed as a standalone finished anticoagulant device.\",\"geography\":\"Netherlands \/ EU; partner-specific availability\",\"claim\":\"Drug-free lipid-bilayer\/cell-membrane-mimetic coating positioned for catheters and implants.\",\"partnership\":null,\"link\":\"https:\/\/www.lipocoat.com\/solution\/the-technology\/\",\"evidenceChain\":\"https:\/\/www.lipocoat.com\/solution\/the-technology\/ | https:\/\/www.lipocoat.com\/solution\/ | https:\/\/cordis.europa.eu\/project\/id\/791547\/it | https:\/\/extremetechchallenge.org\/finalists\/lipocoat\/\"},{\"id\":511,\"player\":\"UCLA \/ University of Michigan\",\"device\":\"Nitric-oxide-generating coating material for implanted devices\",\"sku\":\"Catheter \/ heart valve \/ vascular graft material concept\",\"category\":\"Research \/ emerging technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"UCLA \/ University of Michigan\",\"agent\":\"Endogenous nitric oxide generated locally\",\"modality\":\"Material-intrinsic \/ structural\",\"immobilization\":\"Undisclosed\",\"release\":\"Material intrinsic\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":3,\"evidence\":2,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"Partial\",\"availability\":\"Research \/ preclinical\",\"geography\":\"United States\",\"claim\":\"NO-generating rather than NO-releasing material; aims to mimic natural endothelial NO flux.\",\"partnership\":\"Academic collaboration\",\"link\":\"https:\/\/newsroom.ucla.edu\/releases\/new-coating-material-developed-254869\",\"evidenceChain\":\"https:\/\/newsroom.ucla.edu\/releases\/new-coating-material-developed-254869\"},{\"id\":516,\"player\":\"University of Pennsylvania \/ CD47 vascular biomaterials research\",\"device\":\"CD47-functionalized vascular stent surface\",\"sku\":\"CD47 peptide\/functionalized stent prototype\",\"category\":\"Coronary \/ peripheral intervention\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Protein \/ peptide\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Academic research\",\"agent\":\"CD47-derived bioactive ligand; not an anticoagulant drug\",\"modality\":\"Immobilized bioactive surface\",\"immobilization\":\"Covalent bonding\",\"release\":\"Non-eluting \/ immobilized\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":2,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"United States\",\"claim\":\"Bioactive immune-recognition surface distinct from heparin, PC and passive hydrophilic coatings.\",\"partnership\":null,\"link\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5304342\/\",\"evidenceChain\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5304342\/\"},{\"id\":514,\"player\":\"University of Queensland \/ CSIRO-associated research\",\"device\":\"DOPA-pCB anti-thrombogenic coating\",\"sku\":\"Sheep veno-venous extracorporeal circuit prototype\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Zwitterionic \/ anti-fouling\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"University of Queensland \/ academic research\",\"agent\":\"None; zwitterionic non-fouling surface\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Surface graft polymerization\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":4,\"evidence\":2,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ preclinical\",\"geography\":\"Australia\",\"claim\":\"Catechol-anchored zwitterionic pCB surface with large-animal extracorporeal validation.\",\"partnership\":null,\"link\":\"https:\/\/espace.library.uq.edu.au\/view\/UQ%3Ad9b2c6b\/UQd9b2c6b_OA.pdf\",\"evidenceChain\":\"https:\/\/espace.library.uq.edu.au\/view\/UQ%3Ad9b2c6b\/UQd9b2c6b_OA.pdf\"},{\"id\":519,\"player\":\"FlexiCoat \/ patent applicants\",\"device\":\"FlexiCoat blood-interface material\",\"sku\":\"PTFE biointerface plasma-polymerized coating patent family\",\"category\":\"Coating platforms \/ OEM technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Corporate \/ commercial\",\"function\":\"Passive \/ function undisclosed\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":\"FlexiCoat\",\"supplier\":\"Patent applicants; commercial sponsor not confirmed\",\"agent\":\"None disclosed\",\"modality\":\"Passive biomimetic \/ anti-fouling\",\"immobilization\":\"Plasma polymerization\",\"release\":\"Surface passivation only\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":1,\"evidence\":1,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Patent-stage \/ not commercially confirmed\",\"geography\":\"Patent publication\",\"claim\":\"Plasma-polymerized PTFE biointerface modification for blood-contact materials.\",\"partnership\":null,\"link\":\"https:\/\/patents.google.com\/patent\/EP4460344A2\/en\",\"evidenceChain\":\"https:\/\/patents.google.com\/patent\/EP4460344A2\/en\"},{\"id\":513,\"player\":\"University of Michigan \/ NOReL ECLS research\",\"device\":\"Bivalirudin direct-thrombin-inhibitor polymer coating\",\"sku\":\"ECLS\/ECC polymer surface prototype\",\"category\":\"ECMO \/ ECLS\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Other disclosed chemistry\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Academic research group\",\"agent\":\"Bivalirudin\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Pilot \/ Research Use Only\",\"clinical\":0,\"bench\":2,\"evidence\":1,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Research \/ conference-stage\",\"geography\":\"United States\",\"claim\":\"Bivalirudin surface as heparin alternative for HIT-sensitive ECLS use cases.\",\"partnership\":null,\"link\":\"https:\/\/asaio.org\/conference\/program\/2024\/BIO2.cgi\",\"evidenceChain\":\"https:\/\/asaio.org\/conference\/program\/2024\/BIO2.cgi\"},{\"id\":524,\"player\":\"Virginia Commonwealth University\",\"device\":\"Nitric oxide-releasing devices\",\"sku\":\"NO-releasing coating \/ impregnation technology\",\"category\":\"Research \/ emerging technologies\",\"market\":\"Emerging \/ pre-regulatory\",\"playerType\":\"Academic \/ research\",\"function\":\"Antithrombotic \/ hemocompatible\",\"chemistry\":\"Nitric oxide\",\"signal\":\"Standard monitoring\",\"brand\":null,\"supplier\":\"Virginia Commonwealth University\",\"agent\":\"Nitric oxide\",\"modality\":\"Active release \/ elution\",\"immobilization\":\"Polymer matrix controlled release\",\"release\":\"Controlled release\",\"regulatory\":\"Pre-commercial \/ research\",\"regLabel\":\"Prototype \/ Pre-commercial\",\"clinical\":0,\"bench\":1,\"evidence\":1,\"threat\":2,\"threatBand\":\"Low (1\u20132)\",\"transparency\":\"High \u2014 chemistry + immobilization disclosed\",\"availability\":\"Pre-commercial licensing opportunity\",\"geography\":\"United States\",\"claim\":\"University tech-transfer NO device platform with both coating and impregnation approaches.\",\"partnership\":\"Available for licensing via VCU TechTransfer\",\"link\":\"https:\/\/techtransfer.research.vcu.edu\/technologies\/engineering\/nitric-oxide-releasing-devices.html\",\"evidenceChain\":\"https:\/\/techtransfer.research.vcu.edu\/technologies\/engineering\/nitric-oxide-releasing-devices.html\"}];\nconst FIELDS={market:\"fMarket\",category:\"fCategory\",chemistry:\"fChemistry\",function:\"fFunction\",regulatory:\"fRegulatory\",player:\"fPlayer\"};\nlet state={market:\"\",category:\"\",chemistry:\"\",function:\"\",regulatory:\"\",player:\"\",search:\"\"};\n\nconst esc=s=>String(s??\"\").replace(\/[&<>\"']\/g,m=>({\"&\":\"&amp;\",\"<\":\"&lt;\",\">\":\"&gt;\",'\"':\"&quot;\",\"'\":\"&#039;\"}[m]));\nconst uniq=a=>[...new Set(a.filter(v=>v!==null&&v!==undefined&&String(v).trim()!==\"\"))].sort((a,b)=>String(a).localeCompare(String(b)));\nconst countBy=(rows,key)=>rows.reduce((o,r)=>{let v=r[key]||\"Not disclosed\";o[v]=(o[v]||0)+1;return o},{});\nconst avg=(rows,key)=>{let a=rows.map(r=>Number(r[key])).filter(Number.isFinite);return a.length?a.reduce((s,v)=>s+v,0)\/a.length:0};\nconst pct=(n,d)=>d?Math.round(n\/d*100):0;\nconst short=(s,n=34)=>{s=String(s??\"\");return s.length>n?s.slice(0,n-1)+\"\u2026\":s};\nconst topEntries=(obj,n=8)=>Object.entries(obj).sort((a,b)=>b[1]-a[1]).slice(0,n);\n\nfunction fillSelect(key,id){\n const el=document.getElementById(id); el.innerHTML='<option value=\"\">All<\/option>'+\n   uniq(DATA.map(r=>r[key])).map(v=>`<option value=\"${esc(v)}\">${esc(v)}<\/option>`).join(\"\");\n el.addEventListener(\"change\",()=>{state[key]=el.value;render()});\n}\nObject.entries(FIELDS).forEach(([k,id])=>fillSelect(k,id));\ndocument.getElementById(\"searchBox\").addEventListener(\"input\",e=>{state.search=e.target.value.toLowerCase();renderTable(filtered())});\nfunction reset(){\n Object.keys(FIELDS).forEach(k=>{state[k]=\"\";document.getElementById(FIELDS[k]).value=\"\"});\n state.search=\"\";document.getElementById(\"searchBox\").value=\"\";render();\n}\ndocument.getElementById(\"resetTop\").onclick=reset;\n\nfunction filtered(){\n return DATA.filter(r=>Object.keys(FIELDS).every(k=>!state[k]||r[k]===state[k]));\n}\nfunction bars(target,entries,gradient=true){\n const max=Math.max(1,...entries.map(x=>x[1]));\n document.getElementById(target).innerHTML=entries.length?entries.map(([label,val])=>`\n <div class=\"bar-row\"><div class=\"bar-label\" title=\"${esc(label)}\">${esc(label)}<\/div>\n <div class=\"bar-track\"><div class=\"bar-fill\" style=\"width:${val\/max*100}%;${gradient?\"\":\"background:linear-gradient(90deg,#65121F,#B51826)\"}\"><\/div><\/div>\n <div class=\"bar-value\">${val}<\/div><\/div>`).join(\"\"):'<div class=\"empty\">No records for this selection.<\/div>';\n}\nfunction scoreClass(v){return v>=4?\"hi\":v>=3?\"mid\":\"lo\"}\n\nfunction renderKpis(rows){\n const devices=uniq(rows.map(r=>r.device)).length,players=uniq(rows.map(r=>r.player)).length;\n const commercial=rows.filter(r=>\/Commercial\/i.test(r.market||\"\")).length;\n const highThreat=rows.filter(r=>Number(r.threat)>=4).length;\n const highEvidence=rows.filter(r=>Number(r.evidence)>=4).length;\n const transparent=rows.filter(r=>\/^High\/i.test(r.transparency||\"\")).length;\n const cards=[\n  [\"Records\",rows.length,\"Current evidence set\",\"rgba(181,24,38,.24)\"],\n  [\"Distinct assets\",devices,\"Devices & technologies\",\"rgba(101,18,31,.20)\"],\n  [\"Players\",players,\"Organizations represented\",\"rgba(22,22,23,.10)\"],\n  [\"Commercial maturity\",pct(commercial,rows.length)+\"%\",\"Commercial \/ regulated\",\"rgba(181,24,38,.18)\"],\n  [\"High threat\",pct(highThreat,rows.length)+\"%\",\"Threat level 4\u20135\",\"rgba(181,24,38,.28)\"],\n  [\"High evidence\",pct(highEvidence,rows.length)+\"%\",\"Evidence quality 4\u20135\",\"rgba(101,18,31,.26)\"]\n ];\n document.getElementById(\"kpis\").innerHTML=cards.map(c=>`<div class=\"card kpi\" style=\"--glow:${c[3]}\"><small>${c[0]}<\/small><strong>${c[1]}<\/strong><span>${c[2]}<\/span><\/div>`).join(\"\");\n}\n\nfunction renderDonut(rows){\n const ev=avg(rows,\"evidence\"),th=avg(rows,\"threat\");\n const commercial=rows.filter(r=>\/Commercial\/i.test(r.market||\"\")).length;\n const deg=Math.max(0,Math.min(360,commercial\/(rows.length||1)*360));\n const grad=`conic-gradient(var(--brand-red) 0 ${deg}deg,rgba(22,22,23,.10) ${deg}deg 360deg)`;\n document.getElementById(\"evidenceDonut\").innerHTML=`<div class=\"donut-wrap\">\n <div class=\"donut\" style=\"background:${grad}\"><div><b>${pct(commercial,rows.length)}%<\/b><span>commercial \/ regulated<\/span><\/div><\/div>\n <div class=\"signal-list\">\n  <div class=\"signal\"><div class=\"rank\">E<\/div><div><b>Evidence quality<\/b><small>Average score across filtered records<\/small><\/div><span class=\"pill\">${ev.toFixed(1)} \/ 5<\/span><\/div>\n  <div class=\"signal\"><div class=\"rank\">T<\/div><div><b>Competitive threat<\/b><small>Average strategic pressure score<\/small><\/div><span class=\"pill\">${th.toFixed(1)} \/ 5<\/span><\/div>\n  <div class=\"signal\"><div class=\"rank\">D<\/div><div><b>High technical disclosure<\/b><small>Chemistry + immobilization disclosed<\/small><\/div><span class=\"pill\">${pct(rows.filter(r=>\/^High\/i.test(r.transparency||\"\")).length,rows.length)}%<\/span><\/div>\n <\/div><\/div>`;\n}\nfunction renderSignals(rows){\n let c=countBy(rows,\"signal\");\n let entries=topEntries(c,6);\n document.getElementById(\"signals\").innerHTML=entries.length?entries.map(([label,val],i)=>`\n <div class=\"signal\"><div class=\"rank\">${i+1}<\/div><div><b>${esc(label)}<\/b><small>${val} records in current selection<\/small><\/div><span class=\"pill\">${pct(val,rows.length)}%<\/span><\/div>`).join(\"\"):'<div class=\"empty\">No strategic signals found.<\/div>';\n}\nfunction renderMatrix(rows){\n const cats=topEntries(countBy(rows,\"category\"),6).map(x=>x[0]);\n const chems=topEntries(countBy(rows,\"chemistry\"),6).map(x=>x[0]);\n let max=1; const vals={};\n cats.forEach(c=>chems.forEach(h=>{let n=rows.filter(r=>r.category===c&&r.chemistry===h).length;vals[c+\"|\"+h]=n;max=Math.max(max,n)}));\n let out=`<div class=\"matrix-row\"><span><\/span>${chems.map(c=>`<span title=\"${esc(c)}\" style=\"font-size:12px;color:rgba(22,22,23,.62);text-align:center\">${esc(short(c,10))}<\/span>`).join(\"\")}<\/div>`;\n cats.forEach(c=>{out+=`<div class=\"matrix-row\"><span title=\"${esc(c)}\">${esc(c)}<\/span>`+chems.map(h=>{let n=vals[c+\"|\"+h],a=.06+.82*n\/max;return `<span class=\"cell\" title=\"${esc(c)} \u00d7 ${esc(h)}: ${n}\" style=\"background:rgba(181,24,38,${a});color:${n\/max>.45?'#FFFFFF':'#161617'}\">${n||\"\"}<\/span>`}).join(\"\")+`<\/div>`});\n document.getElementById(\"matrix\").innerHTML=out||'<div class=\"empty\">Not enough data.<\/div>';\n}\nfunction playerStats(rows){\n let m={};\n rows.forEach(r=>{let p=r.player||\"Unknown\";if(!m[p])m[p]={n:0,th:0,high:0,disc:0,cats:new Set(),chems:new Set()};\n let x=m[p];x.n++;x.th+=Number(r.threat)||0;if(Number(r.threat)>=4)x.high++;if(\/^High\/i.test(r.transparency||\"\"))x.disc++;if(r.category)x.cats.add(r.category);if(r.chemistry)x.chems.add(r.chemistry)});\n return m;\n}\nfunction renderPlayerLists(rows){\n const ps=playerStats(rows);\n const threat=Object.entries(ps).sort((a,b)=>b[1].high-a[1].high||b[1].n-a[1].n).slice(0,6);\n const disc=Object.entries(ps).filter(x=>x[1].n>=2).sort((a,b)=>(b[1].disc\/b[1].n)-(a[1].disc\/a[1].n)||b[1].n-a[1].n).slice(0,6);\n const make=(arr,type)=>arr.map(([p,s],i)=>`<div class=\"signal\"><div class=\"rank\">${i+1}<\/div><div><b>${esc(short(p,28))}<\/b><small>${type===\"threat\"?s.high+\" high-threat records\":s.disc+\" of \"+s.n+\" highly disclosed\"}<\/small><\/div><span class=\"pill\">${type===\"threat\"?s.n:pct(s.disc,s.n)+\"%\"}<\/span><\/div>`).join(\"\");\n document.getElementById(\"threatPlayers\").innerHTML=make(threat,\"threat\")||'<div class=\"empty\">No data.<\/div>';\n document.getElementById(\"disclosurePlayers\").innerHTML=make(disc,\"disc\")||'<div class=\"empty\">No data.<\/div>';\n}\nfunction renderTable(rows){\n const q=state.search;\n let rr=q?rows.filter(r=>Object.values(r).some(v=>String(v??\"\").toLowerCase().includes(q))):rows;\n document.getElementById(\"resultCount\").textContent=`${rr.length} records`;\n document.getElementById(\"tableBody\").innerHTML=rr.slice(0,220).map(r=>`<tr>\n <td><strong>${esc(r.player)}<\/strong><br>${esc(r.device)}${r.sku?`<br><span style=\"color:rgba(22,22,23,.58)\">${esc(short(r.sku,48))}<\/span>`:\"\"}<\/td>\n <td>${esc(r.category)}<\/td><td><span class=\"tag\">${esc(r.market)}<\/span><\/td><td>${esc(r.function)}<\/td>\n <td>${esc(r.chemistry)}${r.agent?`<br><span style=\"color:rgba(22,22,23,.58)\">${esc(short(r.agent,38))}<\/span>`:\"\"}<\/td>\n <td>${esc(r.regulatory)}${r.regLabel?`<br><span style=\"color:rgba(22,22,23,.58)\">${esc(r.regLabel)}<\/span>`:\"\"}<\/td>\n <td class=\"score ${scoreClass(Number(r.evidence)||0)}\">${esc(r.evidence??\"\u2014\")} \/ 5<\/td>\n <td class=\"score ${scoreClass(Number(r.threat)||0)}\">${esc(r.threat??\"\u2014\")} \/ 5<\/td>\n <td>${esc(r.signal||\"\u2014\")}<\/td><td>${esc(short(r.geography||\"\u2014\",42))}<\/td><\/tr>`).join(\"\") || '<tr><td colspan=\"10\" class=\"empty\">No matching records.<\/td><\/tr>';\n}\nfunction render(){\n const rows=filtered();\n renderKpis(rows);\n bars(\"marketChart\",topEntries(countBy(rows,\"market\"),8));\n renderDonut(rows);\n bars(\"chemChart\",topEntries(countBy(rows,\"chemistry\"),10),false);\n renderSignals(rows);renderMatrix(rows);\n bars(\"playerChart\",topEntries(countBy(rows,\"player\"),10));\n renderPlayerLists(rows);renderTable(rows);\n}\ndocument.getElementById(\"heroRecords\").textContent=DATA.length;\ndocument.getElementById(\"heroPlayers\").textContent=uniq(DATA.map(r=>r.player)).length;\ndocument.getElementById(\"heroCategories\").textContent=uniq(DATA.map(r=>r.category)).length;\ndocument.getElementById(\"heroTech\").textContent=uniq(DATA.map(r=>r.chemistry)).length;\nrender();\n<\/script>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Market intelligence dashboard Executive view Technology Competition Data explorer Evidence-led market intelligence Bioactive coating intelligence for better strategic decisions. Explore the competitive and technology landscape of anticoagulant and antimicrobial medical-device coatings through commercial maturity, evidence quality, chemistry disclosure, regulatory positioning, and strategic threat. Open executive viewClear selections 528evidence records 88organizations 14device segments \u2014chemistry families Executive [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_canvas","meta":{"footnotes":""},"class_list":["post-746","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/coati-x.com\/index.php\/wp-json\/wp\/v2\/pages\/746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/coati-x.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/coati-x.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/coati-x.com\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/coati-x.com\/index.php\/wp-json\/wp\/v2\/comments?post=746"}],"version-history":[{"count":23,"href":"https:\/\/coati-x.com\/index.php\/wp-json\/wp\/v2\/pages\/746\/revisions"}],"predecessor-version":[{"id":773,"href":"https:\/\/coati-x.com\/index.php\/wp-json\/wp\/v2\/pages\/746\/revisions\/773"}],"wp:attachment":[{"href":"https:\/\/coati-x.com\/index.php\/wp-json\/wp\/v2\/media?parent=746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}